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SUMMARY
111
1. The aim of this study was to determine the role of the antioxidant enzymes, 
superoxide dismutase and catalase, in the regulation of vascular tone in 
isolated rings of rat aorta.
2. In the first part of the study a comparison was made of the ability of 
superoxide anion to destroy the relaxant activity of basal and acetylcholine 
(ACh)-stimulated NO.
3. Superoxide dismutase (SOD, 1-300 u ml"'^) had no effect on endothelium- 
denuded rings but it produced a concentration-dependent relaxation of 
phenylephrine (PE)-induced tone in endothelium-containing rings which was 
blocked by the NO synthase inhibitor, N^-nitro-L-arginine (L-NOARG, 30 pM). 
In contrast, SOD (50 u mb'!) had no effect on ACh-induced relaxation. These 
results demonstrated a selective potentiation of basal but not ACh-stimulated 
activity of NO by SOD.
4. Superoxide anion generation using hypoxanthine (HX, 0.1 mM)/xanthine 
oxidase (XO, 16 mu mb'!) augmented PE-induced tone in endothelium- 
containing but not endothelium-denuded rings. This was likely to have resulted 
from removal of the tonic vasodilator actions of basally-produced NO by 
superoxide anion, since it was blocked in tissues treated with SOD (250 u mb 
'^ ), N^-mono-methyl-L-arginine (L-NMMA, 30 pM) or L-NOARG (30 pM). 
Pyrogallol (0.1 mM) had a similar action to HX/XO, but produced an additional 
augmentation of tone by an endothelium-independent mechanism which was 
unaffected by SOD (250 u mb'!). In contrast to their ability to almost 
completely destroy basal activity of NO, HX (0.1 mM)/XO (16 mu mb^) and 
pyrogallol (0.1 mM) had no effect on ACh-induced relaxation. Increasing the 
concentration of HX to 1 mM (keeping XO at 16 mu mb'^) or pyrogallol to 0.3 
mM, however, profoundly blocked ACh-induced relaxation and this was 
prevented by treatment with SOD (250 u mb^).
iv
6. In contrast to its ability to completely destroy basal activity of NO, DETCA 
(0.1 mM) produced only a slight blockade of ACh-induced relaxation. 
Furthermore, DETCA potentiated the ability of HX (0.1 mM)/XO (16 mu mb'!) 
or pyrogallol (0.1 mM) to block ACh-induced relaxation and this was prevented 
by pretreatment with SOD (250 u mb'^).
8. In the second part of the study the role of catalase in the relaxation induced 
by sodium azide, hydroxylamine, glyceryl 
investigated in isolated rings of rat aorta.
5. Treatment with diethyldithiocarbamate (DETCA, 0.1 mM, 1h, followed by 
washout) to irreversibly inhibit endogenous Cu-Zn SOD, augmented PE- 
induced tone in endothelium-containing, but not endothelium-denuded rings, 
and abolished the ability of HX (0.1 mM)/XO (16 mu mb'!) and L-NMMA (30 
pM) to augment tone. It was likely that DETCA had led to destruction of basal 
NO by increasing superoxide anion levels since its actions were reversed by 
SOD (10-300 u m|-1).
7. The data suggest that basal activity of NO is more sensitive to inactivation 
by superoxide anion than ACh-stimulated activity and that endogenous Cu-Zn 
SOD is vital for the protection of endothelial NO.
?iv
l trinitrate and hydrogen peroxide was
9. Hydrogen peroxide (100 nM-1 mM) induced concentration-dependent 
relaxation of PE-induced tone in endothelium-containing rings. It also relaxed 
endothelium-denuded rings but higher concentrations (0.1-1 mM) were 
required. The endothelium-dependent component of hydrogen peroxide- 
induced relaxation was abolished with N^-nitro-L-arginine methyl ester (L- 
NAME, 30 pM), and thus was due to enhanced production of NO. In contrast,
:methylene blue (MeB, 30 pM) inhibited both the endothelium-dependent and 
endothelium-independent components of hydrogen peroxide-induced
relaxation, suggesting that both were dependent upon the stimulation of 
soluble guanylate cyclase.
10. Pretreatment of endothelium-denuded rings with 3-amino-1,2,4-triazole
:
(AT, 1-50 mM, 90 min) to inhibit endogenous catalase blocked relaxation
induced by sodium azide (1-300 nM) and hydroxylamine (1-300 nM), but had 
no effect on relaxation induced by hydrogen peroxide (100 nM-1 mM) or 
glyceryl trinitrate (1-100 nM). i
11. In a cell free system, incubation of sodium azide (10 pM-3 mM) or 
hydroxylamine (10 pM-30 mM) but not glyceryl trinitrate (10 pM-1 mM) with 
catalase (1000 u mb'!) in the presence of either hydrogen peroxide (1 mM) or 
the glucose (5 mM)/ glucose oxidase (300 mu mb'1) system led to production 
of nitrite, the major breakdown product of NO. Furthermore, AT (0.1-100 mM) 
inhibited, in a concentration-dependent manner, the catalase-dependent 
formation of nitrite from sodium azide (0.3 mM) in the presence of hydrogen 
peroxide.
12. These data thus suggest that metabolism by catalase plays an important 
role in the relaxation induced by sodium azide and hydroxylamine in isolated 
rings of rat aorta. The relaxation appears to be due to formation of NO and 
activation of soluble guanylate cyclase. In contrast, metabolism by catalase 
does not appear to be involved in the relaxant actions of hydrogen peroxide or 
glyceryl trinitrate.
13. In the final part of the study the damage induced by hydrogen peroxide to 
vascular reactivity and the role of endogenous catalase in protection against 
this damage was assessed in isolated rings of rat aorta.
V I
14. Incubation with hydrogen peroxide at 1 mM, but not at 0.1 mM, for 15, 30 
or 60 min followed by washout depressed, in a time-dependent manner, the 
ability of the tissue to contract to PE (10 nM) and relax to ACh, suggesting 
subsequent impairment of vascular reactivity. Furthermore, incubation with 
hydrogen peroxide at 1 mM (30 min, followed by washout) also inhibited 
relaxation induced by glyceryl trinitrate or isoprenaline.
Î
15. Incubation with AT (50 mM, 90 min) to inhibit endogenous catalase led to a 
profound enhancement of the ability of hydrogen peroxide (1 mM) to depress 
PE (10 nM)-induced contraction and to block relaxation to ACh, glyceryl 
trinitrate or isoprenaline.
16. It is likely therefore that endogenous catalase plays an important role in 
protection of vascular reactivity against oxidant damage induced by high (1 
mM) concentrations of hydrogen peroxide. The data are consistent with 
hydrogen peroxide inducing non-selective damage to the vascular smooth
'.wmuscle, but endothelial damage may also be sustained.
17. In conclusion, the data from this study suggest a vital role for endogenous 
Cu-Zn SOD and catalase in the regulation of normal vascular reactivity in rat 
aorta.
I
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INTRODUCTION
Chapter 1
1.1 The vascular endothelium
1.1.1 Role of the endothelium In the regulation of homeostasis
'Endothelial cells [are] more than a sheat of nucleated cellophane '
Lord Florey, 1966
'
■;k:The original concept of the vascular endothelium as a physical and 
biochemical barrier between the circulating blood and the interstitium, with no 
other functional properties, has changed dramatically over the past three 
decades. In the adult human, the net mass of the endothelium is equivalent to 
approximately 1 % of the body mass and has a surface area of approximately 
5000 m2 (Jaffe, 1984). In certain aspects, the endothelium fulfils the 
definitions of an “organ” and perhaps today, as our knowledge of its biological 
significance develops, it should be considered as such.
it has been widely demonstrated that the endothelium plays an important role 
in both short- and long-term regulation of vascular homeostasis as well as the 
modulation of several physiological functions, such as inflammation, platelet 
aggregation, fibrinolysis, angiogenesis and mechanoreception (Vane et al., 
1990; Marin & Rodriguez-Martinez, 1995).
■
Endothelial cells synthesise and release a great variety of paracrine 
substances. The first endothelium-derived vasoactive substance was 
discovered in 1976, when it was demonstrated that endothelial cells 
synthesise prostacyclin (PGI2), a metabolite of arachidonic acid, in response
to chemical or mechanical stimuli (Moncada et a l, 1976). Another potent 
vasodilator substance produced by the endothelium was originally termed 
“endothelium-derived relaxing factor” (EDRF; Furchgott & Zawadzki, 1980a) 
but is now believed to be nitric oxide (NO; Palmer et a l, 1987). PGI2 and NO 
are both potent anti-aggregating substances (Moncada et al, 1976; Moncada, 
1982; Azuma et al, 1986; Radomski et al., 1987a,b). NO has additionally 
been shown to inhibit adhesion of platelets to endothelial monolayers 
(Sneddon & Vane, 1988) whereas PGI2 has been shown to inhibit adhesion 
only of activated platelets (Fry et al, 1980).
1.2 Endothelium-derived relaxing factor (EDRF)
1.2.1 Requirement for endothelial cells
In 1914, Dale found that intravenous injection of acetylcholine (ACh) at doses 
that had no effect upon the strength of the heart led to transient, but profound 
falls in blood pressure and he attributed this to dilatation of blood vessels 
(Dale, 1914). Similarly, Flunt (1915) demonstrated a fall in blood pressure 
following injection of ACh into the femoral vein of rabbit leg, but in one 
particular experiment he observed an unexpected vasoconstriction when he 
injected ACh into the perfusion cannula in rabbit ear (the outflow fell from 17 to 
2 drops according to the perfusion pressure). Subsequently, Burn and 
Robinson noted a biphasic action (Burn & Robinson, 1951); they 
demonstrated that ACh when injected repeatedly into the circulation of the 
perfused rabbit ear, initially caused dilatation which, over a period of few 
hours, changed into a constriction. In isolated blood vessels, however, there 
seemed to be consensus on the actions of ACh: a review of the literature by 
Furchgott (1955) indicated that all reports showed constriction to ACh. One 
subsequent report (Jellife, 1962), however, using a chain of rabbit aortic rings
i
precontracted with 5-HT, reported that ACh produced relaxation at low 
concentrations and contraction at higher concentrations. Several hypotheses 
were put forward to explain the biphasic activity of ACh, including the ability of 
ACh to release the vasoconstrictor agent, noradrenaline (Jellife, 1962).
1,2.2 Release of EDRF
1.2.2.1 Agonist-stimulated release of EDRF
The paradox regarding the in vivo/in vitro action of ACh was resolved with a 
report in 1980 (Furchgott & Zawadzki, 1980a), demonstrating the obligatory 
role of endothelial cells in relaxation of vascular tissue. For many years, 
workers in Furchgott's laboratory had been using strips of helically cut rabbit 
aorta and had consistently obtained contractions to ACh. However, when they 
began to use aortic rings, they sometimes found that ACh relaxed the 
preparation. In investigating this apparent discrepancy Furchgott's group 
discovered that the loss of relaxation to ACh in the case of helical strips had 
resulted from the unintentional rubbing of the intimai surface during the 
preparation. The strict dependence of the relaxation on endothelial cells was 
confirmed using both scanning electron microscopy and en face microscopy 
after silver staining (Furchgott & Zawadzki, 1980a). They suggested that 
endothelial cells on the intimai surface of the aorta were activated by ACh 
acting on muscarinic receptors, leading to the release of a relaxing substance 
(Furchgott & Zawadzki, 1980b). Furchgott called this relaxing substance 
endothelium-derived relaxing factor (EDRF).
Direct evidence for EDRF release from endothelial cells by ACh was obtained 
in rabbit aortic rings by the use of a so-called “sandwich” mount (Furchgott & 
Zawadzki, 1980a; Furchgott, 1981). In this procedure, an endothelium-
denuded transverse aortic strip (the recipient strip) whose contractile activity 
was recorded was mounted with an endothelium-containing longitudinal strip 
(the donor strip) whose contractile state did not register on the recorder. It was 
demonstrated that following precontraction with phenylephrine (PE), ACh 
acting on the endothelium of the longitudinal strip induced release of a 
substance which relaxed the transverse strip.
Subsequent reports demonstrated that many other substances including ATP, 
substance P, bradykinin, the calcium ionophore A23187, histamine, 5-HT and 
thrombin (Furchgott, 1984; Stork & Cocks, 1994; Drummond & Cocks, 1995) 
in many preparations including arteries, veins and microvessels require the 
presence of endothelium to produce relaxation. Table 1.1 lists some of these 
substances together with the tissues in which they have been shown to act.
1.2.2.2 Flow-induced release of EDRF
Endothelium-dependent relaxation occurs not only in response to a wide 
variety of endothelial agonists, but also to an increase in flow rate. The strict 
dependence of flow-induced dilatation on the endothelium was confirmed 
when its mechanical removal by means of a balloon catheter abolished both 
flow-dependent and local ACh-induced dilatation (Pohl et al., 1986). As the 
blood flow rate in a vessel increases so does the shear force on the 
endothelium. Since blood flow rate depends on the vessel size and shape, the 
shear stress experienced by the endothelial surface varies considerably 
throughout the vasculature. The ability of methylene blue (MeB), an inhibitor of 
soluble guanylate cyclase (Gruetter et al., 1979; Holzmann, 1982), and of 
haemoglobin (Hb, binds and inactivates EDRF, Martin et al., 1985a,b) to 
inhibit flow-dependent vasodilatation in canine femoral arteries (Pohl et al.,
1986) and the perfused rabbit ear (Griffith et al., 1987), suggested that
Stimulus Vessel Species Reference
ACh Femoral artery Rabbit Griffith et a l, 1984
Coronary artery Rabbit Griffith etal., 1984
Femoral vein Dog De Mey & Vanhoutte, 1982
Saphenous vein Dog De Mey & Vanhoutte, 1982
Bradykinin Intrapulmonary
artery
Dog Chand & Altura, 1981
Aorta Pig Gordan & Martin, 1983
Epicardial Human Stork & Cocks, 1994
coronary artery
Substance Epicardial Human Stork & Cocks, 1994
P coronary artery
Coronary artery Dog Cocks & Angus, 1983
ATP Aorta Rabbit Furchgott, 1981
■v
Aorta Pig Gordan & Martin, 1983
Saphenous vein Dog De Mey & Vanhoutte, 1982
Thrombin Femoral artery Dog De Mey & Vanhoutte, 1982
Coronary artery Dog Cohen et al., 1984
Histamine Aorta Rat Van de Voorde & Leusen, 
1983
A23187 Aorta Rabbit Furchgott, 1983
Aorta Rat Rapoport & Murad, 1983
Epicardial Human Stork & Cocks, 1994
coronary artery
Table 1.1 Vasorelaxant agents classified as “endothelium-dependent” and 
some of the tissues in which they have been shown to act.
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flow-dependent dilatation was mediated by release of the same EDRF as was 
released by ACh. In addition, pulsatile flow which increases the shear stress in 
arteries was shown to stimulate the release of EDRF from the endothelium of 
perfused canine arteries (Rubanyi etal., 1986; Rubanyi, 1993).
1.2.2.3 Hypoxia-induced release of EDRF
Endothelium has been shown to play a functional role in vasodilatation of 
isolated arteries at low levels of oxygen. It was demonstrated that endothelial 
cells release vasoactive autacoids such as EDRF and PGI2 in response to 
hypoxia (Pohl & Busse, 1989). Endothelium can, therefore, sense reductions 
in oxygen levels and subsequently instigate a rapid vasodilator response to 
counter such decreases (Busse et al., 1993).
1.2.2.4 Spontaneous release of EDRF
Several lines of evidence suggest that, in addition to release following 
stimulation by agonists or shear stress, there is a continuous basal release of 
EDRF from the endothelium. Cascade bioassay experiments provided direct 
evidence for this spontaneous release of EDRF from endothelial cells. In these 
experiments an endothelium-denuded vessel was used as a bioassay tissue 
for the detection of EDRF released from an endothelium-containing blood 
vessel. Using such cascade systems, basal release of EDRF has been 
detected from various preparations, including rabbit aorta (Griffith et a i, 1984), 
rat aorta (Long & Stone, 1985), and femoral artery of the dog (Rubanyi et al.,
1985). In these experiments, however, the extent to which flow-induced 
release contributed to “basal” activity was not determined.
The most compelling evidence for the basal release of EDRF came from 
experiments conducted in isolated preparations demonstrating the 
endothelium-dependent depression of vasoconstriction i.e. endothelium- 
containing vessels were less sensitive to constrictors than endothelium- 
denuded vessels (Egléme et a i, 1984; Martin et ai., 1986; Mian & Martin, 
1995a). Furthermore, the inhibitors of EDRF, Fib and MeB, were found to 
augment drug-induced tone in endothelium-containing but not in endothelium-
denuded rings (Martin etal., 1985a,b).
■ |V
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Further evidence for basal release of EDRF has come from the measurements 
of cyclic GMP (cGMP) levels. EDRF-induced relaxation was shown to be 
associated with increased levels of cGMP in vascular smooth muscle cells 
(Flolzmann, 1982; Rapoport & Murad, 1983), resulting from activation of
■soluble guanylate cyclase (this will be discussed in detail later). Resting levels 
of cGMP were found to be higher in endothelium-containing than in 
endothelium-denuded preparations of rat aorta (Rapoport & Murad, 1983;
Martin et al., 1986), rabbit aorta (Martin et al., 1985a) and bovine coronary 
artery (Holzmann, 1982). Moreover, in the presence of the inhibitors of EDRF,
Hb and MeB, the resting levels of cGMP were lowered in endothelium- 
containing but not in endothelium-denuded blood vessels (Holzmann, 1982;
Martin et al., 1985a), suggesting that higher levels of cGMP in endothelium- 
containing arteries are produced by the tonic action of basally released EDRF.
Thus, basal release of EDRF exerts a tonic vasodilator influence on the 
vasculature.
1.2.3 Characterisation of EDRF
Early experiments conducted on rabbit aorta in attempts to characterise EDRF 
ruled out the possibility that it was a product of the cyclooxygenase pathway
-.1,
since indomethacin, an inhibitor of cyclooxygenase, had no effect on 
relaxation (Furchgott & Zawadzki, 1980a; Furchgott, 1981). There was 
speculation that EDRF was a product of arachidonic acid metabolism by the 
lipoxygenase pathway. This was based on the findings that inhibitors of 
lipoxygenase, nordihydroguaiaretic acid and 5,8,11,14-eicosatetraynoic acid, 
or phospholipase A2 , quinacrine and p-bromophenacylbromide (Flower, 1974; 
Flower & Blackwell, 1976; Roberts et a/., 1977) were able to inhibit ACh- 
induced relaxation in rabbit aorta (Furchgott & Zawadzki, 1980a) and rat aorta 
(Van de Voorde & Leusen, 1983). Furthermore, arachidonic acid itself was 
shown to relax arteries in an endothelium-dependent manner (Singer & 
Peach, 1983). However, other findings appeared inconsistent with the role for 
lipoxygenase. For example, BW 7550, another inhibitor of lipoxygenase, failed 
to inhibit ACh-induced relaxation of rabbit aorta (Furchgott, 1984). As an 
alternative, it was proposed that EDRF was a cytochrome P450 
monoxygenase product of arachidonic acid (Forstermann & Neufang, 1984). 
However, the inconsistent blockade of endothelium-dependent relaxation 
obtained with the inhibitor of cytochrome P450 , SKF 525A (Rees et a/., 1988) 
questioned this speculation.
The possibility that EDRF was a free radical intermediate produced by the 
oxidation of arachidonic acid (or some other unsaturated fatty acid) also found 
some favour, since various free radical scavengers including hydroquinone 
were shown to inhibit relaxations induced by ACh, A23187 and histamine 
(Furchgott, 1981; Van de Voorde & Leusen, 1983). In contrast, Griffith et al.
(1984) using spin trap reagents and specific oxygen-centred radical 
scavengers proposed that EDRF was not a free radical.
Up until the mid 1980's, there was no clear idea as to the identity of EDRF. 
Following on from the "sandwich" preparation described by Furchgott &
Using such techniques it was established that EDRF was a labile substance 
with a half-life between 4 and 50 seconds, depending on the experimental 
procedure, in oxygenated physiological salt solutions (Griffith et al., 1984; 
Cocks et al., 1985; Rubanyi et al., 1985; Gryglewski et al., 1986a,b).
Zawadzki (1980a), cascade bioassay techniques were used to confirm the 
humoral nature of EDRF. For example, Griffith et al. (1984) and Rubanyi et al.
(1985) perfused the isolated endothelium-intact aorta and passed the effluent 
over endothelium-denuded vascular rings, and thereby demonstrated release 
of a vasodilator factor. Although, this perfused vascular donor/detector system 
allowed the labile characteristics of EDRF to be studied, they provided only 
small amounts of EDRF for chemical analysis and did not provide a separation 
of endothelial cells from the underlying smooth muscle (Griffith et al., 1984; 
Rubanyi et al., 1985). Subsequently, however. Cocks et al. (1985) modified 
the technique and perfused vascular endothelial cells cultured on microcarrier 
beads packed in the barrel of a syringe. This technique allowed the generation 
of greater amounts of EDRF in a relatively small volume and therefore 
facilitated detection by the assay tissue. This technique was improved yet 
further by Gryglewski et al. (1986a) who used the effluent from microcarrier 
cultures of endothelial cells in a modified jacketed chromatographic column to 
superfuse a sequential series of endothelium-denuded detector strips.
Bioassay studies proved valuable since they allowed the study of the effects of 
physical or chemical manipulation on the generation, stability, and action of 
EDRF. Using such techniques, it was found that superoxide anion CO2") 
contributed to the instability of EDRF, since its activity was prolonged by the 
addition of the superoxide anion scavengers, superoxide dismutase (SOD; 
Gryglewski et al., 1986b; Moncada et al., 1986; Rubanyi & Vanhoutte, 
1986a,b) and Cu2+ (Gryglewski et al., 1986b). The activity of EDRF was also
10
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inhibited by Fe2+ (Gryglewski et al., 1986b) and by hyperoxia (Rubanyi & 
Vanhoutte, 1986a), both of which lead to enhanced production of *0 2 ”. 
Furthermore, a number of redox compounds described as inhibitors of EDRF, 
such as pyrogallol and hydroquinone, were shown to act by generating *0 2 " in 
solution (Flutchinson etal., 1987; Palmer ef a/., 1987; Radomski et al., 1987a). 
Indeed. SOD attenuated their inhibitory effects on EDRF (Moncada et al.,
1986). Moreover, another substance capable of removing *0 2 ”, i.e. oxidised 
cytochrome C, was shown to inhibit the actions of these redox compounds on 
EDRF (Moncada et al., 1986). Pyrogallol has been widely used by a number 
of authors to investigate the biological properties of EDRF (Ohistein & Nichols, 
1989; Abrahamsson et al., 1992; Mian & Martin, 1995a). The wide variations 
in the half-life reported for EDRF by different groups, might be explained in 
terms of different concentrations of *0 2 " present. Different experimental 
conditions in different laboratories will result in different oxygen tensions and, 
consequently, different concentrations of intracellular and extracellular *0 2 " 
will be produced.
1.2.4 Mechanism by which EDRF induces relaxation
1.2.4.1 Nitrovasodilators and cGMP
Prior to the discovery of endothelium-dependent relaxation, other workers had 
reported that in certain smooth muscles there was a positive relationship 
between an increase in cGMP and relaxation (Schultz et al., 1979; Murad et 
al., 1979). The mechanisms of humoral regulation of cGMP synthesis and 
possible biochemical or physiological functions of cGMP, however, were not 
known.
n
Initial experiments conducted to characterise the enzyme guanylate cyclase 
which synthesised cGMP from GTP (Kimura & Murad, 1974), revealed that 
there were two isoforms in the smooth muscle; soluble (cytosolic) and 
particulate (membrane-bound). Kimura et al. (1975), while performing 
experiments to define the kinetic properties of the enzyme, accidentally found 
that sodium azide activated preparations of soluble guanylate cyclase. This 
was an exciting turn of events and provided a valuable insight into the 
regulation of the enzyme. In addition to sodium azide, many other 
nitrocompounds including glyceryl trinitrate, isosorbide dinitrate, amyl nitrite, 
sodium nitrite, sodium nitroprusside, nitrosamines, hydroxylamine, and some 
hydrazines were also shown to activate the enzyme and increase cGMP levels 
in preparations from many tissues (Katsuki et al., 1977). Atrial natriuretic 
factors, which also relax vascular smooth muscle, were subsequently shown 
to activate the particulate but not the soluble form of guanylate cyclase 
(Waldman et al., 1984). The finding that 8-bromo cyclic GMP, a membrane 
permeant analogue of cGMP, induced vasorelaxation (Schultz et al., 1979), 
suggested that increases in cGMP levels were closely associated with 
relaxation. Moreover, the ability of a specific inhibitor of cGMP- 
phosphodiesterase, M & B 22948 (zaprinast) to potentiate relaxations by 
activators of soluble and particulate guanylate cyclase, further supported a 
role for cGMP in vascular relaxation (Kukovetz et al., 1979; Martin et al., 
1986a).
It has been suggested that the broad class of guanylate cyclase activators 
mediate their effects by the formation of nitric oxide (NO; Katsuki et al., 1977; 
Arnold et al., 1977, Murad, 1994). Murad coined the term "nitrovasodilator” to 
categorise these compounds (Murad et al., 1978). Thus, it appeared that 
sodium azide, hydroxylamine, glyceryl trinitrate and isosorbide could be 
converted enzymatically or non-enzymatically, depending on the prodrug
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used, to the active intermediate, NO (Katsuki et a/., 1977; Feelisch, 1991; 
Murad, 1994, also see Chapter 2). It has been shown that nitrovasodilators 
such as sodium azide and hydroxylamine are metabolised to NO by the 
peroxidase activity of the enzyme, catalase (Klebanoff & Nathan, 1993; Mian 
& Martin, 1995b), whereas glyceryl trinitrate is metabolised via glutathione-S- 
transferase (Armstrong et al., 1980), cytochrome P450 (Schroder, 1992) or by 
a direct reduction by tissue thiols (Feelisch, 1991).
The precise mechanism of activation of soluble guanylate cyclase by NO is not 
clear. However, it has been proposed that NO binds to the haem group of 
soluble guanylate cyclase to form nitrosyl-haem-enzyme ternary complex 
which represents the activated state of the enzyme (Ignarro, 1991). Binding of 
NO produces an immediate increase in catalytic activity of 50-200-fold. NO 
activates the enzyme by pulling the iron molecule away from the enzyme and 
out of plane from the planar porphyrin ring configuration (Ignarro et a!., 1984), 
thus enabling the conversion of GTP to cGMP.
1.2.4.2 EDRF and cGMP
Endothelium-dependent relaxation induced by ACh and other agents was 
subsequently shown to correlate with increases in cGMP, which preceded the 
relaxation of the smooth muscle (Holzmann, 1982; Rapoport & Murad, 1983). 
In addition, EDRF generated by ACh in isolated arteries was shown to directly 
activate soluble guanylate cyclase in cell homogenates (Forstermann et a!.,
1986), suggesting that within the vascular system EDRF could act as an 
“endogenous nitrovasodilator”. Furthermore, the vascular relaxation and 
concomitant increase in cGMP induced by both EDRF and nitrovasodilators 
was found to be inhibited by Mb (Martin et a!., 1985a,b) and MeB (Gruetter et 
a!., 1979; Holzmann, 1982; Garcia-Pascual eta!., 1995).
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1.2.4.3 Mechanism by which cGMP induces relaxation
In vascular smooth muscle the cycle of contraction-relaxation is mainly 
regulated by changes in the free intracellular Ca2+ concentration. Cytosolic 
Ca2+ binds to calmodulin and the Ca2+-complex subsequently activates 
myosin light chain kinase (MLCK; Dabrowska et al., 1977), which 
phosphorylates myosin light chains leading to an increase in actin-myosin 
Mg2+-ATPase activity and hence, muscle contraction. Inhibition of excitation- 
contraction coupling, i.e. smooth muscle relaxation, can result from withdrawal 
of the contractile stimulus leading to a decrease in intracellular Ca^+ or can be 
mediated by an inhibitor of contraction in the continued presence of the 
contractile agonist. The latter mechanism involves the generation of an 
intracellular second messenger. cGMP is one of the major second 
messengers mediating relaxation in vascular smooth muscle (Murad, 1994).
As discussed previously, cGMP synthesis is catalysed from GTP by soluble 
guanylate cyclase which is activated by a number of compounds including NO 
(Arnold et al., 1977; Murad, 1994). The primary mechanism by which cGMP 
causes smooth muscle relaxation is by lowering intracellular Ca2+ (Collins et 
al., 1986). cGMP exerts its action through the activation of a protein kinase, 
termed cGMP-dependent protein kinase. The mechanisms by which cGMP- 
dependent protein kinase decreases intracellular Ca2+ include: (i) inhibition of 
phopholipase 0 , presumably through the phosphorylation of a regulatory 
protein, resulting in the inhibition of inositol 1,4,5-trisphosphate (IP3) formation 
(Hirata et al., 1990); (ii) stimulation of Ca^+-activated K"*" channels leading to 
hyperpolarisation with consequent inhibition of Ca2+ entry through voltage- 
operated Ca2+ channels (Robertson et al., 1993); and (iii) stimulation of Ca2+- 
ATPase activity leading to augmentation of Ca2+ sequestration into the 
sarcoplasmic reticulum (Amrani et al., 1995).
14
1.2.5 Identification of EDRF as NO
Although a clear picture had emerged on the mechanisms by which EDRF 
induced relaxation, its chemical identity remained to be determined. NO had 
long been suspected to account for the vasorelaxant activity of 
nitrovasodilators (Katsuki et al., 1977; Arnold et al., 1977). The similarities in 
the known properties, i.e. stability, biological activity and susceptibility to 
inhibitors and potentiators, of EDRF and NO, led to the suggestion that EDRF 
may be NO or a closely related species.
The identification of EDRF as NO was further supported by their 
indistinguishable action on vascular and non-vascular smooth muscles 
(Gillespie & Sheng, 1988). An additional similarity in the pharmacological 
properties became evident when both EDRF and NO were reported to inhibit 
platelet aggregation (Radomski et al., 1987a). Moreover, their biological half- 
lives as inhibitors of platelet aggregation were similar (Radomski et al., 
1987a).
The major breakthrough came when EDRF released from cultured porcine 
aortic endothelial cells was shown both to mimic the biological actions of 
authentic NO in a cascade bioassay and be indistinguishable from it, as 
assessed by a chemical assay based upon the formation of a luminescent 
product by the reaction of NO with ozone (see section 1.3.3) (Palmer et al.,
1987). Moreover, the amount of NO released by the endothelial cells was 
sufficient to account for the vascular relaxation attributed to EDRF (Palmer et 
al., 1987). Furthermore, EDRF released from the perfused intact bovine 
pulmonary artery and vein was shown to be identical to authentic NO, as 
assessed by a chemical assay based on diazotization, where NO combines 
with sulphanilic acid at acid pH and the resulting diazo product couples with N-
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(l-naphthyl)-ethyienediamine to produce an intense colour (Ignarro et al., 
1987a,b). In addition, a spectrophotometric assay based on the reaction 
between NO and Hb (see section 1.3.4) was used to compare the release of 
NO from vascular endothelial cells in culture with the vasorelaxant effect of 
EDRF and NO determined by bioassay (Kelm et al., 1988). These authors 
provided further evidence that endothelial cells release NO in amounts 
sufficient to account for the vasorelaxant activity of EDRF.
More recently, Rand & Li (1995) demonstrated the ability of carboxy-PTIO, an 
NO-trapping agent, to inhibit relaxations mediated by both EDRF and 
authentic NO in rat aorta. Furthermore, La et al. (1996) by comparing the 
effects of hydroxocobalamin and oxyhaemoglobin on the relaxant responses 
to NO and EDRF in rat aorta showed that these compounds could not 
discriminate between NO and EDRF.
1.2.6 Controversy over the chemical identity of EDRF
Although the evidence for EDRF being NO is compelling, several lines of 
research have questioned this conclusion. Early reports that EDRF generated 
from the endothelium only relaxed vascular smooth muscle whereas authentic 
NO relaxed vascular, tracheal and taenia coli smooth muscles (Shikano et al.,
1987) might be due to low concentrations of EDRF generated since tracheal 
and taenia coli smooth muscle was shown to be less sensitive to NO and 
EDRF than vascular smooth muscle (Dusting et al., 1988). Moreover, EDRF 
and NO have clearly been shown to relax vascular and non-vascular smooth 
muscle preparations in a bioassay system (Gillespie & Sheng, 1988). The 
stabilisation of EDRF but not NO by acidification (Murray et al., 1986) might be 
explained by EDRF being an NO-releasing molecule rather than NO itself. 
Myers et al. (1990) compared the vasodilator potencies of NO, 8-
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nitrosocysteine and EDRF and suggested that EDRF was much more likely to 
be a nitrosylated compound such as a nitrosothiol than authentic NO. Another 
group (Kukreja et al., 1993) compared the effects of NO and S-nitrosocysteine 
on cerebral arteriolar caliber in relation to the associated increment in nitrite 
concentration in the effluent and concluded that S-nitrosocysteine resembled 
EDRF more closely than authentic NO. In contrast, Feelisch et al. (1994) 
found that EDRF was more likely to be NO than an S-nitrosothiol as the 
activities of both EDRF and NO were inhibited by L-cysteine but the actions of 
S-nitrosothiol were not. It has also been proposed that NO is not released in 
pure form from endothelial cells but may be bound to a carrier such as in a 
ferrous iron dithiolate complex (Vanin, 1991). Dinitrosyl ferrous iron complexes 
have indeed been shown to exhibit similar biological activity and stability to 
EDRF (Vedernikov et al., 1992). Thus, there is still debate as to the true 
identity of EDRF.
An alternative hypothesis involves the notion that EDRF is a mixture of NO 
and S-nitrosothiol. It has been proposed that basal EDRF is free NO whereas 
the enhanced formation of EDRF elicited by endothelium-dependent relaxants 
such as ACh may be attributed to Ca2+-dependent exocytosis of recently 
preformed S-nitrosothiol (Myers et al., 1990; Ignarro, 1991; Cocks & Angus, 
1991). The S-nitrosothiol could be synthesised within acidic granules as a 
result of a simple nitrosation reaction between NO and a thiol (perhaps L- 
cysteine) and stored temporarily in a relatively stable form. Although S- 
nitrosocysteine is less lipophilic than NO, some S-nitrosocysteine would be 
expected to continually leak out of the granules and undergo decomposition to 
NO and L-cystine (the disulphide of L-cysteine). According to this scheme, 
exocytotic discharge of S-nitrosocysteine would result in the liberation of NO 
from the S-nitrosothiol (Ignarro, 1990). The ability of the inhibitors of NO
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synthesis to rapidly inhibit actions of both basal and agonist-stimulated EDRF 
(Müisch & Busse, 1990; Rees et al., 1990a), however, argues against prior 
storage.
The general line of evidence suggests that even if EDRF is released from 
endothelial cells as a NO-containing compound, its biological effects are 
mediated ultimately by NO.
1.3 Physical and chemical properties and metabolism of NO
NO is a small molecule composed of the two most common atmospheric 
gases. It is soluble both in water (up to 2 mmol/L at 20 “C and one 
atmosphere) and lipid (Henry et al., 1993). It is an uncharged molecule with an 
unpaired electron. Being uncharged, NO can diffuse freely across 
membranes. Having an unpaired electron, it is a free radical molecule and is 
highly reactive with a half-life of 4 to 50 seconds (Griffith et al., 1984). NO can 
both donate and receive electrons, it therefore behaves both as an oxidant 
and a reductant. Some of the important chemical reactions involving NO are 
discussed below.
1.3.1 Reactivity with oxygen
NO in the gas phase readily reacts with oxygen (O2 ; Ignarro et al., 1993) 
forming NO2 and the overall reaction is:
■Ï.Î"
I 1I
2N0 + O2 2NO2
IrI
This reaction is rapid at high concentrations of NO, but slow at low 
concentrations. NO in aqueous solution containing O2 has a different chemical
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fate from NO in gaseous mixtures containing O2 . In aqueous solution 
containing O2 , NO is oxidised mainly to nitrite (NO2”) with little or no formation 
of nitrate (NO3-) (Ignarro etal., 1993).
1.3.2 Reactivity with superoxide anion
NO reacts with superoxide anion ("O2") resulting in the formation of 
peroxynitrite anion (ONOO"). ONOO" is a powerful oxidant (Freeman, 1994), 
At physiological pH, ONOO" has a half-life of 1.9 seconds, since when 
protonated to form ONOOH it undergoes spontaneous homolysis to form the 
highly reactive hydroxyl radical ("OH) and nitrogen dioxide radical (’ NO2 ) 
(Beckman et al., 1990). NO3" is the end-product of this interaction;
NO + *02" ONOO" + H+ -> ONOOH 
ONOOH "OH + "NO2
NO3-
Superoxide anion can rapidly destroy NO and SOD by scavenging superoxide 
anion protects NO (Gryglewski etal., 1986b; Moncada et a l ., 1986; Rubanyi & 
Vanhoutte, 1986a,b; Mian & Martin, 1995a).
1.3.3 Reactivity with ozone
NO reacts with ozone (O3 ) leading to the production of activated (high energy 
state) NO2 . This excited NO2 is of sufficient energy to dissociate to ground 
state NO2 with concomitant generation of light which can easily be detected 
by chemiluminescence (Zafiriou & McFarland, 1980). This is the technique 
which was originally used to identify EDRF as NO in biological
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systems (Palmer et al., 1987). The reaction is as follows:
NO + 0 3 -^  NO2 (excited) + O2 
NO2 (excited) -> NO2 + hv
1.3.4 Reactivity with oxyhaemoglobin
NO reacts with oxyhaemoglobin in the presence of oxygen to yield 
methamoglobin (metHb) and NO3" according to the overall reaction shown 
below:
Hb0 2  + NO metHb + NO3- 
Looking at this reaction in more detail, the component reactions are as follows:
Hb2+0 2 “ + NO metHb + ONOO"
and
ONOO- NO3"
i.e. molecular oxygen binds to the haem iron atom of the protein (Wallace et 
al., 1974) and this species reacts rapidly with NO to yield ONOO", which 
isomerises to NO3". This principle of reacting NO with Hb02 to yield metHb 
has been used as a spectrophotometric assay for NO (Kelm et al., 1988).
The reaction of NO with haem-containing proteins such as haemoglobin, 
myoglobin and soluble guanylate cyclase (Stamler, 1994; Tsai, 1994) is rapid. 
The reaction of NO with haem groups is thought to be the predominant 
interaction in vivo, and to account both for its activity in smooth muscle cells
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and its rapid inactivation in blood (Stamler et al., 1992).
1.3.5 Reactivity with thiols
NO reacts with thiols (R-SH) to form S-nitrosothiols (R-SNO). The reaction is 
rapid but the resulting S-nitrosothiol is unstable and spontaneously 
decomposes to NO gas and corresponding disulphides. This process is 
reported to be enhanced by heat, light, oxygen, and only efficient at acid pH 
(Ignarro, 1990; Feelisch, 1991). The presence of S-nitrosothiols in human 
plasma supports the suggestion that these may represent a stabilised form of 
NO in biological systems (Keaney etal., 1993).
1.3.6 Reactivity with sulphanilic acid
NO reacts with sulphanilic acid at acid pH to yield a diazo product which can 
be further coupled with N-(1-naphthyl)-ethylenediamine to form an intense 
chromophore (Green et al., 1982). This reaction is widely used for the 
spectrophotometric measurement of NO and nitrite (Ignarro et al., 1987a; Mian 
Martin, 1995b).
1.4 Biochemical origin of NO
Even prior to the finding that endothelial cells release NO, it was reported that 
the body produces nitrogen oxides. The first suggestion of endogenous 
production of NO3" in humans was based on nutritional studies reported by 
Mitchell et al. (1916). For a long time, it was believed that this NO3- was 
produced by intestinal microbial metabolism and, therefore, had a little 
relevance to mammalian biology. It was not until 1978 when Tannenbaum and 
his colleagues (Tannenbaum et al., 1978) proved that NO3” was
21
biosynthesised mainly outside the intestine that interest in this area was 
renewed. Subsequent studies of NO2" and NO3- metabolism revealed that 
more NO2" and NO3" were produced than could be accounted for by food 
intake (Green et al., 1981a). Furthermore, studies in germ-free conventional 
rats, has demonstrated that NO3 '  biosynthesis is mammalian in origin (Green 
et al., 1981b). A marked increase in urinary NO3" excretion was observed in 
humans with diarrhoea and fever (Hegesh & Shiloah, 1982). Furthermore, 
treatment of rats with Escherichia coli lipopolysaccharide (LPS) led to a 10-fold 
increase in the urinary output of NO3" which correlated with the degree of 
fever (Wagner et al., 1983). These results, therefore, demonstrated a 
correlation between immunostimulation and increased NO3" synthesis. Later 
work by Stuehr and Marietta (1985) demonstrated an increased NO2" and 
NO3- production in vitro following exposure to lipopolysaccharide (LPS, 
endotoxin) in LPS-sensitive, but not LPS-resistant, mouse peritoneal 
macrophages. Thus, the macrophage seemed to be the most likely source of 
NO2 '  and NO3" synthesis in vivo.
Further studies on the RAW 264.7 macrophage cell line demonstrated that the 
synthesis of NO2" and NO3", after activation with LPS and interferon-y (IFN-y), 
was dependent upon the presence of the amino acid L-arginine (Iyengar et al.,
1987). These experiments with '^^N-labelled L-arginine showed that the 
nitrogens in both NO2" and NO3" were derived from one of the two equivalent 
terminal guanidino nitrogen atoms of this amino acid (Iyengar et al., 1987). At 
about the same time, the cytotoxicity of activated macrophages against 
tumour target cells was also shown to be dependent upon the presence of L- 
arginine (Hibbs et al., 1987a). This latter group also demonstrated that 
activated macrophages synthesised L-citrulline and NO2" from L-arginine and 
that the close structural analogue of L-arginine, N^-monomethyl-L-arginine (L- 
NMMA), prevented the formation of both of these products as well as the
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expression of cytotoxicity (Hibbs et al., 1987a,b). It was proposed that NO was 
an intermediate in the formation of NO2" and NOg" from L-arginine in activated 
macrophages and that it was responsible for the cytotoxic properties of these 
cells (Stuehr et al., 1989).
1.4.1 Identification of L-arginine as a precursor of NO in 
endotheiial celis
The above classic experiments demonstrating the synthesis of NO2", NO3" 
and L-citrulline from L-arginine by cytotoxic macrophages led to the discovery 
that vascular endothelial cells also utilise L-arginine in the biosynthesis of NO 
(Palmer et al., 1988a). These experiments indicated that when bovine isolated 
aortic endothelial cells were grown in the absence of L-arginine for the final 24 
hours of culture, they failed to generate NO in response to bradykinin and 
A23187, as assessed by a bioassay cascade technique. Furthermore, infusion 
with L-arginine enhanced the release of NO by these agents, suggesting the 
need for free L-arginine (Palmer et ai, 1988a). In addition, L-NMMA, an 
inhibitor of NO2" and NO3" synthesis in the macrophage (Hibbs et ai, 
1987a,b), blocked relaxations induced by ACh and histamine in guinea-pig 
pulmonary artery and this inhibition was rapidly and completely reversed by L- 
arginine but not D-arginine. These data were consistent with endothelium- 
derived NO originating by enzymatic action on the guanidino nitrogen(s) of an 
endogenous pool of L-arginine (Sakuma et ai, 1988). Almost simultaneously. 
Palmer and his colleagues obtained similar results with L-NMMA in cultured 
porcine aortic endothelial cells (Palmer et ai, 1988b).
1.5 Biosynthesis of NO
It is well established that NO is synthesised from one of the guanidino
nitrogens of L-arginine, and this is catalysed by the enzyme NO synthase
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(NOS, Marietta, 1994). This reaction appears to involve a five-electron 
oxidation of the guanidino nitrogen atom of L-arginine to NO (Nathan & Xie, 
1994). The reaction to form NO occurs in two steps. The first is known to 
involve an initial N-oxygenation of L-arginine to generate N^-hydroxy-L- 
arginine (NOHA) (Leone et al., 1991; Marietta, 1993). The second step 
consists of an oxidative cleavage of the C = N bond of N^-hydroxy-L-arginine 
leading to formation of L-citrulline and NO (Leone et al., 1991; Marietta, 1993; 
Korth et al., 1994). Both steps consume nicotinamide adenine dinucleotide 
phosphate (NADPH) and O2 (Leone et al., 1991; Marietta, 1993; Marin & 
Rodriguez-Martinez, 1995) (see Figure 1.1).
1.6 Isoforms of NO Synthase
So far, at least, three isoforms of NOS have been isolated, purified and cloned 
and they appear to be the products of three distinct genes (Nishida et al., 
1992; Marsden etal., 1992; Nakane etal., 1993).
Two isoforms: the endothelial-type (eNOS) and neuronal-type (nNOS) are 
present as normal constituents in certain cell types and are also referred to as 
constitutive NOS (cNOS; Zhang & Synder, 1995). In contrast, the third isoform 
(macrophage-type) is not normally present in healthy cells but can be induced 
after exposure to endotoxin or certain cytokines (Nussler & Billiar, 1993), and 
is termed inducible NOS (iNOS).
All three isoforms require NADPH, as an electron donor, and contain one 
molecule each of flavin mononucleotide (FMN), flavin adenine dinucleotide 
(FAD) and tetrahydrobiopterin (B4 H) (Müisch & Busse, 1991, Stuehr et al., 
1991a; Bredt et al., 1992; Schmidt et al., 1992) and also contain haem 
(Forstermann et al., 1994). The activity of cNOS is calmodulin-dependent.
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Figure 1.1 Synthesis of nitric oxide (NO). The endothelial cell activation by 
A23187 (Ca2+ ionophore), electrical stimulation or agonists that interact with 
specific receptors, increasing intracellular Ca2 + levels, which leads to 
activation of NO synthesis. NO formation occurs in two steps catalysed by NO 
synthase (NOS); the first one consists of an N-oxygenation of L-arginine to 
NO_hydroxy~L-arginine (NOHA), and the second one, which can also be 
catalysed by cytochrome P4 50 . consists of an oxidative cleavage of the C = N 
bond of NOHA leading to L-citrulline and NO formation. Endothelial cell NOS 
uses as cofactors reduced nicotinamide adenine dinucleotide phosphate 
(NADPH), O2 , Ca2+/calmodulin, tetrahydrobiopterin (H4 B), flavin adenine 
dinucleotide (FAD), and flavin mononucleotide (FMN) (modified from 
Marin & Rodriguez-Martinez, 1995).
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Calmodulin binds reversibiy to cNOS in response to elevated Ca2+ and 
binding of calmodulin allows NADPH-derived electrons to pass onto the haem 
group of the enzyme (Abu-Soud & Stuehr, 1993). In contrast, the activity of 
iNOS is not regulated by Ca2+. Originally it was thought that this isoform was 
Ca2+/calmoduIin independent, but it has recently been shown to bind 
calmodulin so firmly that dissociation does not occur even in the presence of 
the Ca2+~chelator, EGTA (Oho eta/., 1992). The amino acid sequence is well 
conserved across species: cNOS has been shown to exhibit over 90 % 
homology between humans and other species and iNOS exhibits over 80 % 
homology (Morris & Billiar, 1994).
The first cNOS isoforms purified were from rat and porcine cerebellum (Bredt 
& Synder, 1990; Nathan, 1992). The isoform in brain is mainly cytosolic and 
migrates with a molecular mass of 150 to 160 kD on sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis (Bredt & Synder, 1990). This isoform is 
also present in peripheral non-adrenergic non-cholinergic (NANG) inhibitory 
neurons in many tissues including the rat anococcygeus and the bovine 
retractor penis muscle (Martin et al., 1988; Gillespie et a!., 1989). The nerves 
in the bovine retractor penis and rat anococcygeus, however, contain both 
soluble and particulate NOS (Forstermann et a!., 1991). The endothelial form 
of cNOS has been isolated from native and cultured bovine aortic endothelial 
cells, shows a molecular mass of 135 kD (Pollock et a!., 1991) and is mainly 
membrane-bound (Sessa etal., 1993).
When cNOS-containing cells are given an appropriate stimulus, e.g. ACh 
(endothelial cells) or glutamate (cerebellar neurons), receptor activation leads 
to an increase in cytosolic Ca2+, which activates cNOS to give a burst of NO. 
This activation is short-lived and the NO produced serves as a diffusible 
signalling molecule mediating numerous physiological processes including
vasodilatation and neurotransmission (Morris & Billiar, 1994).
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The inducible NOS can be induced following stimulation with LPS and/or 
cytokines in marophages (Marietta et al., 1988; Stuehr et al., 1991a) and 
many other cell types including endothelial cells (Radomski et al., 1990a), 
vascular smooth muscle cells (Busse & Müisch, 1990), hépatocytes (Curran et 
al., 1989), Kupffer cells (Billiar et al., 1989) and neutrophils (Van Dervort et al.,
1994). Like nNOS, this isoform is predominantly soluble (Stuehr et al., 1991a; 
Hevel et al., 1991) and the protein has a molecular mass of 125 to 135 kD 
(Hevel et al., 1991). Following stimulation, NO synthesis depends on the de 
novo synthesis of iNOS protein and essential cofactors (Beasley et al., 1991; 
Morris & Billiar, 1994; Fukuto & Chaudhuri, 1995). One of the main 
characteristics of iNOS is that it releases large amounts of NO continuously 
since its activity does not depend on Ca2+. The role of NO in activated 
immune cells is to act as a killer molecule. By releasing massive amounts of 
NO lethal oxidative injury is inflicted on the target cells (Nussler & Billiar, 
1993). In addition to regulation of the activity of iNOS at the transcriptional 
level, a further level of control appears to be exercised by mRNA stability 
(Nathan & Xie, 1994; Fukuto & Chaudhuri, 1995). Figure 1.2 shows the 
structure of endothelial and macrophage NOS and highlights similarities with 
cytochrome P450 reductase.
1.7 Pharmacological regulation of NOS and NO synthesis
Analogues of L-arginine represent the largest and potentially most useful class 
of NOS inhibitors. The most widely used inhibitors are L-NMMA, N^-nitro-L- 
arginine (L-NOARG) and N^-nitro-L-arginine methyl ester (L-NAME) (Palmer 
et al., 1988b; Rees et al., 1989; 1990a; Moore et al., 1990; Losonczy et al., 
1996). The structure of each of these inhibitors is shown in Figure 1.3. Many 
analogues of L-arginine act as competitive inhibitors and their inhibitory effects 
can be prevented or rapidly reversed with L-arginine. Earlier reports indicated
2 7
-I f  ’ •
NO SYNTHASES
Endothelial
•Macrophage
N^H
i|ii1 lift! Iff!N g H - N ^ H - FMN fi'
r,
j'l FAD
CM
•COOH
NADPH
CYTOCHROME P 4 5 0 -  
REDUCTASE
Figure 1.2 Structure of endothelial and macrophage NO synthases and 
cytochrome P450  reductase. The common binding sites for reduced 
nicotinamide adenine dinucleotide phosphate (NADPH), flavin adenine 
dinucleotide (FAD) and flavin mononucleotide (FMN) in the carboxyl-terminal 
domains are shown. The proposed sites for calmodulin (CAM) and protein 
phosphorylation (P), are also shown (from Marin & Rodriguez-Martinez, 1995).
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Figure 1.3 The chemical structure of some of the substrate analogue 
inhibitors of NO synthase: N^-monomethyl-L-arginine (L-NMMA), N^-nitro-L- 
arginine (L-NOARG) and N^-nitro-L-arginine methyl ester (L-NAME). The 
structure of the substrate, L-arginine (L-ARG) is also shown.
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that L-NMMA was a competitive inhibitor of both cNOS from endothelial cells 
and iNOS from macrophages (Gross etal., 1990), however, later work showed 
that it can under certain circumstances irreversibly inhibit iNOS (Olken et al.,
1991). In same cells L-NMMA has been shown to undergo both iNOS- and 
cNOS-catalysed oxidation to generate N-hydroxy-N-methyl-L-arginine, which 
upon further conversion to L-citrulline, generates an irreversibly binding 
species (Feldman et al., 1993). An unusual ability of L-NMMA to act as a 
substrate for production of NO has also been found in porcine brain (Klatt et 
al., 1994), rat aorta (Frew et al., 1993), bovine retractor penis (Martin et al., 
1993) and murine macrophages (Olken & Marietta, 1993). L-NOARG has 
been shown to essentially inhibit irreversibly cNOS both In vitro and in vivo 
(Dwyer et ai, 1991), whereas its effects are fully reversible on INOS (Furfine 
et ai, 1993). Thus, L-NOARG shows some selectivity for cNOS over iNOS. 
Another N-substituted L-arginine analogue, N^-amino-L-arginine (L-NAA), is a 
potent inhibitor of both cNOS and iNOS (Fukuto et ai, 1990). The rank order 
of potency for inhibition of NO synthesis varies in different cell systems (see 
Fukuto & Chaudhuri, 1995 for review), indicating that some degree of isoform 
selectively can be accomplished by simple derivatization of L-arginine.
A variety of nitrogen compounds also have the ability to inhibit both iNOS and 
cNOS, although the exact mechanism by which they do so is yet to be 
elucidated. 3-Amino-1,2,4-triazole is one such inhibitor (Fukuto & Chaudhuri,
1995). However, we found this compound to have no effect on ACh-induced 
relaxation in rat aorta (Mian & Martin, 1995b). Another is aminoguanidine, 
which contains the guanido group of L-arginine linked to hydrazine; this has 
been shown to be more potent at inhibiting iNOS compared to cNOS (Misko et 
ai, 1993). Further, Moore et al. (1993) demonstrated that 7-nitroindazole is a 
fairly potent and selective inhibitor of nNOS. Most recently, Handy et a i (1995) 
demonstrated that a nitrogen-containing heterocyclic compound, 1-(2-
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trifluoromethylphenyl)imidazole, is a potent and relatively selective inhibitor of 
nNOS both in vitro and in vivo. Thus, isoform-selective inhibitors of NOS may 
prove useful for the treatment of a wide variety of disease states.
Since both cNOS and INOS require NADPH-dependent FAD and FMN, it 
would be expected that flavoprotein inhibitors would inhibit NOS activity. 
Indeed, diphenyleneiodonium, an inhibitor of NADPH-flavoprotein oxidation, 
and several of its analogues, are potent inhibitors of NOS activity (Stuehr et 
a/., 1991b).
Both iNOS and cNOS are iron haem-containing proteins. The haem prosthetic 
group is required for catalytic activity and haem-binding agents would, 
therefore, be expected to inhibit the activity of the enzyme. Carbon monoxide 
is an extremely good ligand for ferrous (Fe2+) haem and is a potent inhibitor of 
NOS activity (White & Marietta, 1992; Klatt et al., 1992). Other haem ligands 
such as cyanide (Klatt et al., 1992), and even NO itself (Roger & Ignarro,
1992) have been shown to inhibit NOS activity. is a further cofactor 
required for activity of both iNOS and cNOS (Müisch & Busse, 1991; Schmidt 
et al., 1992) and its inhibition would therefore be expected to block NOS 
activity. Indeed, inhibition of the biosynthesis of this cofactor with the drug, 
2,4-diamino-6-hydroxypyrimidine which acts by inhibiting the rate-limiting 
enzyme in the synthesis of FI^B, GTP-cyclohydrolase I, has been shown to 
inhibit the production of NO from both iNOS and cNOS (Schmidt et al., 1992; 
Bogdan et al., 1995). Furthermore, cNOS is activated and regulated by Ca2+ 
via the reversible binding of calmodulin, whereas iNOS is not regulated by 
Ca2+ since calmodulin is tightly bound (Cho et al., 1992; Abu-Soud & Stuehr,
1993). It has been shown that calmodulin binders such as calcineurin, 
trifluoroperazine, calmidazolium, W-7 and fendiline inhibit cNOS activity while 
having no effect on iNOS (Schini & Vanhoutte, 1992).
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Expression of iNOS can be inhibited by the protein inhibitor cycloheximide 
(Radomski et al., 1990a). Furthermore, steroids such as hydrocortisone and 
dexamethasone but not progesterone inhibit the expression of iNOS without 
directly affecting the activity of the enzyme (Radomski et al., 1990a; Rees et 
al., 1990b). Inhibition of the induction of NOS by glucocorticoids is a receptor- 
mediated event involving blockade of the synthesis of mRNA for de novo 
synthesis of this enzyme (Radomski et al., 1990a).
The L-arginine/NO pathway can also be interfered with by directly targeting 
NO. Flaemoglobin has been shown to inhibit relaxations induced by 
endothelium-dependent agonists such as ACh, and by endothelium- 
independent nitrovasodilators such as glyceryl trinitrate in rabbit aortic rings 
(Martin et al., 1985a,b). These authors proposed that haemoglobin inhibits 
relaxations induced by these agents by directly binding NO before it gains 
access to soluble guanylate cyclase. In addition, as the vasorelaxant effects of 
NO are mediated through activation of soluble guanylate cyclase and 
subsequent increase in cGMP (Rapoport & Murad, 1983), this can be targeted 
as a means of inhibiting the effects of NO. Methylene blue (MeB) has been 
shown to inhibit the activity of soluble guanylate cyclase (Holzmann, 1982; 
Gruetter ef a/., 1979; Martin etal., 1985a). Martin etal. (1985a) suggested that 
MeB may produce inhibition by oxidising the ferrous (Fe2+) haem component 
of soluble guanylate cyclase. A recent report by Marczin et al. (1992) 
demonstrated that MeB inhibited nitrovasodilator- and EDRF-induced cGMP 
accumulation in cultured pulmonary arterial smooth muscle cells via an
additional action involving generation of superoxide anion. A specific inhibitor 
of soluble guanylate cyclase, which does not involve generation of superoxide
anion, is 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ, Cellek et al., 
1996). Thus, this compound may be useful in elucidating the role of cGMP in 
the biological actions of NO.
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The activity of NO can be destroyed as a result of interaction with superoxide 
anion and SOD has been shown to protect it (Gryglewski et al., 1986b; 
Moncada et al., 1986; Rubanyi & Vanhoutte, 1986a,b; Mian & Martin, 1995a). 
The mechanism of this interaction and its consequences will be discussed in 
more detail in the next Chapter.
1.8 Role of NO in mammalian physiology
NO has gained attention as a representative of a newly discovered class of 
messenger molecule, amongst which is carbon monoxide (Zakhary et al.,
1996), serving a variety of functions in the cardiovascular system, central and 
peripheral nervous systems and immune system.
1.8.1 NO in the cardiovascular system
The vasculature is in a constant state of dilation mediated by NO produced 
continuously by endothelial cells under physiological conditions (Egléme et al., 
1984; Martin et al., 1986; Martin, 1988). Inhibitors of NOS such as L-NAME or 
L-NMMA, when infused (systemically) into animals (Baylis et al., 1992) or 
humans (Haynes et al., 1993), contract vascular smooth muscle and increase 
the blood pressure due to loss of basal dilator tone mediated by NO. Thus, a 
basal level of NO acts as an endogenous autoregulator of blood flow. The 
concept of basal release of NO indicates that arterial pressure and vascular 
resistance are determined as much by active vasodilatation as by active 
vasoconstriction.
NO dilates blood vessels by directly relaxing vascular smooth muscle cells. 
Agonists such as ACh, bradykinin, Ca^*^ ionophore A23187, substance P, 
thrombin, ADP and 5-HT (Furchgott, 1984; Stork & Cocks, 1994) bind to their
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corresponding receptors on endothelial cells causing a transient increase in 
intracellular Ca2+ which then binds to calmodulin and the resulting complex 
activates endothelial NOS which synthesises NO. NO is a small lipophilic 
molecule which travels freely through cell membranes and can, therefore, act 
on neighbouring target cells. For example, NO released from endothelial cells 
acts on the vascular smooth muscle cell immediately beneath it where it binds 
to the haem group on the soluble guanylate cyclase. The enzyme is activated 
to produce cGMP (Murad, 1994) which, through a cascade of protein kinases 
(see section 1.2.4.3), induces smooth muscle relaxation (Warner etal., 1994).
Shear stress on the vessel wall also activates ion channels in the endothelial 
cells and leads to increased NO production (Pohl et al., 1986). This effect
accounts for the phenomenon of flow-dependent vasodilatation, a form of 
autoregulation that might control tissue perfusion (Lowenstein et al., 1994).
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The release of NO into the vasculature is also controlled by the autonomic 
nervous system. Parasyrhpathetic nerves containing NOS terminate in the 
adventitia of certain large vessels such as the cerebral and retinal arteries. NO 
released from these nerves diffuses into the muscular media from the outside 
of the vessel, causing vasorelaxation (see Lowenstein et al., 1994 for review).
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NO influences other areas of the cardiovascular system besides blood 
vessels. It has been shown to exert a negative chronotropic effect on the heart 
and a negative inotropic effect on cardiac muscle cells (Flenderson et al.,
1992).
NO produced by endothelial cells reduces the blood clotting process by 
inhibiting platelet aggregation (Radomski et al., 1987a,b; 1990b) and adhesion 
(Sneddon & Vane, 1988). In addition, platelets also express the L-
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arginine/NO system which may have a negative feedback role in the 
regulation of platelet function (Radomski et al., 1990b). The inhibitory effects 
of NO on platelets, like on vascular smooth muscle, are mediated by elevation 
of cGMP levels (Merritt, 1993). In addition, NO synergises with PGI2 to inhibit 
platelet aggregation (Radomski et al., 1987b), suggesting that these two 
mediators play a role in the thrombo-resistant properties of the endothelium 
(Davies & Hagen, 1993; Curzen et al., 1994). NO has also been shown to 
inhibit leukocyte adhesion to the endothelium, which is one of the early events 
in the development of atherosclerosis (Kubes et al., 1991). It additionally 
exerts an antiproliferative effect on vascular smooth muscle (Lüscher, 1993).
Abnormalities of the L-arginine/NO pathway have been shown to contribute to 
many cardiovascular pathologies. For example, impaired endothelium- 
dependent relaxation to ACh has been demonstrated in spontaneously 
hypertensive rats (Dohi et al., 1990). Similarly, intra-arterial infusion of ACh 
into the human forearm circulation of hypertensive subjects results in impaired 
endothelium-dependent vasodilatation (Linder et al., 1990). Also, in patients 
with essential hypertension, infusion of L-NMMA into the brachial artery 
causes less vasoconstriction (decreased forearm blood flow) in hypertensives 
as compared to normotensives (Panza et al., 1993), suggesting a reduced 
basal formation of NO in hypertension. Hypercholesterolemia and 
atherosclerosis are also associated with a reduction in vasodilatation mediated 
by the endothelium (Wennmalm, 1994). The release of biologically active 
EDRF (NO) from coronary artery from hypercholesterolemic pigs, as assessed 
by bioassay, has been shown to be significantly reduced (Shimokawa & 
Vanhoutte, 1989). Moreover, reduced endothelium-dependent vascular 
relaxation has also been observed in rats with streptozotocin-induced or 
spontaneous diabetes (Heygate et al., 1995). Calver et al. (1992) studied 
endothelium-dependent vasodilatation in patients with Type 1 (insulin-
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dependent) diabetes and in healthy controls and reported a decreased basal 
formation in the former group. Decreased NO production or activity has also 
been associated with vasospasm and thrombosis (Quinn et al., 1995).
As mentioned previously, production of NO can be induced in vascular smooth 
muscle cells and other cells following exposure to endotoxin and/or certain 
cytokines (Stuehr et al., 1991a), resulting in the massive production of NO for 
sustained periods. Such an action is believed to underly the pathogenesis of 
the circulatory failure in endotoxin shock (Thiemermann, 1994).
1.8.2 NO and the central and peripheral nervous system
NO mediates both central and peripheral neurotransmission. Garthwaite et al. 
(1988) showed that a substance similar to EDRF was released through 
activation of NMDA receptors in the cerebellum. NO may participate in long­
term potentiation which may serve as a model for learning and memory. 
Pathological effects of NO in the central nervous system have been linked to 
activation of the NMDA receptors. The brain enzyme is implicated in neural 
cell death following stimulation of the NMDA receptors in stroke, Parkinson's 
disease, Alzheimer's disease, Huntington's chorea, and AIDS-related 
dementia (Springall, 1995; Zhang & Synder, 1995).
In the periphery, NO acts as a non-adrenergic non-cholinergic inhibitory 
transmitter leading to relaxation of smooth muscle in the reproductive, 
digestive and respiratory systems (see Zhang & Synder, 1995 for review). 
Neuronal NOS is present in these nerves and blocking NO formation with L- 
NMMA and L-NOARG or its action with Hb inhibits the effects of nerve 
stimulation (Bowman et al., 1982; Gillespie et al., 1989). The relaxing effect of 
NO facilitates propulsion of food through pyloric sphincter, just as NO is
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presumably involved in the relaxation phase of peristalsis (Desai et al., 1991). 
Inhibition of the synthesis or actions of NO may lead to intestinal dysmobility 
and bronchial asthma (Springall, 1995).
1.8.3 NO and the immune system
iNOS in macrophages and other cells has been proposed to play a primary 
defence role against intracellular microoarganisms as well as pathogens such 
as fungi and helminths that are too large to be phagocytosed (Langrehr et al., 
1993). NO has also been shown to kill tumour cells (Stuehr & Nathan, 1989) 
and may therefore act as an endogenous anti-neoplastic agent. The 
mechanism of the cytostatic effect of macrophage-derived NO on tumour 
cells, fungi, mycobacteria and parasites is not clear. However, activated 
macrophages can inhibit a number of key enzymes present in microbial and 
tumour cells by nitrosylating the non-haem iron moiety (Stuehr & Nathan,
1989). High concentrations of NO released by macrophages inhibit 
mitochondrial respiratory enzymes, DNA synthesis and aconitase activity in 
tumour cells (Nathan, 1992; Kam & Govender, 1994). Other immune cells 
including lymphocytes and neutrophils also synthesise and release NO (Quinn 
etal., 1995).
Unregulated NO release may be responsible for the vascular leakage 
(oedema) and tissue damage seen in some inflammatory conditions (Curzen 
et al., 1994). In addition, NO may damage normal host cells in autoimmune
disease in which iNOS is inappropriately induced (Vallance & Collier, 1994).
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Chapter 2
2.1 Oxygen free radicals and reactive 
oxygen species
A free radical is defined as a chemical species possessing an unpaired 
electron. It can also be considered as fragments of molecules which are 
generally very reactive. Free radicals can be formed in three ways: (i) by the 
homolytic cleavage of a covalent bond of a normal molecule, with each 
fragment retaining one of the paired electrons (X : Y X* + Y*); (il) by the loss 
of a single electron from a normal molecule; or (iii) by the addition of a single 
electron to a normal molecule (A + e~ A"*). The latter, electron transfer, is a 
common process in biological systems. Free radicals can be positively 
charged, negatively charged or electrically neutral (Cheeseman & Slater, 
1993).
The electrons in one of the most important molecules in free radical 
biochemistry, oxygen, are distributed in such a way that two of the electrons 
are “unpaired”. Thus, oxygen is sometimes considered a di-radical. The di­
radical nature of oxygen enables it to react readily with many other free 
radicals (Bast et a/., 1991) and it reacts relatively slowly with non-radical 
species (Cheeseman & Slater, 1993).
2.1.1 Superoxide radical
The most important free radicals in biological systems are derivatives of 
oxygen. A transfer of a single electron to oxygen results in its reduction and 
subsequent production of superoxide free radical anion (superoxide).
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0 2  + e" -4- *0 2 " (superoxide anion)
Superoxide anion is formed in all aerobic animal cells (Fridovich, 1983). Under 
normal circumstances, the major source of superoxide production in cells is 
electron “leakage” from electron transport chains such as those in 
mitochondria and endoplasmic reticulum (Cheeseman & Slater, 1993). Liver 
microsomes, when supplied with NADPH, have been shown to generate 
superoxide (Rashba-Step & Cederbaum, 1993). The rate of production in 
mammalian liver has been estimated to be 24 nmole *0 2 " min-'l gm-'l and the 
intramitochondrial steady state concentration of this radical to be 
approximately 1 x 10-11 |y| (Chance et al., 1979). Another important source of 
superoxide production is the respiratory burst of phagocytic cells when they 
contact foreign particles or immune complexes (Halliwell, 1982). Phagocytic 
cells known to produce superoxide include neutrophils, monocytes, 
macrophages and eosinophils (Halliwell & Gutteridge, 1984). In addition, 
endothelial cells are a potential source of superoxide anion (Rosen & 
Freeman, 1984), This free radical is also extensively produced by a number of 
enzymes including xanthine oxidase, aldehyde oxidase and a variety of flavin 
dehydrogenases (Fridovich, 1983). In addition, autooxidation of certain 
compounds such as ascorbic acid (vitamin C), catecholamines, haemoglobin 
and thiols (e.g. glutathione and L-cysteine) (MIsra & Fridovich, 1972; Misra, 
1974; Freeman & Crapo, 1982; Cheeseman & Slater, 1993) results in the 
formation of superoxide. Superoxide production has also been shown to be 
potentiated by hyperoxia (Freeman & Crapo, 1981).
Superoxide has a short half-life (1 x 10"® seconds at 37 °C; Yu, 1994) and 
spontaneously or enzymatically dismutases to produce more damaging 
species such as hydrogen peroxide (see later). The dismutation process is 
also catalysed by superoxide dismutase (SOD) which dramatically increases
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the rate of reaction (Salvemini & Botting, 1993). The antioxidant aspects of 
SOD will be discussed in detail later.
Several roles have been attributed to superoxide anion in the vascular wall. 
Among these are alterations of endothelial cell integrity, vascular constriction 
and vasodilatation.
Endothelial cells contain both xanthine dehydrogenase and xanthine oxidase 
in the ratio of 2:1 which following a contact with activated neutrophils is 
converted to 1:2 (Ward, 1991). The increase in the xanthine oxidase activity 
facilitates the generation of superoxide anion. The interaction between 
endothelial cells and activated neutrophils leads to endothelial cell killing as 
measured by 1^Cr release (Ward, 1991). The role of superoxide anion in 
endothelial cell killing is supported by experiments demonstrating that 
preloading of endothelial cells with SOD attenuates injury caused by activated 
neutrophils (Ward, 1991). Furthermore, superoxide anion generated by 
xanthine/xanthine oxidase was shown to cause endothelial disruption in rat 
aortic rings as assessed by scanning electron microscopy (Lawson et al., 
1990). Furthermore, studies in our own laboratory (Berman & Martin, 1993) 
measured albumin transfer across monolayers of bovine aortic endothelial 
cells as an indicator of endothelial barrier function and demonstrated an 
increase in albumin transfer across monolayers on addition of 
hypoxanthine/xanthine oxidase. However, it is likely that superoxide anion may 
itself be reduced to hydrogen peroxide or it may reduce Fe3+ to Fe2+ 
permitting the Fenton reaction and formation of hydroxyl radical (Kvietys et al., 
1989; Bast et al., 1991, see later), which may finally be responsible of 
endothelial cell damage.
Endothelial cells produce superoxide anion in addition to NO (Rosen &
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Freeman, 1984). The inactivation of NO by superoxide anion has been well 
established in a number of studies (Gryglewski et al., 1986b; Moncada et al., 
1986; Rubanyi & Vanhoutte, 1986a,b). The interaction between superoxide 
anion and NO leads to induction of endothelium-dependent vasoconstriction in 
arterial rings from loss of the dilator actions of basally produced NO (Katusic & 
Vanhoutte, 1989; Ohistein & Nichols, 1989). The generation of superoxide 
anion may be a common mechanism for the inhibitory actions of many other 
redox compounds, such as hydroquinone and pyrogallol, on NO (Flutchinson 
et ai, 1987; Halliwell & Gutteridge, 1989).
The ability of superoxide anion to inactivate NO has been mentioned above. 
Of a special note is the role of NO in the decrease of superoxide anion levels 
by direct removal of this radical. Rubanyi et al. (1991) demonstrated that 
exogenously added NO inactivated superoxide anion produced by human 
leukocytes. The antioxidant role of NO may be important under pathological 
conditions.
Superoxide anion has also been shown to attenuate the contractions induced 
by catecholamines (Wolin & Belloni, 1985). This action was suggested to be 
due to oxidation of catecholamines by superoxide anion since it was prevented 
by SOD (Wolin & Belloni, 1985).
In contrast to the above, vasodilatory effects resulting from superoxide anion 
are suggested to be mediated via formation of peroxynitrite (Liu et ai, 1994). 
This will be discussed in detail later.
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2.1.2 Hydrogen peroxide
Hydrogen peroxide is a normal cellular metabolite (Chance et al., 1979) 
formed in all subcellular compartments (Boveris et al., 1972) capable of 
undergoing oxidation-reduction reactions. Mitochondria are potential source of 
hydrogen peroxide in cells (Boveris & Chance, 1973; Dionisi et al., 1975) 
where it is predominantly formed from superoxide anion by the dismutation 
reaction:
•02" + *02" + 2H+ H2O2 + O2
Hydrogen peroxide (H2O2 ) has no unpaired electrons (i.e. is not a free 
radical). In addition to mitochondrial electron transport, hydrogen peroxide is 
generated in tissues by various mechanisms: enzymatic activities e.g. glucose 
oxidase, xanthine oxidase and cytochrome P450 (Sevanian & Hochstein, 
1985); autooxidation of normal physiological reductants such as glutathione 
and ascorbate (Chance, 1950; Misra, 1974); and autooxidation of small 
molecules such as catecholamines and flavins (Freeman & Crapo, 1982; 
Cheeseman & Slater, 1993). Furthermore, hydrogen peroxide is generated by 
phagocytic granulocytes during inflammation processes (Setty etal., 1984).
Unlike superoxide anion, hydrogen peroxide is fairly stable and is 
enzymatically broken down to water and oxygen by catalase (Halliwell & 
Gutteridge, 1989; Cheeseman & Slater, 1993, see later). Additionally, 
glutathione peroxidase catalyses the breakdown of hydrogen peroxide (Little & 
O'Brien, 1968; Christophersen, 1969; Smith et ai, 1989).
Hydrogen peroxide is potentially more toxic than superoxide anion since it 
diffuses through cell membranes with relative ease and directly attacks certain
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target components within the cell (Yu, 1994). Hydrogen peroxide has the 
ability to generate highly reactive radicals through its interaction with redox- 
active transitional metals.
Hydrogen peroxide performs two main effects in the vascular wall. The first of 
these effects is its ability to produce cytotoxicity of cultured endothelial cells. 
Oxidation injury is thought to be an important mechanism in vascular damage. 
Hydrogen peroxide provokes a variety of adverse biological effects on the 
endothelial cells such as morphological alterations (Weiss et al., 1981; 
Krautschick et al., 1995), modulation of prostacyclin production (Harlan & 
Callahan, 1984; Whorton et al., 1985), enhancement of neutrophil adhesion 
(Lewis et al., 1988), and increases in permeability of endothelial monolayers 
(Johnson et al., 1989; Berman & Martin, 1993). Exposure of endothelial cells 
to hydrogen peroxide produced a concentration-dependent reduction of 
glutathione and ATP levels (Spragg et al., 1985; Varani et al., 1990). In 
addition, hydrogen peroxide produces numerous effects on the vascular 
smooth muscle: inhibition of contractions induced by various vasoactive 
agents (Sheehan et al., 1993; lesaki et al., 1994), stimulation of membrane 
associated protein kinase C activity and phospholipase A activity, and 
arachidonic acid release (Stauble et al., 1994; Rao et al., 1995). Hydrogen 
peroxide-induced cytotoxicity has been reported to be mediated, at least in 
part, by an enhanced release of intracellular Ca2+ in target cells (Hirosumi et 
al., 1988; Sato etal., 1989; Krippeit-Drews etal., 1995).
In addition to its actions as an oxidant, hydrogen peroxide can also induce 
vascular relaxation (Burke & Wolin, 1987; Furchgott, 1991; Zembowicz et al.,
1993). This occurs by both endothelium-dependent and endothelium- 
independent mechanisms. The endothelium-dependent component is thought 
to be mediated via enhanced endothelial synthesis of NO, whilst the
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endothelium-independent component is due to a direct stimulatory effect on 
smooth muscle soluble guanylate cyclase (Burke & Wolin, 1987, Furchgott, 
1991; Zembowicz et al., 1993). The mechanism by which hydrogen peroxide 
stimulates soluble guanylate cyclase is not fully elucidated but it has been 
proposed that the presence of catalase is vital for this to occur and that the 
active species which stimulates the enzyme is compound I, i.e. the catalase- 
hydrogen peroxide complex formed as an intermediate (Burke & Wolin, 1987; 
Wolin & Burke, 1987).
2.1.3 Hydroxyl radical
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The hydroxyl radical is considered to be potentially the most potent oxidant 
encountered in biological systems. Addition of an electron to hydrogen 
peroxide generates hydroxyl radical ("OH). This reaction is, however, slow 
and a metal catalyst is needed to accelerate the reaction. The presence of 
traces of transition metal ions (Fe2+ and Cu"*") leads to formation of hydroxyl 
radical by the Fenton reaction:
IFe^ "*" + *02" —> Fe^^ + O2 
Fe2+ + H2O2 Fe "^*" + *0H + OH"
Although hydroxyl radical is highly reactive, its in vivo formation is contingent 
upon the availability of physiological iron (Cross et al., 1987). Two thirds of the 
4 g of iron present in an adult is stored in haemoglobin. Ten percent is found in
myoglobin with a small portion in iron-containing enzymes and in the transport 
protein, transferrin (Bast et al., 1991). The majority of intracellular iron is stored 
in ferritin as Fe^'*’ (Halliwell & Gutteridge, 1984). Iron, as Fe^+, does not 
participate in the Fenton reaction, so it must be reduced to Fe^+ and 
dissociated from ferritin. Such processes are achieved either in a reductive
environment caused by superoxide anion or in an acid medium as occurs in 
hypoxic and ischemic tissues (Bast et al., 1991). Ferrous iron (Fe^+), as 
shown above, then reacts with hydrogen peroxide and promotes generation of 
hydroxyl radical. Hydroxyl radical can also be generated by an iron- 
independent pathway, via decomposition of peroxy nitrite (Beckman et al.,
1990).
The interaction of hydroxyl radical with a number of cellular targets initiates 
events that lead eventually to cell death. The most important of such targets 
include: the phospholipids of cellular membranes with the initiation and 
propagation of lipid peroxidation; the mitochondrial inner membrane with the 
loss of energization and cellular stores of ATP; and DNA with the appearance 
of single-strand breakage (Halliwell & Gutteridge, 1984; Farber et al., 1990).
Being highly reactive hydroxyl radical has a very short half-life of about 1x10 "  
9 seconds at 37 °C (Yu, 1994) and therefore does not diffuse far from its site 
of production (Cheeseman & Slater, 1993). Generation of this radical also 
plays an essential role in the tissue damage caused by high energy radiation 
(Cross et al., 1987), and could explain part or all of the cytotoxicity attributed to 
excess of superoxide anion and hydrogen peroxide, since both species can 
lead to formation of hydroxyl radical.
To protect against hydroxyl radical damage, scavengers such as 
dimethylsulfoxide, mannitol, N,N-dimethyl thiourea, uric acid and compounds 
with thiol or sulphydryl groups (RSH) have been used under experimental 
conditions (Rubanyi, 1988; Bast et al., 1991). Besides that, chelators of 
divalent metal ions e.g. deferoxamine, which inhibits the formation of hydroxyl 
radical, have also been utilised (Cross et al., 1987; Rubanyi, 1988).
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ONOO' + -> ONOOH (peroxynitrous acid)
ONOOH -4. *OH + *N02
:
N 0 3 -
Hydroxyl radical has been suggested to facilitate ACh-induced relaxation in 
canine coronary arteries with endothelium (Rubanyi & Vanhoutte, 1986b). This 
conclusion was prompted by the inhibitory effects on ACh-induced relaxation 
of mannitol, which scavenges hydroxyl radicals (Cheeseman & Slater, 1993). 
Similarly to hydrogen peroxide, hydroxyl radical may trigger the 
synthesis/release of EDRF (Rubanyi, 1988). In smooth muscle cells, this 
radical may mediate vasodilatation by activating the soluble form of guanylate 
cyclase (see Rubanyi, 1988 for review).
2.1.4 Peroxy nitrite
Peroxynitrite is formed as a result of the interaction between NO and 
superoxide anion by the following reaction:
NO" + "0 2 " -> 0 N 0 0 -
■■I, '
In alkaline solutions, peroxynitrite (ONOO") is stable. However, at 
physiological pH peroxynitrite has a half-life of 1.9 seconds and has been 
shown to be the source of a strong oxidising agent with properties identical to 
those of the hydroxyl radical (Beckman et al., 1990). It has been proposed that 
peroxynitrite when protonated can lead to formation of nitrogen dioxide radical 
("NO2) and hydroxyl radical ("OH) as follows:
Furthermore, peroxynitrite can be generated by cells such as macrophages,
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neutrophils and vascular endothelium by the simultaneous generation of both 
superoxide anion and NO (Hogg et al., 1992).
Peroxynitrite is a powerful oxidant. In addition to producing oxidising hydroxyl 
radicals (shown above), it directly attacks sulphydryl groups of small molecules 
and proteins and initiates lipid peroxidation (Beckman et al., 1990; Radi etal., 
1991; Hogg et al., 1992), and may also be involved in endothelial damage 
(Kooy & Royall, 1994). Transition metals including copper in the active site of 
SOD catalyse the formation of N02"^-like species, which results in the nitration 
of aromatics substances (Ischiropoulos et al., 1992). Moreover, due to its 
ability to modify proteins by nitration of tyrosine residues, peroxynitrite has 
been shown to inactivate some important proteins including manganese- 
containing SOD (Ischiropoulos & Al-Mehdi, 1995), thus compromising an 
important component of the intrinsic antioxidant defence mechanism of the 
cell.
In addition to its actions as an oxidant, peroxynitrite is a powerful vasorelaxant. 
Wu et al. (1994) demonstrated relaxation of bovine pulmonary arteries by 
peroxynitrite which appeared to be due to nitrosylating tissue thiol groups that 
subsequently release NO. More recently, Mayer et al. (1995) demonstrated 
peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and 
stimulation of purified soluble guanylate cyclase.
2.2 Defences against reactive oxygen species
All forms of aerobic organisms are constantly subjected to oxidant pressure 
from molecular oxygen (O2 ) and from reactive oxygen metabolites produced 
both during the biochemical utilisation of O2 and by prooxidant stimulation of 
O2 metabolism (Cotgreave et al., 1988). Substances that neutralise the
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potential ill effects of free radicals are generally grouped in the so-called 
antioxidant defence system. The antioxidant systems responsible for cellular 
protection against oxidative stress are as diverse as the free radicals 
themselves. A variety of substances capable of scavenging many different 
species of free radicals are compartmentalised in the subcellular organelles 
within the cells to provide maximum protection. There are two main strategies 
of antioxidant defence. The first strategy is to prevent the generation of free 
radicals e.g. allopurinol by inhibiting xanthine oxidase activity prevents the 
production of superoxide anion, and transition metal-binding proteins, such as 
transferrin, by tightly binding the metal prevents its accessibility to act as a 
catalyst in the production of free radicals. The second strategy is to scavenge 
the radicals once they have been formed with antioxidants such as vitamin E, 
ascorbic acid (vitamin C), p-carotene (a metabolic precursor to vitamin A), or 
with specific enzymes such as superoxide dismutase, catalase and glutathione 
peroxidase (Cross et al., 1987; Cotg reave et al., 1988; Cheeseman & Slater,
1993).
2.2.1 Superoxide dismutase
Superoxide dismutases (SODs) are a family of metalloenzymes that catalyse 
the dismutation reaction, involving oxidation of one molecule of superoxide 
anion (*0 2 ") to oxygen (O2 ) and reduction of another *0 2 " to hydrogen 
peroxide (H2O2) (Halliwell, 1991):
SOD
*02" + *02" 2H"*" — >  H2O2 + O2
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The levels of superoxide anion within the cells are maintained at a low level (at 
10-12 -1Q-11 M) by SOD (Chance et al., 1979). The superoxide dismutases 
are very efficient catalysts and operate over a broad range of pH values 
(Fridovich, 1985). It is proposed that the clustering of positive charges around 
the active site of SOD, coupled with the broad distribution of negative charges 
elsewhere on the protein, attracts the negatively charged superoxide anion to 
the active site (Getzoff et al., 1983).
Superoxide dismutases are classified into four distinct classes. In mammalian 
systems three isoenzymes: Cu-Zn SOD, Mn-SOD and extracellular SOD (EC- 
SOD, also Cu-Zn-containing) are known (Marklund, 1984). Table 2.1 indicates 
the general properties of the mammalian isoenzymes. The fourth enzyme, Fe- 
SOD is structurally homologous to Mn-SOD and is only found in bacteria. All 
types catalyse the same reaction (shown above) with comparable efficiency.
Cu-Zn SOD is widely distributed mainly in the cytosol of eukaryotes (Hassan, 
1988) but also exists in the mitochondrial intermembrane space and in 
lysosomes (Taniguchi, 1992). Cu-Zn SOD is also present in some bacteria and 
chloroplasts (James, 1994). Cu-Zn SOD is composed of two identical subunits 
(i.e. a dimer) of molecular weight 16,000. Each subunit contains one Cu and 
one Zn molecule, noncovalently linked (Fridovich, 1975). Cu-Zn SOD is 
encoded by chromosome 21 in humans. It contains a glycated site and may 
undergo a non-enzymatic glycosylation under hyperglycemic conditions. 
Increased glycation is thought to be involved in the structural and functional 
changes in body proteins during normal aging and at accelerated rates in 
diabetes. Indeed, a high percentage of glycated Cu-Zn SOD has been 
reported in diabetic patients (Taniguchi, 1992).
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Property Cu-Zn SOD Mn-SOD EC-SOD
Distribution Cytosol Mitochondrial
matrix
Extracellular
Molecular weight 32,000 88,000 135,000
Subunits Dimer Tetramer Tetramer
(molecular weight) (16,000) (22 ,000) (35,000)
Metal/monomer 1 Cu, 1 Zn 1 Mn 1 Cu. 1 Zn
Inhibition by cyanide + — ++
Inhibition by 
diethyldithiocarbamate
+ — ++
Inhibition by 
chloroform/ethanol
---- + —
Rate constant for 
reaction with *0 2 " (M"1 
s-1)
0.62 X 1Q9 1.2x109 0.72-1.0 X 10®
Table 2.1 Some properties of human superoxide dismutase (SOD) 
isoenzymes (modified from Taniguchi, 1992)
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Cyanide is a reversible inhibitor of Cu-Zn SOD (Fridovich, 1978). Both 
intracellular and extracellular forms of the enzyme are also inhibited by 
diethyldithiocarbamate (DETCA, Heikkila et a/., 1976; Cocco et a/., 1981; 
Kelner et al., 1989). This irreversibly binds Cu at the active site and removes 
the metal from the enzyme. The copper ion appears to function in the 
enzymatic reaction, whereas the zinc stabilises the enzyme (Taniguchi, 1992). 
Furthermore, hydrogen peroxide has the additional action of inhibiting Cu-Zn 
SOD activity (Bray etal., 1974; Taniguchi, 1992).
Some bacteria contain either Mn-SOD or Fe-SOD while some contain both 
types (Fridovich, 1985; James, 1994). In eukaryotes, Mn-SOD is encoded by a 
nuclear gene and its activity is mainly restricted to the mitochondria (Hassan,
1988). In humans, the Mn-SOD gene is located on chromosome 6 (Taniguchi,
1992). Bacterial Mn-SOD can be either homodimeric or tetrameric, whereas 
eukaryotic Mn-SOD is tetrameric (James, 1994). The monomeric size of Mn- 
SOD and Fe-SOD is about 20-24 kDa and both types contain one metal ion 
per monomer. The metal ion is specific and replacement results in the loss of 
activity (James, 1994). In contrast to Cu-Zn SOD, Mn-SOD is not inhibited by 
cyanide or DETCA but is destroyed by chloroform and ethanol (Fridovich,
1978). Involvement of Mn-SOD in aging and disease has also been implicated. 
High levels of Mn-SOD as determined by the ELISA are present in the serum 
of patients with certain malignant conditions including gastric cancer, primary 
hepatoma, epithelial ovarian cancer, and acute myeloid leukemia (see 
Taniguchi, 1992 for review).
Extracellular SOD (EC-SOD) is a tetrameric high molecular weight (about 
135,000) enzyme and is found in numerous extracellular fluids including 
plasma, lymph, and synovical fluid (Marklund, 1990). EC-SOD shows a 
sensitivity to heparin suggesting that it is bound to the cell surface (James,
1994).
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Control of biosynthesis of SODs by their substrates, or by products derived 
from them, provide cells with important regulatory mechanisms. Bacteria 
possesses a series of elaborate and interacting genes that can sense changes 
in intracellular levels of superoxide anion and hydrogen peroxide and 
accordingly regulate the synthesis of the enzymes. In higher organisms, metal 
ion cofactors and cytokines such as interleukin-1 and tumour necrosis factor 
(TNF-a) impose pre- and post-translational control over the genetic expression 
of the enzymes (see Fridovich, 1983; 1985; Harris, 1992 for review).
The biological importance of SODs is demonstrated in simple organisms such 
as bacteria and yeast mutants devoid of the enzyme. Such mutants are more 
susceptible to oxidative stress and develop greater resistance to oxidative 
challenge following réintroduction of the SOD gene (Harris, 1992; Warner, 
1994). In humans, altered expression of SOD has been linked to two genetic 
diseases; Downs syndrome in which an extra copy of chromosome 21 is 
present and a 50 % elevation in Cu-Zn SOD levels has been observed 
(Garber et al., 1979), and familial amyotrophic lateral sclerosis (ALS) which is 
an age-dependent degenerative disorder of motor neurons in the cortex, brain 
stem and spinal cord arising from the mutation in the gene encoding the 
cytosolic Cu-Zn SOD (Rosen et al., 1993). Taken together, SOD plays an 
important role in the survival of an organism. The potential role of SOD in 
protecting endothelial NO from inactivation by superoxide anion remains to be 
determined.
2.2.2 Catalase
With the exception of certain micro-organisms such as the bacterium Bacillus 
popilliae, catalase activity is present in nearly all forms of life (Halliwell & 
Gutteridge, 1989). As with SOD, human catalase levels show great tissue
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heterogeneity; they are highest in erythrocytes, liver and kidney and low in 
brain, skeletal muscle, pancreas, and lung tissue (Halliwell & Gutteridge, 1989;
Yu, 1994). Catalase consists of 4 protein subunits (i.e. is tetrameric), each of 
which contains a haem (Fe^+.protoporphyin) group bound to its active site and 
has a molecular weight of about 60,000 (Brill, 1962). Catalase is mainly 
localised in subcellular organelles such as peroxisomes (microbodies) or in 
much smaller aggregates such as the microperoxisomes of the cells 
(Schonbaum & Chance, 1976; Chance et al., 1979).
Catalase Is a major primary antioxidant defence component that primarily 
works to catalyse the decomposition of hydrogen peroxide to water, sharing 
this function with glutathione peroxidase (Halliwell & Gutteridge, 1989; 
Cheeseman & Slater, 1993). Both enzymes detoxify oxygen reactive radicals 
by catalysing the removal of hydrogen peroxide derived from superoxide. In 
addition to the difference in their substrate specificities (Chance et al., 1979;
Yu, 1994), these two enzymes have different substrate affinities. Catalase has 
a high capacity for the reduction of hydrogen peroxide but a low affinity for its 
substrate (Cotgreave et al., 1988) whereas, glutathione peroxidase and other 
peroxidases have a low capacity but a high affinity. Consequently, it is 
generally believed that low levels of hydrogen peroxide are preferentially 
removed by peroxidases. However, higher concentrations of hydrogen 
peroxide are metabolised by catalase (Cohen & Hochstein, 1963; Nicholls,
1972; Jones et al., 1981; Dobrina & Patriarca, 1986; Verkerk & Jondkind,
1992).
The mechanism by which catalase acts is rather complex. It appears to be the 
only antioxidant enzyme that exhibits dual activities: (1) decomposition of 
hydrogen peroxide (H2O2) to give water and oxygen (catalytic activity, Chance 
et al., 1952); and (2 ) oxidation of hydrogen donor substances (AH2 )
I
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such as ascorbate, ferrocyanide, phenols, short chain alcohols, sodium azide 
and hydroxylamine in the presence of low concentrations of hydrogen 
peroxide (peroxidatic activity, Theorell & Ehrenberg, 1952; Keilin & Hartree, 
1954; Keilin & Nicholls, 1958; Nicholls & Schonbaum, 1963; Nicholls, 1964; 
Schonbaum & Chance, 1976). The three key steps shown below provide a 
complete description of the kinetics of catalase (CAT) in its catalytic (Eqn 1 
and 2) and peroxidatic (Eqn 1 and 3) functions:
CAT-Fe^"^ + H2O2 compound I (1)
compound I + H2O2 CAT-Fe^+ + 2H2O + O2 (2)
compound I + AH2 CAT-Fe^"*" + 2 H2O + A (3)
The predominant reaction depends on the concentration of the hydrogen 
donor and the steady-state concentration or rate of production of H2O2 in the 
system. The catalytic reaction proceeds exceedingly rapidly whereas 
peroxidatic reactions proceed relatively slowly (Schonbaum & Chance, 1976). 
Both reactions involve the formation of the intermediate, compound I. The 
green compound I (Fe^"^) observed in cells and tissues involves the transfer of 
two-electrons from the ferric (Fe^'*') iron of the haem in the resting state of 
catalase to the peroxide, and thus peroxide is reduced (Chance et al., 1979; 
Du & Loew, 1995). Catalase in the native form (Fe^+) shows characteristic 
optical spectra with a, p and Soret bands around 600, 500, and 400 nm, 
respectively (Schonbaum & Chance, 1976). The decrease in absorbance at 
405 nm in the Soret band and the red shift of the a-band to 660 nm are
characteristics of compound I (Schonbaum & Chance, 1976).
Two well characterised hydrogen donors which act as substrates for 
peroxidation are sodium azide and hydroxylamine. These undergo oxidation to 
nitrous oxide, nitrogen, and nitric oxide (Theorell & Ehrenberg, 1952; Keilin &
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Hartree, 1954; Nicholls, 1964). The nitric oxide thus produced is believed to 
underly ability of sodium azide and hydroxylamine to activate soluble 
guanylate cyclase and promote vascular relaxation (Katsuki et al., 1977; 
Waldman & Murad, 1987; Murad, 1994). Although biochemical evidence 
supporting the role of catalase in the activation of soluble guanylate cyclase by 
sodium azide and hydroxylamine is strong (Miki et al., 1976; Katsuki et al., 
1977; Craven et al., 1979), direct proof of the involvement of this enzyme in 
vascular relaxation is lacking.
Catalase activity can be inhibited by sodium azide and hydroxylamine in the 
presence of hydrogen peroxide. This phenomenon depends on the reduction 
of catalase compound I to a ferrous derivative; the derivative with bands at 
587 and 559 nm is probably nitric oxide ferrocatalase (Keilin & Nicholls, 1958). 
Cyanide by accelerating the reduction of compound I to compound II (inactive 
form) inhibits the activity of catalase (Keilin & Nicholls, 1958). Furthermore, 
superoxide anion has been shown to inhibit the activity of catalase by reducing 
compound I to compound II (Shimizu et al., 1984). This inhibition is rapidly 
reversed by SOD and may provide the basis for a synergism between SOD 
and catalase (Kono & Fridovich, 1982). A commonly used inhibitor is 3-amino-
1,2,4-triazole (AT) which inhibits endogenous catalase activity when fed to 
animals or plant tissues. Heim et al. (1956) demonstrated that AT irreversibly 
inhibits the catalytic function in liver. The reaction was originally found to occur 
only in vivo and not with the isolated enzyme. This behaviour was explained 
by Margoliash and Novogrodsky (1958), who noted that the inhibition depends 
upon the presence of peroxides or compounds susceptible to autooxidation, 
and proposed a reaction between catalase compound I and AT:
catalase + H2O2 -> compound I
compound I + AT inhibited enzyme
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Thus, AT binds to the intermediate compound I, and not to the native enzyme.
As for SOD, catalase activity can also be up-regulated in some conditions by 
exposure of cells or organisms to oxidative stress (Cotgreave et al., 1988). It 
has been demonstrated that the development of resistance to high H2O2 
concentrations in Chinese hamster fibroblasts was concomitant with 20-fold
' ;
2GSH + H2O2 GSSG + 2 H2O
or
2GSH + ROOM GSSG + H2O + ROM
Gpx needs reduced GSH to detoxify peroxides. A high concentration of 
reduced GSH is maintained within the cell. Glutathione reductase is a dimeric
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increase in catalase activity. These cells were also more resistant to hyperoxia 
(Spitz et al., 1992). Furthermore, an increase in the levels of catalase has 
been demonstrated in diabetic rats (Langenstroer & Pieper, 1992). These 
studies suggest an important role for catalase in the overall antioxidant 
capacity of the cell. The potential role of catalase in protecting vascular 
function from the oxidant, hydrogen peroxide, remains to be determined.
2.2.3 Glutathione peroxidase
Glutathione peroxidase (Gpx) is present in most species and is located 
intracellularly in the cytosol and mitrochondrial matrix (Chance et al., 1979;
;
Meister & Anderson, 1983). It catalyses the reduction of hydrogen peroxide 
(H2O2) and organic hydroperoxides (ROOH), while oxidising two molecules of 
glutathione (GSH) to form oxidised glutathione disulphide (GSSG) and water 
(Little & O'Brien, 1968; Christophersen, 1969; Smith et al., 1989). The 
reactions are as follows:
jîv
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enzyme containing FAD in the active sites and utilises NADPH to reduce the 
oxidised GSSG back to GSH (Meister & Anderson, 1983). Gpx enzyme exists 
in two broad families; selenium-dependent (Se-Gpx) and selenium- 
independent (non Se-Gpx). Both types have been shown to catalyse the 
above reactions and thus protect against oxidant damage by reducing 
peroxides. Se-Gpx is tetrameric with a molecular weight of about 76,000 and 
non Se-Gpx is dimer with a molecular weight of about 46,000 (Chance et al.,
1979). The non Se-Gpx utilises organic hydroperoxides as preferred 
substrates over H2O2 (Yu, 1994). Gpx being a major pathway for the 
metabolism of lipidic peroxides and H2O2 in many cells is important for the 
protection of biological membranes against lipid peroxidation (McCay et al., 
1976).
The activity of Gpx is regulated by the levels of NADPH and reduced
glutathione (GSH) in the cells (Meister & Anderson, 1983; Michiels et al., 
1994). In addition, the levels of the enzyme may be up-regulated in oxidative 
stress. Prolonged exposure to hyperoxia has been shown to raise the levels of 
Gpx and glutathione reductase in rat lungs (see Cotg reave et al., 1988; Harris, 
1992 for review).
A key protective role for glutathione peroxidase has been suggested in a 
variety of tissues including the heart (Doroshow et al., 1980; Simmons & 
Jamall, 1989), liver (Simmons & Jamall, 1988), endothelial cells (Harlan et al., 
1984; Tsan et al., 1985; Suttorp et al., 1986), tumour cells (Nathan et al., 
1980; Arrick et al., 1982), red blood cells (Lai et al., 1980), cultured gastric 
mucous cells (Hiraishi et al., 1991), and human fibroblasts (Michiels & 
Remade, 1988).
2.3 Reactive oxygen species in pathological processes
Enzymatic and non-enzymatic reactions continuously generate reactive 
oxygen metabolites and free radicals in cells and tissues. The organism 
possesses a delicate equilibrium between free radical production and 
antioxidant systems which may be altered in many pathological processes,
hypercholesterolemia/atherosclerosis and diabetes (Cheeseman & Slater,
1993).
such as ischemia-reperfusion injury, hypertension.
Ischemia is the deprivation of oxygen to tissues. The extent of the damage 
caused to the affected tissue is dependent upon the duration of the ischemic 
period and the level of oxygen deprivation (Halliwell & Gutteridge, 1989).
Tissues respond to ischemia in number of ways, including a fall in ATP levels 
and degradation of AMP resulting in the accumulation of hypoxanthine (Kloner 
et al., 1989). In addition, cytosolic Ca^+ concentrations increase owing to an 
anoxia-dependent cation gradient alteration which leads to the activation of 
proteases that convert xanthine dehydrogenase to xanthine oxidase (McCord, :
1985). When the ischemic tissue is reperfused, hypoxanthine reacts with 
molecular oxygen in the presence of xanthine oxidase to form superoxide and 
xanthine; xanthine is in turn converted to superoxide and uric acid by xanthine 
oxidase (Parks & Granger, 1986; Rubanyi, 1988). Activated neutrophils are 
another potential source of oxygen free radicals (Werns & Lucchesi, 1990;
Ward, 1991). Evidence supporting the role of free radicals in ischemia- 
reperfusion damage has been provided by studies in the intestine (Granger,
1988), myocardium (Downey, 1990; Flaherty, 1991), kidney (Greene & Palier,
1994) and brain (Tsung et al., 1989; Liu et al., 1989). Furthermore, the 
protective effects of exogenous SOD and catalase alone or when combined 
are well demonstrated in myocardial and brain ischemia-reperfusion injury
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(Jolly et al., 1984; Gross et al., 1986; Aoki et al., 1988; Tamura et al., 1988; 
Llu etal., 1989; Tsung etal., 1989; Moore & Traystman, 1994).
In acute hypertension, the generation of superoxide and other radicals (Kontos 
et al., 1981) and impairment of endothelium-dependent vasodilatation (Wei et 
al., 1985) has been demonstrated. Vega et al. (1995) demonstrated a lower 
EDRF/NO availability in vessels of hypertensive rats and suggested that this 
was due to enhanced production of superoxide anion. Furthermore, reductions 
in the SOD activity are reported to occur in the myocardium (Ito et al., 1995) 
and aorta of the spontaneously hypertensive rat (SHR) (Vega et al., 1995), 
and the erythrocytes of patients with pregnancy-induced hypertension (Chen 
et al., 1994). Moreover, the infusion of a membrane-permeant form of SOD 
has been shown to lower blood pressure in SFIR rats but not in their 
normotensive Wistar Kyoto controls (Nakazono et al., 1991). Angiotensin li­
med iated hypertension in rats has also been shown to be associated with 
increased vascular superoxide production and, again, membrane-permeant 
SOD improves endothelial NO activity in hypertensive vessels (Rajagopalan et 
al., 1996).
Another major cardiovascular disease where the role of superoxide anion has 
been implicated is hypercholesterolemia/atherosclerosis. In this case, the 
enhanced production of superoxide anion has been suggested to arise from 
the oxidation of low density lipoproteins (LDL, Kimura et al., 1995; Ohara et 
al., 1995). Oxidised LDL has been demonstrated to inhibit endothelium- 
dependent relaxations in various preparations (Jacobs et al., 1990; Taner et 
al., 1991; Plane et al., 1992; Jiang et al., 1995). Furthermore, a massive 
breakdown of NO has been reported to occur in atherosclerotic rabbits (Minor 
et al., 1990). This observation may suggest an increased formation of 
superoxide anion and/or decreased activity of SOD in the vascular wall leading
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to enhanced destruction of NO. Furthermore, administration of membrane- 
permeant SOD, poiyethyiene-glycolated (PEG-SOD) partially restores the 
impaired endothelium-dependent relaxation in vessels from 
hypercholesterolemic rabbits (Mügge etal., 1991a).
There is considerable evidence to show that the generation of free radicals is 
enhanced in diabetes (Langenstroer & Pieper, 1992; Chang et al., 1993) and 
that these reactive species mediate impairment of endothelium-dependent 
relaxations (Pieper & Gross, 1988; Diederich et al., 1994; Tesfamariam, 1994). 
Furthermore, administration of SOD has been shown to restore the impaired 
endothelium-dependent relaxation in diabetic rat aorta (Hattori et al., 1991).
The role of free radicals has also been implicated in inflammation (Halliwell, 
1982; Cross etal., 1987) and cytotoxic brain injury (Lipton et al., 1993).
SOD clearly, therefore, offers enormous therapeutic potential in a large 
number of vascular diseases. Liposome encapsulated SOD or CAT may 
provide a useful means of delivering these enzymes to the tissues (Freeman 
etal., 1985).
2.4 Aims of the study
The aims of the study were:
1 . To determine if basal and ACh-stimulated activity of NO were equally 
sensitive to destruction by superoxide anion. The effects of superoxide anion 
were assessed by generating the free radical either using the 
hypoxanthine/xanthine oxidase (HX/XO) system or the drug pyrogallol.
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2. To determine the extent to which endogenous Cu-Zn SOD protects basal 
and ACh-stimulated activity of NO against destruction by superoxide anion. 
The inhibition of endogenous Cu-Zn SOD was achieved with the copper 
chelator, diethyldithiocarbamate (DETCA).
3. To test the hypothesis that metabolism by catalase is necessary in order to 
express the relaxant activities of hydrogen peroxide and the nitrovasodilators, 
sodium azide and hydroxylamine.
4. To assess the impairment induced by hydrogen peroxide of vascular 
reactivity.
5. To determine the protective role of endogenous catalase against hydrogen 
peroxide-induced damage. The inhibition of endogenous catalase was 
achieved with 3-amino-1,2,4-triazole (AT).
5
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METHODS
Chapter 3
Rat Aortic Rings
3.1 Preparation of tissues, tension recording and experimental 
conditions
3.1.1 Preparation of rat aortic rings
3.1.2 Tension recording
Male Wistar rats (200-300 g) were killed by stunning and exsanguination. The 
thoracic aorta was carefully dissected and removed into Krebs' solution in a 
Petri dish. The aorta was cleared of adhering fat and connective tissue and 
cut into 2.5 mm long transverse rings using a razor blade slicing device. In i
some experiments, the endothelium was removed to eliminate the contribution 
of constitutively produced nitric oxide (NO). This was achieved by locating the 
aortic ring between two stainless steel hooks, placing a 2 g weight on the 
bottom hook and gently rubbing the intimai surface with a moist matchstick for 
10-20 s. Removal of the endothelium was deemed successful if no relaxation 
took place in response to the endothelium-dependent relaxant, acetylcholine 
(ACh; 1 pM) following development of phenylephrine (PE; 10-30 nM)-induced 
tone.
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,The aortic rings were mounted on stainless-steel hooks under 1 g resting 
tension in 20 ml organ baths and bathed at 37 °C in Krebs' solution aerated 
with 95 % O2 and 5 % CO2 . Great care was taken during the whole procedure 
to avoid unnecessary stretch of the tissue. Tension was recorded isometrically 
by means of Grass FT03C transducers and responses were displayed on a
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Grass polygraph, model 7. The tissues were allowed to equilibrate for 60-90 
min before experiments were carried out, during which time the resting tension 
was re-adjusted to 1 g, as required. The Grass polygraph and isometric 
transducers were calibrated at the start of each day.
3.1.3 Krebs' Solution
The composition (mM) of the Krebs' solution was based on that described by 
Krebs and Henseleit (1932):
NaCI 118.0 KCI4.8 CaCI^ 2.5
MgSO^ 1.2 KH2PO4 1.2 NaHCOg 24.0 
glucose 11.0
All components, except glucose and NaHCOg were prepared as a 10-times 
concentrated stock solution with distilled water. The stock solution was diluted 
by 1:10 with distilled water. Glucose and NaHCO^ were added last and the 
final Krebs' solution was bubbled with 5 % COg and 95 % Og for 15-20 min 
before use.
3.1.4 Temperature
The Krebs' solution in organ baths and in the tubes delivering Krebs to the 
baths was maintained at 37 °C by a water jacket heated by a thermostatically 
controlled pump (Techne Tempette Junior TE-8J).
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3.1.5 Induction of tone
The alpha-j-adrenoreceptor agonist, phenylephrine (PE, 10-100 nM), was 
used to induce contractile tone in the rings. Once the contraction to PE had 
stabilised, the relaxant stimuli were added. Responses to relaxant stimuli were 
expressed as a percentage (%) relaxation of the PE-induced tone.
3.2 Experimental protocol for assessing the effects of 
superoxide anions on basal and agonist-stimulated activity of 
nitric oxide (NO) and role of superoxide dismutase
3.2.1 Basal activity of NO
Basal activity of NO was assessed indirectly by measuring the endothelium- 
dependent depression of phenylephrine (PE)-induced vasoconstriction (Martin 
et al., 1986). The rationale for these experiments is that basal production of 
NO in endothelium-containing rings of rat aorta exerts a tonic vasodilator 
action opposing the effects of vasoconstrictor agents (Eglème et al., 1984;
Martin et al., 1986; Martin, 1988). Consequently, this endothelium-dependent 
depression of vasoconstriction would expected to be blocked or enhanced by 
agents which inhibit or enhance the activity of NO, respectively.
-H
3.2.1.1 Effects of superoxide anion generators and superoxide
dismutase on basal activity of NO
We utilised two well known superoxide anion generators; hypoxanthine 
(HX)/xanthine oxidase (XO) and pyrogallol to produce superoxide anion in the 
solution surrounding the tissue.
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HX o  xanthine + *0 2 “ 
x L x o  
uric acid + *02“
HX/XO is a simple enzymic system where xanthine oxidase catalyses the 
conversion of hypoxanthine to xanthine and superoxide anion. Xanthine is 
further converted to uric acid by xanthine oxidase with concomitant release of 
another superoxide anion (Halliwell & Gutteridge, 1989).
pyrogallol semlquinone + O2 <=> quinone + *02"
Pyrogallol autooxidises to semlquinone which then reacts reversibly with 
oxygen to form quinone and superoxide anion (Halliwell & Gutteridge, 1989).
in these experiments, endothelium-containing rings were contracted with PE 
(10-30 nM) and when the contraction had stabilised, the effects of 
hypoxanthine (HX, 0.1 mM)/xanthine oxidase (16 mu mh'1) and pyrogallol (0.1 
mM) were examined on tone.
The effects of superoxide dismutase (SOD, 1-300 u mb'!) were also studied 
on PE (10-30 nM)-contracted endothelium-containing rings. SOD scavenges 
superoxide anion by converting it to hydrogen peroxide (H2O2).
SOD
:
*02 ' + 2 H2O ^^2 ^2
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This dismutation can also occur spontaneously, but the presence of SOD 
dramatically accelerates the reaction (Salvemini & Botting, 1993). SOD acts 
as an important antioxidant defence mechanism against the damage resulting 
from the overproduction of superoxide anion in the cells.
In the early experiments with HX/XO, it was clear that a delayed relaxant 
effect was produced resulting from the generation of hydrogen peroxide 
(H2O2). Consequently, where indicated in the Results, experiments were 
performed in the presence of catalase (3000 u ml” "^ ) to prevent the 
accumulation of hydrogen peroxide.
CAT
2 H 2 O 2  —> 2 H 2 O  +  O 2
Catalase is present in many cell types and acts as a natural defence against 
the accumulation of hydrogen peroxide (Halliwell, 1982; Cheeseman & Slater,
1993).
3.2.1.2 Effects of diethyldithiocarbamate on basai activity of NO
In certain experiments, we wished to use diethyldithiocarbamate (DETCA), an 
inhibitor of Cu-Zn SOD (Heikkila et al., 1976; Cocco et al., 1981, Halliwell & 
Gutteridge, 1989), to inhibit the activity of endogenous SOD. There are two 
major forms of this enzyme, a Cu-Zn-containing form which is located both 
extracellularly and intracellularly and a Mn-containing form which mainly 
resides in the mitochondria (Hassan, 1988). The copper chelator, DETCA, 
inhibits Cu-Zn SOD both intracellularly and extracellularly (Kelner et al., 1989),
3.2.1.3 Effects of NO synthase inhibitors on basal activity of NO
Each of the above experiments (sections 3.2.1.1; 3.2.1.2 and 3.2.1.3) was 
also conducted in endothelium-denuded rings but the concentration of PE 
used was lowered to 1-3 nM so as to attain a similar degree of tone to that 
obtained in endothelium-containing rings.
but has no effect on Mn-SOD. The effects of inhibiting endogenous Cu-Zn 
SOD were investigated on the endothelium-dependent depression of PE- 
induced tone. In these experiments, endothelium-containing rings were 
incubated with DETCA (0.1 mM) for 1h, followed by extensive washing, before 
the contractile actions of PE (20 nM) were examined. Since DETCA 
irreversibly inhibits the SOD by chelating copper in the enzyme, once it has 
produced its effect it no longer needs to be present. Adopting this procedure 
also meant that any non-specific effects of the drug would have been removed 
following washing. Moreover, washing the DETCA out permitted the option of 
putting back exogenous SOD (250 u ml"'^) to try to reverse the inhibitory 
effects of the drug.
Inhibitors of the NO synthesis are known to block the endothelium-dependent 
depression of vasoconstriction induced by basal NO (Frew et a i, 1993) and so 
can be used to determine the magnitude of basal NO activity in a tissue. In 
these experiments, endothelium-containing rings were contracted with PE (20 
nM) and when the tone had stabilised, the effects of inhibiting the NO 
synthesis with analogues of L-arginine: N*^-monomethyl-L-arginine (L-NMMA, 
30 pM; Rees et al., 1989; 1990a) or N^-nitro-L-arginine (L-NOARG, 30 pM; 
Moore et al,, 1990) alone or in combination with HX (0.1 mM)/XO (16 mu ml~ 
1) were examined on PE (20 nM)-induced tone.
V:
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3.2.2 Agonist-stimulated activity of NO
The production of NO is stimulated by a large number of biological mediators 
such as acetylcholine (ACh, Furchgott & Zawadzki, 1980a) and by the 
physical shearing force of the flowing blood (Pohl et al., 1986).
Agonist-stimulated activity of NO was determined by assessing ACh-induced 
relaxation. Cumulative concentration-response curves to ACh (10 nM-3 pM) 
were constructed in endothelium-containing rings following induction of sub- 
maximal PE (30-100 nM)-induced tone. The baths were washed out, and the 
tissues allowed to re-equilibrate.
3.2.2.1 Effects of superoxide anion generators on ACh-stimuiated 
activity of NO
In experiments in which the effects of HX (0.1 or 1 mM)/XO (16 mu mb'*) and 
pyrogallol (0.1 or 0.3 mM) were to be studied on ACh (10 nM-3 pM)-induced 
relaxation, we ensured that the level of tone prior to inducing relaxation was 
similar to that of untreated preparations. In order to achieve this, tissues were 
initially precontracted with lower concentrations of PE (10-30 nM). Subsequent 
addition of the free radical generators produced a further elevation of tone in 
endothelium-containing tissues by destroying basal NO activity, and when the 
contraction had stabilised, a further cumulative concentration-response curve 
to ACh was obtained.
In some experiments, the ability of exogenously added SOD (250 u mh^, 20 
min) to protect against the inhibitory effects of HX/XO and pyrogallol was 
also studied. All experiments were conducted in the presence of catalase 
(3000 u mb'!) to prevent the relaxant effects of HX/XO and pyrogallol resulting
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from the accumulation of hydrogen peroxide.
3.2.2 2 Effects of superoxide dismutase on ACh-stimulated activity 
of NO
In these experiments, endothelium-containing rings were initially contracted 
with PE (10-30 nM). Subsequent addition of superoxide dismutase (SOD, 50 u 
ml"'^) produced a relaxation of PE-induced tone. We ensured that the level of 
tone prior to inducing relaxation to ACh (10 nM-3 pM) was similar to that of 
untreated preparations. In order to achieve this, the concentration of PE was 
increased to 100 nM.
3.2.2.3 Effects of diethyldithiocarbamate on ACh-stimulated activity 
of NO
In studies involving inhibition of endogenous Cu-Zn SOD, the rings were 
incubated with DETCA for 1h followed by extensive washing. Various 
concentrations of DETCA were tested, and 0.1 mM was chosen for most 
experiments since it produced a sub-maximal (25-30 %) inhibition of ACh- 
induced relaxation by itself. Cumulative concentration-response curves to ACh 
(10 nM-3 pM) in the presence of HX (0.1 mM)/XO (16 mu m|-1) and pyrogallol 
(0.1 mM) were also constructed in DETCA-treated rings. All experiments 
involving HX/XO, pyrogallol or DETCA were conducted in the presence of 
catalase (3000 u m|-1), added as 5 min pretreatment to prevent the 
accumulation of hydrogen peroxide.
In some experiments, the ability of exogenously added SOD (250 u m|-1) to 
protect against the inhibitory effects of HX/XO, pyrogallol or DETCA was 
studied and, in these, it was added as a 20 min pretreatment.
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3.3 Experimental protocol for assessing the role of catalase In 
relaxations Induced by hydrogen peroxide and 
n Itrovasod I lators
3.3.1 Hydrogen peroxide-induced relaxations
The effects of hydrogen peroxide (H2O2 , 100 nM-1 mM) were examined on 
both endothelium-containing and endothelium-denuded rings, precontracted 
with PE 100 nM and 10 nM, respectively.
In a separate series of experiments, the effects of methylene blue, an inhibitor 
of soluble guanylate cyclase (MeB, 30 pM, Gruetter et a/., 1979; Holzmann, 
1982; Martin et al., 1985a) and N^-nitro-L-arginine methyl ester (L-NAME, 30 
pM; Rees et al., 1990a) alone or in combination with L-arginine (L-arg, 2 mM) 
were studied on hydrogen peroxide-induced relaxations. In these experiments, 
rings were incubated with MeB or L-NAME for 20 min. We ensured that the 
level of tone prior to inducing relaxation to hydrogen peroxide was similar to 
that of untreated preparations. In order to achieve this, tissues were initially 
precontracted with a lower concentration of PE (3-30 nM) before addition of 
the inhibitors. This was necessary since both L-NAME and MeB potentiated 
tone by blocking the synthesis and actions of basal NO, respectively.
The effects of superoxide dismutase (SOD, 50 u mb'!) and catalase (CAT, 
1000 or 3000 u mh'^) were also studied on hydrogen peroxide-induced 
relaxation precontracted with PE (10-30 nM). In these experiments rings were 
incubated with SOD or CAT for 20 min and cumulative concentration- 
response curves to hydrogen peroxide were constructed.
I
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3.3.2 Vasodilator actions of sodium azide, hydroxyiamlne and 
glyceryl trinitrate
In a separate series of experiments, the vasodilator actions of three 
nitrovasodilators: sodium azide (NaNg, 1-300 nM), hydroxylamine (NH2OH, 1- 
300 nM) and glyceryl trinitrate (GTN, 1-100 nM) were investigated in 
endothelium-denuded rings, precontracted with PE (10-30 nM). The effects of 
the inhibitor of soluble guanylate cyclase, MeB (30 pM), were also studied on 
relaxations induced by these nitrovasodilators.
3.3.3 Use of 3-amino-1,2,4-triazoie
In certain experiments, we wished to use 3-amino-1,2,4-triazole (AT), a 
selective inhibitor of catalase (Heim et al., 1956; Margoliash & Novogrodsky, 
1958), to inhibit the endogenous catalase activity of rat aortic rings.
Pretreatment with AT (50 mM, 90 min) depressed PE (10 nM)-induced tone by 
31.8 ± 2.2 % (n=15), but we ensured that the level of tone prior to inducing 
relaxation was similar to that of untreated preparations by increasing the 
concentration of PE (to 30-100 nM). AT (50 mM), when added to the tissue
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In order to establish the conditions necessary to produce optimum inhibition, 
we first conducted a series of experiments using exogenous catalase (bovine 
liver). In these experiments, endothelium-denuded rings were incubated either 
with catalase (1000 u mh^) or with catalase together with AT (50 mM) for 30 
and 90 min. As shown in the Results (Figure 5.8), incubation of catalase with 
AT for 90 min was required to maximally inhibit the ability of the enzyme to 
block hydrogen peroxide-induced relaxation. Consequently, in all subsequent 
experiments involving AT, tissues were incubated with the drug for 90 min.
baths, remained in solution and had no effect on the pH of the Krebs' solution. 
The addition of AT clearly resulted in an increase of the osmotic strength of 
Krebs' solution. This, however, played no role in the actions of AT since 
addition of the inert substance, mannitol, at the same concentration (50 mM, 
90 min) had no effect on relaxations induced by sodium azide (1-300 nM), 
hydroxylamine (1-300 nM), glyceryl trinitrate (1-100 nM) or hydrogen peroxide 
(10 pM-1 mM) (data not shown).
In order to determine if the depression of PE-induced tone by AT was due to 
activation of soluble guanylate cyclase, the effects of the inhibitor of guanylate 
cyclase, MeB, were studied on AT-induced relaxation. In these experiments, 
endothelium-denuded rings were precontracted with PE (30-100 nM) and 
cumulative concentration-response curves to AT (1-100 mM) were constructed 
in the presence of MeB (30 pM, 20 min).
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3.3.4 Effects of 3-amino-1,2,4-triazole on relaxations induced by 
sodium azide, hydroxylamine, glyceryl trinitrate and hydrogen 
peroxide
Catalase has been proposed to play an important role in mediating relaxations 
induced by certain nitrovasodilators and hydrogen peroxide. This hypothesis 
was tested by inhibiting endogenous catalase with AT (1-50 mM, 90 min). 
Consequently, the effects of this inhibition were studied on relaxations of 
endothelium-denuded rings induced by sodium azide (NaNs, 1-300 nM), 
hydroxylamine (NH2OH, 1-300 nM), glyceryl trinitrate (GTN, 1-100 nM) and 
hydrogen peroxide (H2O2 , 10 pM-1 mM), following precontraction with PE 
(30-100 nM).
■
3.4 Measurement of nitrite production
It has been proposed that conversion of azide and hydroxylamine to NO by 
catalase requires the presence of low concentrations of hydrogen peroxide 
and thus occurs as a consequence of the peroxidase activity of the enzyme 
(Theorell & Ehrenberg, 1952; Keilin & Hartree, 1954; Nicholls, 1964; Klebanoff 
& Nathan, 1993; Figure 3.1). Using bovine liver catalase we measured the 
production of nitrite, a major stable product of NO, from certain 
nitrovasodilators.
3.4.1 Nitrite assay
NO has a short half life of around 5 seconds and decays to form the stable 
end products of nitrite and nitrate.
NO N0 2 ’ (nitrite) + NO3- (nitrate)
The majority of NO decays to nitrite in vitro (Stuehr & Marietta, 1987a,b). In 
vivo, however, NO is mainly converted to nitrate in whole blood, but in plasma, 
a ratio of 5:1 nitrite: nitrate is formed (Wennmalm et al., 1992). The presence 
of haemoglobin in blood is thought to be responsible for the conversion to 
nitrate. However, Ignarro et al. (1993) demonstrated that in aqueous solutions 
in the absence of any haem containing proteins, nitrite is the major oxidation 
product of NO.
3.4.2 Greiss reaction
The accumulation of nitrite was measured by the formation of a diazo product 
using a variant of the method of Green ef a/. (1982), i.e. the samples (80
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HoO2^2
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2 H 2 O + O 2
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CAT - H2O2 
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Figure 3.1 Proposed dual function of catalase: breakdown of hydrogen 
peroxide (H2O2) to water and oxygen (catalase activity) and oxidation of 
hydroxylamine (NH2OH) and sodium azide (NaNs) in the presence of H2O2 
(peroxidase activity) (Keilin & Hartree, 1945; Chance et aJ., 1952; Theorell & 
Ehrenberg, 1952; Nicholls, 1964).
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pi) were mixed with 80 pi of 1% sulphanilic acid in 2M HCI. After 5 min, 80 pi 
of 1% (w/v) aqueous N-(1-napthyl)-ethylenediamine dihydrochloride was 
added, and the absorbance of the pink complex was determined at 550 nm 
using a Dynatech Microplate Reader model no MR 5000/7000. A standard 
curve was prepared with solutions of sodium nitrite (1-30 pM, Figure 3.2). The 
nitrite concentration of unknowns was determined automatically by the 
computer-controlled plate reader by interpolation from the standard curve.
3.4.3 Catalase-dependent formation of nitrite
above.
We measured nitrite, the major breakdown product of NO, formed from 
nitrovasodilators by the peroxidase activity of catalase. Briefly, the reaction 
mixtures containing phosphate buffer (pH 5.6, 0.08 M), bovine liver catalase 
(300 or 1000 u mb'!), hydrogen peroxide (1 mM) or the glucose (5 
mM)/glucose oxidase (300 mu ml"'^) system, and a nitrovasodilator, i.e. 
sodium azide (10 pM-3 mM), hydroxylamine (10 pM-30 mM) or glyceryl 
trinitrate (10 pM-1 mM) were incubated in a final volume of 80 pi at 37 °C in an 
incubator for the times indicated in the Results. At the end of these times, 
nitrite content was determined as above.
We also measured nitrite formation from nitrovasodilators by the thiol, L- 
cysteine. In these experiments the reaction mixtures containing HEPES buffer 
(pH 7.4, 5 mM), L-cysteine (3 mM), and a nitrovasodilator, i.e. sodium azide (1 
mM), hydroxylamine (1 mM) or glyceryl trinitrate (1 mM) were incubated for 1h
at 37 ‘’C. At the end of 1h incubation period, nitrite content was determined as
:Phosphate buffer contained two components: potassium dihydrogen
orthophosphate (A) and disodium phosphate (B). Solutions of A and B
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Figure 3.2 Standard curve for measurement of nitrite formation in 
experimental samples using the Dynatech Microplate Reader model no MR 
5000/7000. Standards consisted of sodium nitrite in phosphate buffer (pH, 5.6, 
0.08 M). The concentration of nitrite (1-30 pM) is plotted against absorbance 
at 550 nm. The instrument was zeroed using blanks consisting of phosphate 
buffer (pH 6.5, 0.08 M).
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were prepared with saline. The composition of phosphate buffer was as 
follows:
X ml A + (100 - x) ml B (for pH 5.6, x= 95.5 ml)
Finally, 4.5 ml of solution B was added slowly to 95.5 ml of solution A and pH 
was measured constantly.
HEPES-buffered Krebs was prepared from 10-times concentrated stock 
Krebs’ solution containing NaCI, KOI, CaCl2 , IVIgSO^ and KH2PO4 . The 
concentrated stock solution of Krebs was diluted with distilled water, and 
glucose, HEPES and NaHCO^ were added. The final concentration of 
reagents was: NaCI 118.0 mM, KCl 4.8 mM, CaCl2 2.5 mM, MgSO^ 1.2 mM, 
KH2 PO4 1.2 mM, glucose 11.0 mM, NaHCOa 24.0 mM and HEPES 5 mM. 
The final solution was taken to pH 7.4 with 1 M NaOH.
3.4.4 Effects of 3-ammo-1,2,4-triazole on catalase-dependent 
formation of nitrite
In some experiments, we studied the effects of catalase inhibitor, 3-amino-
1,2,4-triazole (AT) on catalase-dependent formation of nitrite from sodium 
azide. The reaction mixtures containing phosphate buffer (pH 5.6, 0.08 M), AT 
(0.1-100 mM), bovine liver catalase (300 or 1000 u mb^), hydrogen peroxide 
(1 mM) and sodium azide (0.3 mM) were incubated in a final volume of 80 pi 
at 37 "C in an incubator for the times indicated in the Results.
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3.5 Experimental protocol for assessing hydrogen peroxide- 
induced impairment of vascular reactivity and its potentiation 
by 3-amino-1,2,4-triazole
3.5.1 Hydrogen peroxide-induced impairment of vascular reactivity
The effects of incubation with hydrogen peroxide (0.1 or 1 mM) for 15, 30, or 
60 min followed by washout were examined on PE (10 nM)-induced 
contraction in endothelium-containing rings of rat aorta.
The effects of incubation with hydrogen peroxide were also examined on ACh- 
induced relaxation. In these experiments the endothelium-containing rings, 
precontracted with PE (10-30 nM), were incubated with hydrogen peroxide 0.1 
or 1 mM for 15, 30 or 60 min. The tissues were then washed out and 
cumulative concentration-response curves to ACh (10 nM-3 pM) were 
constructed to determine if any impairment of endothelium-dependent 
relaxation had taken place.
The ability of exogenous catalase (bovine liver, 1000 u m f ) to protect against 
hydrogen peroxide-induced impairment was also studied. In these 
experiments catalase was added to the baths 15 min before the addition of 
hydrogen peroxide. Again the tissues were washed out and cumulative 
concentration-response curves to ACh were constructed to assess the level of 
relaxation obtained.
In early experiments (see Results, Chapter 7), incubation with hydrogen 
peroxide (1 mM) for 30 min produced a sub-maximal (20-30 %) inhibition of 
ACh-induced relaxation by itself. In all subsequent experiments involving
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hydrogen peroxide at 0.1 or 1 mM, tissues were incubated with the drug for 30 
min. Hydrogen peroxide was washed out at the end of 30 min incubation 
period.
The effects of incubation with hydrogen peroxide were also examined on 
endothelium-independent relaxations induced by glyceryl trinitrate and 
isoprenaline. In these experiments the endothelium-denuded rings, 
precontracted with PE (3-10 nM), were incubated with hydrogen peroxide (0.1 
or 1 mM) for 30 min. The tissues were then washed out and cumulative 
concentration-response curves to glyceryl trinitrate (1-100 nM) and 
isoprenaline (10 nM-3 pM) were constructed to determine if any impairment of 
endothelium-independent relaxation had taken place.
3.5.2 Use of 3-amino-1,2,4-triazole
In certain experiments, we wished to use 3-amino-1,2,4-triazole (AT), a 
selective inhibitor of catalase (Helm et al., 1956; Margoliash & Novogrodsky, 
1958), to inhibit the activity of endogenous catalase. This was done to 
determine if endogenous catalase exerted a protective action against 
exogenous hydrogen peroxide. In all experiments involving AT, tissues were 
incubated with the drug (50 mM) for 90 min. AT was washed out at the end of 
90 min incubation period.
3.5.3 Effects of 3-amino-1,2,4-tnazole
To assess the selectivity of action of AT (50 mM, 90 min), its effects were 
studied on relaxations of endothelium-containing rings induced by ACh (10 
nM-3 pM) and endothelium-denuded rings induced by glyceryl trinitrate (1-100 
nM) and isoprenaline (10 nM-3 pM) following precontraction with PE (10-30 
nM).
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3.6 Drugs
Acetylcholine chloride, 3-amino-1,2,4-triazole, L-arginine hydrochloride,
3.5.4 Effects of 3-amino-1,2,4-triazole on hydrogen peroxide- 
induced Impairment of vascular reactivity
We examined the ability of AT (50 mM) to enhance hydrogen peroxide (0.1 or 
1 mM)-induced impairment by assessing relaxation induced by all 3 
vasodilators, i.e. ACh, glyceryl trinitrate and isoprenaline. In these 
experiments, following incubation with AT for 60 min, the tissues were 
contracted with PE (10-30 nM) and then hydrogen peroxide at 0.1 or 1 mM 
was added and left for 30 min. All the drugs were then washed out and 
cumulative concentration-response curves to ACh, glyceryl trinitrate and 
isoprenaline were constructed.
The effects of incubation with AT (50 mM, 90 min, followed by washout) alone 
or together with hydrogen peroxide (0.1 or 1 mM, present during the final 30 
min of 90 min incubation with AT, followed by washout) were also examined 
on PE (10 nM)-induced contraction.
I
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catalase (bovine liver), diethyldithiocarbamate, glucose oxidase, hydrogen 
peroxide (30 %), hydroxylamine chloride, hypoxanthine, isoprenaline 
hydrochloride, N^-nitro-L-arginine, N^-nitro-L-arginine methyl ester, N-(1- 
napthyl)-ethylenediamine dihydrochloride, phenylephrine hydrochloride, 
methylene blue, sodium azide, sodium nitrite, sulphanilic acid, superoxide 
dismutase (bovine erythrocyte, Cu-Zn-containing) and xanthine oxidase 
(buttermilk) were obtained from Sigma (Poole, Dorset).
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Glucose and pyrogallol were obtained from BDH (Poole, Dorset).
N^-monomethyl-L-arginine was a gift from Wellcome Laboratories 
(Beckenham, Kent).
Glyceryl trinitrate (GTN) was obtained from NAPP Laboratories (Cambridge, 
UK).
All drugs were dissolved and dilutions made in saline (0.9 %), except for 
hypoxanthine which was dissolved in 0.1 % sodium hydroxide. N^-nitro-L- 
arginine at 10"2 was soluble only after sonication. Concentrations of drugs are 
expressed as the final molar concentration in the organ bath.
3.7 Statistical analysis
Results are expressed throughout as the mean ± the standard error of the 
mean for n separate experiments. Statistical significance was determined by 
one-way analysis of variance followed by Fisher's test. A probability of 0.05 or 
less was considered significant.
1
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RESULTS
Chapter 4
Assessment of the effects of superoxide 
anion on basal and agonist-stimulated 
activity of nitric oxide
In vascular endothelium, the production of nitric oxide (NO) is subject to 
complex control; it is stimulated by a large number of biological mediators 
such as acetylcholine (ACh, Furchgott & Zawadzki, 1980a) and by the physical 
shearing force of the flowing blood (Pohl et al., 1986). Agonist-stimulated 
activity of NO was determined by assessing ACh-induced relaxation.
=:
■i.In addition, there is a basal production of NO which exerts a tonic vasodilator 
action on endothelium-containing arterial rings (Eglème et al., 1984; Martin et 
al., 1986; Martin, 1988). Basal activity of NO was assessed indirectly by 
measuring the endothelium-dependent depression of phenylephrine (PE)- 
induced vasoconstriction.
In this part of the study, we determined if basal and ACh-stimulated activity of 
NO in rat aorta were equally sensitive to destruction by superoxide anion. The 
effects of superoxide anion were assessed either by generating the free 
radical using the hypoxanthine/xanthine oxidase (HX/XO) system or the drug, 
pyrogallol (Halliwell & Gutteridge, 1989), or by increasing the background level 
of the free radical by inhibiting the endogenous Cu-Zn form of SOD with 
diethyldithiocarbamate (DETCA, Heikkila et al., 1976; Cocco et al., 1981;
Halliwell & Gutteridge, 1989).
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4.1 Effects of superoxide dismutase (SOD) on basal and ACh- 
stimulated activity of NO
4.1.1 Effects of SOD on basal activity of NO
Superoxide dismutase (SOD) scavenges superoxide anions (Halliwell & 
Gutteridge, 1989; Cheeseman & Slater, 1993). Following induction of 
phenylephrine (PE, 10-30 nM)-induced tone (1.6 ±0.1 g, n=8) in endothelium- 
containing rings of rat aorta, SOD (1-300 u mb'*) produced a powerful 
concentration-dependent relaxation (maximum relaxation obtained was 79.9 ± 
2.0 %, Figure 4.1, 4.2, 4.5 and 4.6). In endothelium-denuded rings, lower 
concentrations of PE (3-10 nM) were required to induce a similar degree of 
tone (1.5 ± 0.2 g, n=6 ) as in endothelium-containing rings, but in these, SOD 
produced no relaxation (Figure 4.1, 4.2 and 4.7).
We reasoned that if the relaxation of aortic rings produced by SOD was 
mediated by NO, then this action would be expected to be blocked by 
inhibitors of NO synthase. Indeed, pretreatment with N^-nitro-L-arginine (L- 
NOARG, 30 pM, Moore et al., 1990) for 10 min completely blocked SOD- 
induced relaxation in endothelium-containing rings (Figure 4.2).
The relaxant effects of SOD are therefore likely to have arisen from removal of 
superoxide anions generated either within the tissue or in the oxygenated 
Krebs' solution, which were destroying the basally produced NO.
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Figure 4.1 Individual experimental tracings showing the ability of superoxide 
dismutase (SOD) to relax phenylephrine (PE)-contracted endothelium- 
containing (+EC) but not endothelium-denuded (-EC) rings of rat aorta. Drug 
concentrations are expressed in log molar units and enzyme concentrations 
are expressed in units ml"^.
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4.1.1.1 Effects of diethyldithiocarbamate (DETCA) on SOD-induced 
relaxation
Mammalian cells contain two major forms of SOD: Cu-Zn SOD which is 
located both intracellularly and extracellularly and Mn-SOD which is mainly 
present in the mitochondria (Hassan, 1988). The Cu-Zn SOD, but not Mn- 
SOD, is inactivated by the copper chelator DETCA (Heikkila et al., 1976; 
Cocco et a!., 1981; Halliwell & Gutteridge, 1989). DETCA inhibits the Cu-Zn- 
containing form both intracellularly and extracellularly (Kelner et al., 1989). 
Consequently, its effects were examined on SOD-induced relaxation in 
endothelium-containing rings. The rings were pretreated with DETCA (0.1 mM) 
for 1h and this was followed by extensive washing to permit the effects of 
exogenous SOD to be studied. Pretreatment with DETCA led to a 30.0 ±1.4  
% (n=6 ) reduction in the maximal relaxation induced by SOD (300 u ml"^) 
(Figure 4.2 and 4.11), indicating that loss of basal activity of NO had occurred 
as a consequence of destruction by the greater steady-state levels of 
superoxide anion.
4.1.2 Effects of SOD on ACh-stimulated activity of NO
Having established the effects of exogenous SOD on basal activity of NO, we 
sought to determine the effects of this enzyme on ACh-stimulated activity of 
NO. In endothelium-containing rings pretreated with SOD (50 u ml"'^), higher 
concentrations of PE (100 nM) were required to induce a similar degree of 
tone (1.1 ±0.1 g, n=6) to untreated rings (1.1 ±0.1 g, n=6) contracted with PE 
(10-30 nM). In contrast to potentiation of basal activity NO, SOD produced 
absolutely no effect on ACh (10 nM-3 pM)-induced relaxation (Figure 4.3).
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Figure 4.2 Concentration-response curves showing relaxation to superoxide 
dismutase (SOD) on phenylephrine-contracted endothelium-containing (•) and 
endothelium-denuded (■) rings of rat aorta and blockade of this relaxation 
following inhibition of nitric oxide synthesis with N^-nitro-L-arginine (L- 
NOARG, 30 pM, T ) and the inhibition of endogenous Cu-Zn SOD with 
diethyldithiocarbamate (DETCA, 0.1 mM, 1h, wash, a). Each point is the mean 
± s.e. mean of 6 observations. **P<0.005 and ***P<0.001 indicate a significant 
difference from maximal relaxation in untreated endothelium-containing rings, 
respectively.
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Figure 4.3 Concentration-response curves showing relaxation to acetylcholine 
(ACh, • )  on phenylephrine-contracted endothelium-containing rings of rat 
aorta and the inability of superoxide dismutase (SOD, 50 u m |- \ ■) to affect 
this relaxation. Each point is the mean ± s.e. mean of 6 observations.
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These findings suggested a selective potentiation of basal but not ACh- 
stimulated activity of NO by SOD. In order to gain an insight into the 
mechanisms that may be responsible for this difference we adopted different 
approach by examining the effects of direct generation of superoxide anion.
4.2 Effects of hypoxanthine/xanthine oxidase (HX/XO) on basal 
and ACh-stlmulated activity of NO
4.2.1 Effects of HX/XO on basal activity of NO
HX/XO system is commonly used to generate superoxide anion (Fridovich,
1970; Halliwell & Gutteridge, 1989; Berman & Martin, 1993). We utilised this 
system to study the effects of superoxide anion on basal and agonist- 
stimulated activity of NO.
"'a:
Following induction of tone with PE (3-30 nM) subsequent application with MX 
(0.1 mM)/XO (16 mu mh^) produced two effects on rings of rat aorta. The first 
of these effects was an immediate and profound rise in PE-induced tone (from 
0.8 ±0.1 g to 1.5 ± 0.1 g, n=6) in endothelium-containing (Figure 4.4, 4.5 and 
4.6) but not endothelium-denuded rings (Figure 4.4 and 4.7).
In order to determine whether this rise in PE-induced tone had resulted from 
destruction of basally produced NO by superoxide anion, it was necessary to 
assess the actions of SOD on this enhancement of tone. In these 
experiments, addition of SOD (35 u mb'*) produced an immediate reversal of 
potentiation of PE-induced tone by HX/XO (Figure 4.4). Furthermore, in 
endothelium-containing rings pretreated with SOD, subsequent application 
with HX/XO failed to enhance the tone (Figure 4.5 and 4.6).
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The second of the effects of HX/XO was a delayed (about 5 min) fail in tone 
which was seen in both endothelium-containing and endothelium-denuded 
rings (Figure 4.4). It was considered likely that this relaxation was due to 
production of hydrogen peroxide from spontaneous dismutation of superoxide 
anion. A test of this hypothesis was carried out using catalase which 
eliminates hydrogen peroxide by converting it to water and oxygen (Halliwell,
1982; Halliwell & Gutteridge, 1989; Cheeseman & Slater, 1993). Addition of 
catalase (30-3000 u ml""l) was seen to produce an immediate reversal of this 
delayed relaxant action of HX/XO in both endothelium-containing and 
endothelium-denuded rings (Figure 4.4). Moreover, in endothelium-containing :
rings pretreated with catalase (3000 u mh'1), subsequent application with 
HX/XO produced only one effect; an immediate and sustained rise in PE- 
induced tone (Figure 4.4 and 4.5).
In our study we wished to examine specifically the interaction between NO and 
superoxide anion and, consequently, catalase at a concentration of 3000 u 
mh '1 was included in all subsequent experiments in order to prevent the 
accumulation of hydrogen peroxide.
4.2.1.1 Effects of L-NMMA and L-NOARG alone or in combination 
with HX/XO on basal activity of NO
The effects of inhibiting the basal synthesis of NO were also examined on PE- 
induced tone. Following induction of tone with PE (1-20 nM, 0.8 ± 0.1 g, n=6) 
subsequent treatment with the NO synthase inhibitors, L-NMMA (30 pM; Rees 
et al., 1989; 1990a) or L-NOARG (30 pM; Moore et a/., 1990) significantly 
potentiated tone in endothelium-containing (maximum potentiation 2.1 ± 0.1 g 
and 2.2 ± 0.1 g, respectively, n=6) (Figure 4.5 and 4.6) but not in
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Figure 4.4 Individual experimental tracings showing the two separate effects 
of hypoxanthine (HX, 0.1 mM)/xanthine oxidase (XO, 16 mu mh^) on rings of 
rat aorta; an immediate rise in phenylephrine (PE)-induced tone in 
endothelium-containing (+EC) but not endothelium-denuded (-EC) rings which 
was reversed by superoxide dismutase (SOD, 35 u ml""^), and a delayed fall in 
tone in both endothelium-containing and endothelium-denuded rings which 
was inhibited by catalase (CAT, 30-3000 u mh'1). Drug concentrations are 
expressed in log molar units and enzyme concentrations are in units mb'!
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Figure 4.5 Individual experimental tracings showing the potentiation of 
phenylephrine (PE)-induced tone by hypoxanthine (HX, 0.1 mM)/xanthine 
oxidase (XO, 16 mu ml"*^) in endothelium-containing rings of rat aorta. N ^- 
mono-methyl-L-arginine (L-NMMA, 30 pM) also potentiated PE-induced tone 
and, moreover, prevented the ability of HX/XO to enhance tone. Superoxide 
dismutase (SOD, 250 u ml"*l) relaxed PE-induced tone and prevented the 
potentiation induced by HX/XO. All experiments were conducted in the 
presence of catalase (CAT, 3000 u ml"'^) to prevent the relaxant effects of 
hydrogen peroxide. Drug concentrations are expressed in log molar units and 
enzyme concentrations are expressed in units ml"1.
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Figure 4.6 Hypoxanthine (HX, 0.1 mM)/xanthine oxidase (XO, 16 mu ml"'^), 
N^-monomethyl-L-arginine (L-NMMA, 30 pM) and N^-nitro-L-arginine (L- 
NOARG, 30 pM) all potentiated phenylephrine (PE, 20 nM)-induced tone in 
endothelium-containing rings of rat aorta. Superoxide dismutase (SOD, 250 u 
mh"^) relaxed PE-induced tone and prevented the potentiation induced by 
HX/XO. Furthermore, following treatment with L-NMMA or L-NOARG, 
subsequent treatment with HX/XO failed to enhance tone further. Each column 
is the mean ± s.e. mean of 6 observations. **P<0.005 and ***P<0.001 indicate 
a significant difference from rings receiving PE only, respectively, or between 
groups joined by a bracket.
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endothelium-denuded rings (Figure 4.7). Furthermore, HX/XO failed to 
enhance PE-induced tone in L-NMMA- or L-NOARG-treated endothelium- 
containing rings (Figure 4.5 and 4.6), thus confirming that HX/XO augments 
tone through destruction of basal NO by superoxide anion.
4.2.2 Effects of HX/XO on ACh-stimulated activity of NO
Having established the ability of HX/XO to powerfully destroy basal activity of 
NO, through production of superoxide anion, its actions were investigated on 
ACh-stimulated activity of NO.
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In the presence of HX (0.1 mM)/XO (16 mu mh'^), lower concentrations of PE 
(10-30 nM) were required to induce a similar degree of tone (1.3 ±0.1  g, 
n=11) to that of control rings (1.4 ±0.1 g, n=11) contracted with PE (30-100 
nM). HX/XO despite substantially blocking basal activity of NO, had no 
significant effect on relaxations produced by ACh at any concentration in 
endothelium-containing rings (Figure 4.8). :
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Figure 4,7 Graph showing the lack of effect of hypoxanthine (HX, 0.1 
mM)/xanthine oxidase (16 mu mh^), N^-monomethyl-L-arginine (L-NMMA, 30 
pM), N^-nitro-L-arginine (L-NOARG, 30 pM) and superoxide dismutase (SOD, 
250 u ml"'^) on phenylephrine (PE, 1 nM)-induced tone in endothelium- 
denuded rings of rat aorta. Each column is the mean ± s.e. mean of 6 
observations.
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Figure 4.8 Individual experimental traces (a) and concentration-response 
curves (b) showing relaxation to acetylcholine (ACh, • )  on phenylephrine (PE)- 
contracted endothelium-containing rings of rat aorta and the inability of 
hypoxanthine (HX, 0.1 mM)/xanthine oxidase (XO, 16 mu m |- \ ■) to block this 
relaxation. All experiments were conducted in the presence of catalase (CAT, 
3000 u m|-'1) to prevent the relaxant effects of hydrogen peroxide. Each point 
is the mean ± s.e. mean of 11 observations. Drug concentrations are 
expressed in log molar units and enzyme concentrations are in units mb').
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4.2.2.1 Effects of higher concentrations of HX/XO on ACh- 
stimulated activity of NO
The data presented so far suggest a greater sensitivity of basal than ACh- 
stimulated activity of NO to destruction by superoxide anion. In order to 
determine whether this difference was absolute, the levels of superoxide anion 
were increased by employing higher concentrations of HX/XO.
Increasing the concentration of HX to 1 mM which meeting XO (16 mu ml"'^) 
did, however, lead to a profound blockade of ACh-induced relaxation in PE 
(30-100 nM)-contracted endothelium-containing rings. The maximal relaxation 
induced by ACh at 3 pM was inhibited by 40.0 ± 3.5 % (n= 5-12, Figure 4.9 
and 4.10). HX (1 mM)/XO (16 mu mh'^) also reduced the duration of relaxation 
induced by ACh at 3 pM (Figure 4.9).
It was important to establish if the blockade by HX/XO occurred as a 
consequence of destruction of ACh-stimulated activity of NO by superoxide 
anion. The tissues were, therefore, pretreated with exogenous SOD (250 u mh 
^^ ) for 20 min and its ability to protect against the inhibitory effects of HX (1 
mM)/ XO (16 mu mb'!) was assessed. SOD offered complete protection 
against this blockade (Figure 4.10).
These results suggested that higher concentrations of superoxide anion were 
required to destroy ACh-stimulated activity of NO than basal NO.
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Figure 4.9 Individual experimental tracings showing the ability of hypoxanthine 
(HX, 0.1 mM and 1 mM)/xanthine oxidase (XO, 16 mu mh^) to inhibit 
acetylcholine (ACh)-induced relaxation in phenylephrine (PE)-contracted 
endothelium-containing rings of rat aorta. All experiments were conducted in 
the presence of catalase (CAT, 3000 u mh'^) to prevent the relaxant effects of 
hydrogen peroxide generated by HX/XO. Drug concentrations are expressed 
in log molar units and enzyme concentrations are in units mh'^.
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Figure 4.10 Concentration-response curves showing relaxation to 
acetylcholine (ACh, • )  on phenylephrine-contracted endothelium-containing 
rings of rat aorta, blockade of relaxation by hypoxanthine (HX, 1 mM)/xanthine 
oxidase (XO, 16 mu m h \ a) but not by HX (0.1 mM)/XO (16 mu m l" \ ■), and 
protection against blockade by the former by superoxide dismutase (SOD, 250 
u m\~ ,^ t). Each point is the mean ± s.e. mean of 5-12 observations. 
***P<0.001 indicates a significant difference from maximal relaxation in 
untreated rings.
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4.3 Effects of DETCA on basal and ACh-stimulated activity of 
NO
4.3.1 Effects of DETCA on basal activity of NO
1 0 1
It was thought that the greater sensitivity of basal than ACh-stimulated activity
,of NO to destruction by superoxide anion might reflect differential protection by ■k
endogenous SOD. Consequently, the effects of inhibiting the endogenous Cu- 
Zn SOD with copper chelator, DETCA (Heikkila et al., 1976; Cocco et al.,
1981; Halliwell & Gutteridge, 1989), were assessed.
Treatment for 1h with DETCA (0.1 mM) to inhibit endogenous Cu-Zn SOD 
followed by washout enhanced PE (20 nM)-induced tone (from 0.6 ±0.1 g to 
0.9 ± 0.1 g, n=6 ) in endothelium-containing rings (Figure 4.11 and 4.12). 
Furthermore, HX (0.1 mM)/XO (16 mu mb'!), L-NMMA (30 pM) or the 
combined presence of L-NMMA and HX/XO, which would ordinarily augment 
PE-induced tone in endothelium-containing rings through loss of basal activity 
of NO, failed to do so in DETCA-treated rings (Figure 4.11). These findings 
suggested that DETCA had led to destruction of all basal activity of NO.
The potential ability of exogenous SOD (250 u mb'!) to reverse the inhibition 
by DETCA of basal activity of NO was also studied. Pretreatment with SOD for 
20 min depressed PE (20 nM)-induced tone by 30.0 ± 1 .4  % (n=6 . Figure 
4.11) in DETCA-treated endothelium-containing rings. The restoration of basal 
activity of NO following addition of SOD to DETCA-treated tissues, albeit 
reduced in comparison to control tissues, suggested that the loss had 
occurred as a consequence of destruction by the greater steady-state levels of 
superoxide anion.
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Figure 4.11 Diethyldithiocarbamate (DETCA, 0.1 mM, 1h, wash) enhanced 
phenylephrine (PE, 20 nM)-induced tone in endothelium-containing rings of rat 
aorta and prevented the ability of hypoxanthine (HX, 0.1 mM)/xanthine 
oxidase (XO, 16 mu m|-1) and N^-monomethyl-L-arginine (L-NMMA, 30 pM) 
to potentiate tone. Superoxide dismutase (SOD, 250 u ml"'^) produced a 
partial relaxation of PE-induced tone in DETCA-treated endothelium- 
containing rings. Each column is the mean ± s.e. mean of 6 observations. 
*P<0.05 indicates a significant difference from rings receiving PE only. 
^P<0.05 indicates a significant difference from DETCA-treated, endothelium- 
containing rings receiving PE only.
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The effects of pretreatment with DETCA (0.1 mM, 1h) followed by washout, 
were also studied on endothelium-denuded rings. In these experiments, the 
concentration of PE was reduced from 20 nM to 1 nM to attain the same level 
of tone as in experiments with endothelium-containing rings. DETCA had no 
effect on the sensitivity of endothelium-denuded rings to PE (Figure 4.12). 
These findings confirm the ability of DETCA to augment tone of endothelium- 
containing rings by destruction of basal activity of NO.
The effects of DETCA suggest that Cu-Zn SOD plays a vital role in protecting 
basal activity of NO from destruction by superoxide anion.
4.3.2 Effects of DETCA on ACh-stimulated activity of NO
The effects of inhibition of endogenous Cu-Zn SOD with DETCA (0.1-3 mM, 
1h) were studied on ACh-induced relaxation, in these experiments, 
pretreatment with DETCA (0.1-3 mM) followed by washout led to a 
concentration-dependent inhibition of ACh-induced relaxation (Figure 4.13). 
The maximal relaxation induced by ACh at 3 pM was reduced by 23.1 ± 1.4 %,
55.4 ± 3.5 % and 70.9 ±6.1 % by DETCA at concentrations of 0.1, 1 and 3 
mM, respectively (n=6-12).
The ability of exogenous SOD to reverse the inhibitory effects of the lowest 
(0.1 mM) and the highest (3 mM) concentrations of DETCA on ACh-induced 
relaxation was also investigated. In these experiments, treatment with SOD 
(250 u ml"'^) for 20 min had no significant effect on the ability of DETCA (0.1 or 
3 mM) to inhibit ACh-induced relaxation (Figure 4.13).
These findings suggest that DETCA destroys the activity of NO mainly 
intracellularly in endothelial cells where exogenous SOD cannot penetrate.
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Figure 4.12 Inhibition of endogenous Cu-Zn superoxide dismutase with 
diethyldithiocarbamate (DETCA, 0.1 mM, 1h, wash) enhanced phenylephrine 
(PE, 20 nM)-induced tone in endothelium-containing (+EC) rings of rat aorta. 
The endothelium-denuded (-EC) rings were contracted with a lower 
concentration of PE (1 nM) to attain the same level of tone as in +EC, but in 
these, pretreatment with DETCA had no effect on tone. Each column is the 
mean ± s.e. mean of 6 observations. *P<0.05 indicates a significant difference 
from rings receiving PE only.
1 0 4
cgHh-•
CQ
(Ua :
100 1 
80 
60 
40 
20 
0
-9 -8 -7 -6
log [ACh] M
-5
“ 1
" 4
Figure 4.13 Concentration-response curves showing relaxation to 
acetylcholine (ACh, #) on phenylephrine-contracted endothelium-containing 
rings of rat aorta. Inhibition of endogenous Cu-Zn superoxide dismutase (Cu- 
Zn SOD) with diethyldithiocarbamate (DETCA, 1h, wash) at 0.1 mM (a), 1 mM 
( t )  and 3 mM (A) blocked ACh-induced relaxation in a concentration- 
dependent manner. Furthermore, exogenous SOD (250 u ml"'^, 20 min) had 
no significant effect on the blockade by DETCA at 0.1 mM (♦) and 3 mM (0) of 
ACh-induced relaxation. Each point is the mean ± s.e. mean of 6-12 
observations. *P<0.05, **P<0.005 and ***P<0.001 indicate a significant 
difference from maximal relaxation in untreated rings, respectively.
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4.3.3 Effects of the combination of DETCA and HX/XO on ACh- 
stimulated activity of NO
If Cu-Zn SOD is important in protecting NO then its inactivation with DETCA 
will be expected to potentiate the inhibitory effects of HX (0.1 mM)/XO (16 mu 
ml"'1). Consequently, experiments were carried out to investigate the effects of 
DETCA on the ability of HX/XO to inhibit ACh-induced relaxation. In these 
experiments, HX (0.1 mM)/XO (16 mu mh^) that had no effect on ACh-induced 
relaxation by itself in control tissues led to a profound blockade of relaxation in 
DETCA (0.1 mM, 1h, wash)-treated tissues (Figure 4.14 and 4.15). The 
maximal relaxation Induced by ACh at 3 pM was inhibited by 58.4 ± 3.5 % 
(n=8 . Figure 4.15).
It should be noted in Figure 4.14 that in DETCA-treated tissues no rise PE-
induced tone was obtained when HX/XO was added due to prior destruction of 
all basal activity of NO.
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}
It was necessary to establish if the inhibition of ACh-induced relaxation seen 
with HX/XO in DETCA-treated tissues occurred as a consequence of elevation 
of superoxide anion. The effects of exogenous SOD were, therefore, 
examined on this inhibition. SOD (250 u mb'*) given as a 20 min pretreatment 
almost completely protected against the blockade of ACh-induced relaxation 
by HX (0.1 mM)/XO (16 mu mh'1) in DETCA-treated tissues (n=8 . Figure 
4.15).
The effects of DETCA suggest that endogenous Cu-Zn SOD plays a vital role 
in protecting ACh-stimulated activity of NO from destruction by superoxide 
anion.
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Figure 4.14 Individual experimental tracings showing the inability of 
hypoxanthine (HX, 0.1 mM)/xanthine oxidase (XO, 16 mu mi"'^) to inhibit 
acetylcholine (ACh)-induced relaxation in phenylephrine (PE)-contracted 
endothelium-containing rings of rat aorta. Following treatment with 
diethyldithiocarbamate (DETCA, 0.1 mM, 1h, wash), subsequent treatment 
with HX/XO now produced a profound blockade. All experiments were 
conducted in the presence of catalase (CAT, 3000 u ml"'') to prevent the 
relaxant effects of hydrogen peroxide generated by HX/XO. Drug 
concentrations are expressed in log molar units and enzyme concentrations 
are expressed in units ml"''.
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Figure 4.15 Concentration-response curves showing relaxation to 
acetylcholine (ACh, #) on phenylephrine-contracted endothelium-containing 
rings of rat aorta, and the inability of hypoxanthine (HX, 0.1 mM)/xanthine 
oxidase (XO, 16 mu mb'*, ■) to block this relaxation. Following inhibition of 
endogenous Cu-Zn superoxide dismutase (Cu-Zn SOD) with 
diethyldithiocarbamate (DETCA, 0.1 mM, 1h, wash, a ) ACh-induced relaxation 
was partially inhibited and subsequent treatment with HX/XO (t) now 
produced a profound blockade. Furthermore, this blockade was prevented by 
pretreatment for 20 min with exogenous SOD (250 u m|-1, ♦). Each point is the 
mean ± s.e. mean of 6-12 observations. *P<0.05 and ***P<0.001 indicate a 
significant difference from maximal relaxation in untreated rings, respectively.
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4.4 Effects of pyrogallol on basal and ACh-stimulated activity 
of NO
Pyrogallol is known to generate superoxide anions by autooxidation (Halliwell 
& Gutteridge, 1989, see Methods). We utilised pyrogallol, as another source of 
superoxide anion generator, to determine if it affected basal and ACh- 
stimulated activity of NO in a similar way to HX/XO.
4.4.1 Effects of pyrogallol on basal activity of NO
Subsequently, the effects of pyrogallol (0.1 mM) were studied on basal activity 
of NO. Like HX (0.1 mM)/XO (16 mu mb'!), pyrogallol (0.1 mM) produced an 
immediate and profound rise in PE (20 nM)-lnduced tone in endothelium- 
containing rings (Figure 4.16 and 4.17). The tone increased from 0.3 ±0.1 g to
1.7 ±0.1 g (n=9. Figure 4.17). However, unlike with HX/XO exogenous SOD 
(250 u ml -"1) only partially reversed (by 26.1 ± 1.1 %, n=9. Figure 4.17) the 
augmentation of tone induced by pyrogallol, suggesting that only part of this 
rise is mediated through generation of superoxide anion.
Also unlike HX/XO which augmented PE-induced tone in endothelium- 
containing rings only, pyrogallol (0.1 mM) augmented tone in endothelium- 
denuded rings. The rise in PE (1 nM)-induced tone (from 0.3 ±0.1 to 0.9 ±0.1 
g, n=6 ), however, was less than that obtained in endothelium-containing rings 
(Figure 4.16 and 4.17). Note that the concentration of PE was lowered to 1 nM 
to attain the same level of tone as in endothelium-containing rings. 
Furthermore, the endothelium-independent component of the rise in tone 
induced by pyrogallol was not affected by pretreatment with exogenous SOD 
(250 u m h'l, Figure 4.17).
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Figure 4.16 Individual experimental tracings showing the two separate effects 
of pyrogallol (0.1 mM) on rings of rat aorta; an immediate rise in phenylephrine 
(PE)-induced tone in both endothelium-containing (+EC) and endothelium- 
denuded (-EC) rings, although lesser than that obtained in endothelium- 
containing rings, and a delayed fall in tone in both endothelium-containing and 
endothelium-denuded rings which was inhibited by catalase (CAT, 100-3000 u 
ml"'I). Drug concentrations are expressed in log molar units and enzyme 
concentrations are in units mh'^.
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Figure 4.17 Augmentation of phenylephrine (PE)-induced tone by pyrogallol 
(0.1 mM) in endothelium-containing (+EC) and endothelium-denuded (-EC) 
rings of rat aorta and blockade of the endothelium-dependent but not 
endothelium-independent component by superoxide dismutase (SOD, 250 u 
mb'!). Each column is the mean ± s.e. mean of 6-9 observations. *P<0.05, 
**P<0.005 and ***P<0.001 respectively indicate a significant difference from 
rings receiving PE only or between groups joined by brackets.
Ill
&
1 1 2
Pyrogallol, like HX/XO, also produced a delayed (about 5 min) fall in tone in 
both endothelium-containing and endothelium-denuded rings which was 
blocked by catalase (100-3000 u m h \ Figure 4.16) and was therefore likely to 
be due to the build up of hydrogen peroxide. Consequently, all experiments 
with pyrogallol were conducted in the presence of catalase (3000 u mb'!).
4.4.2 Effects of pyrogallol on ACh-stimulated activity of NO
Having established the effects of pyrogallol on basal activity of NO, its actions 
were assessed on ACh-stimulated activity of NO. In the presence of pyrogallol 
(0.1 mM), lower concentrations of PE (10-30 nM) were required to induce a 
similar degree of tone (1.4 ± 0.1 g, n=6) to that of control rings (1.5 ± 0.1 g, 
n=6 ) contracted with PE (30-100 nM).
In common with HX (0.1 mM)/XO (16 mu mh^), pyrogallol (0.1 mM) had no 
significant effect on relaxations produced by ACh at any concentration in 
endothelium-containing rings (Figure 4.18, 4.19 and 4.20).
4.4.2.1 Effects of higher concentrations of pyrogallol on ACh- 
stimulated activity of NO
The effects of higher concentrations of pyrogallol on ACh-induced relaxation 
were also studied. In these experiments, increasing the concentration of 
pyrogallol to 0.3 mM did, however, lead to a profound blockade of ACh- 
induced relaxation in PE (30-100 nM)-contracted endothelium-containing 
rings. The maximal relaxation induced by ACh at 3 pM was inhibited by 38.1 ±
2.8 % (n=7, Figure 4.18 and 4.19) in the presence of pyrogallol (0.3 mM) and 
this concentration of pyrogallol also reduced the duration of relaxation induced ‘ 
by ACh at 3 pM (Figure 4.18).
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Figure 4.18 individual experimental tracings showing the ability of pyrogallol 
(0.1 mM and 0.3 mM) to inhibit acetylcholine (ACh)-induced relaxation in 
phenylephrine (PE)-contracted endothelium-containing rings of rat aorta. All 
experiments were conducted in the presence of catalase (CAT, 3000 u mh'^) 
to prevent the relaxant effects of hydrogen peroxide generated by pyrogallol. 
Drug concentrations are expressed in log molar units and enzyme 
concentrations are in units mb'*.
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It was necessary to establish if the inhibition seen with pyrogallol in DETCA- 
treated tissues occurred as a consequence of the action of superoxide anion. 
The effects of exogenous SOD were, therefore, assessed on this inhibition. 
SOD (250 u mb'!) given as 20 min pretreatment almost completely protected
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It was important to establish if the blockade by pyrogallol occurred as a 
consequence of destruction of ACh-stimulated activity of NO by superoxide 
anion. The tissues were, therefore, pretreated with exogenous SOD (250 u mb 
for 20 min and its ability to protect against the inhibitory effects of pyrogallol 
(0.3 mM) was assessed. SOD offered almost complete protection against this 
inhibition (Figure 4.19). These results, like those obtained with HX/XO, 
suggested that higher concentrations of superoxide anion were required to 
destroy ACh-stimulated activity of NO than basal NO.
4.4.3 Effects of the combination of DETCA and pyrogallol on ACh- 
stimulated activity of NO
If Cu-Zn SOD is important in protecting NO then its inactivation with DETCA 
will be expected to potentiate the inhibitory effects of pyrogallol (0.1 mM). 
Consequently, experiments were carried out to investigate the effects of 
DETCA on the ability of pyrogallol to inhibit ACh-induced relaxation. In these 
experiments, pretreatment with DETCA (0.1 mM, 1h) followed by washout led 
to a partial inhibition of ACh-induced relaxation by itself. The maximal 
relaxation induced by ACh at 3 pM was reduced by 22.6 ±1.3 % (n=6 . Figure 
4.20). Furthermore, the concentration of pyrogallol (0.1 mM) that had no effect 
on ACh-induced relaxation by itself in control tissues led to a profound 
blockade of this relaxation in DETCA-treated tissues (Figure 4.20). The 
maximal relaxation induced by ACh at 3 pM was inhibited by 75.8 ± 5.0 % 
(n=6-12 , Figure 4.20).
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Figure 4.19 Concentration-response curves showing relaxation to 
acetylcholine (ACh, • )  on phenylephrine-contracted endothelium-containing 
rings of rat aorta, blockade of relaxation by pyrogallol at 0.3 mM (a) but not at 
0.1 mM (■), and protection against blockade by the former by superoxide 
dismutase (250 u m b \ v). Each point is the mean ± s.e. mean of 6-12 
observations. ***P<0.001 indicates a significant difference from maximal 
relaxation in untreated rings.
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against the blockade of ACh-induced relaxation by pyrogallol (0.3 mM) in 
DETCA-treated tissues (Figure 4.20). Thus, these results taken together with 
those obtained with HX/XO in DETCA-treated tissues demonstrate the 
importance of endogenous Cu-Zn SOD in protecting ACh-stimulated activity of 
NO from destruction by superoxide anion.
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Figure 4.20 Concentration-response curves showing relaxation to 
acetylcholine (ACh, #) on phenylephrine-contracted endothelium-containing 
rings of rat aorta, and the inability of pyrogallol (0.1 mM, ■) to block this 
relaxation. Following inhibition of endogenous Cu-Zn superoxide dismutase 
(Cu-Zn SOD) with diethyldithiocarbamate (DETCA, 0.1 mM, 1h, wash. A) ACh- 
induced relaxation was partially inhibited and subsequent treatment with 
pyrogallol ( t )  now produced a profound blockade. Furthermore, this blockade 
was prevented by pretreatment for 20 min with exogenous SOD (250 u m b \ 
♦). Each point is the mean ± s.e. mean of 6-12 observations. *P<0.05 and 
***P<0.001 indicate a significant difference from maximal relaxation in 
untreated rings, respectively.
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Chapter 5
Assessment of the role of catalase in 
relaxations induced by hydrogen peroxide 
and nitrovasodilators
In the previous chapter (Chapter 4), the delayed relaxant effect of superoxide 
anion generators in rat aorta was discussed and it was established that this 
effect was mediated by hydrogen peroxide since it was blocked by 
exogenously added catalase.
From the literature it is clear that hydrogen peroxide-induced relaxation has 
two components; low concentrations produced relaxation which is 
endothelium-dependent and higher concentrations act in an endothelium- 
independent manner (Burke & Wolin, 1987; Furchgott, 1991; Zembowicz et 
a/., 1993). The endothelium-dependent component is thought to be mediated 
via enhanced synthesis of NO, whilst the endothelium-independent 
component is due to a direct stimulatory effect on smooth muscle soluble 
guanylate cyclase. It has been proposed that the presence of catalase is vital 
for the latter effect to occur and that the active species which stimulates 
soluble guanylate cyclase is compound I, i.e. the catalase-hydrogen peroxide 
complex formed as an intermediate (Burke & Wolin, 1987; Wolin & Burke, 
1987).
Certain nitrovasodilators, i.e. hydroxylamine and sodium azide are believed to 
be metabolised by catalase to NO (Theorell & Ehrenberg, 1952; Keilin & 
Hartree, 1954; Nicholls, 1964) and thereby activate soluble guanylate cyclase 
(Miki at a/., 1976; Katsuki at ai., 1977; Craven at a/., 1979) in cell free 
systems. This metabolism by catalase is therefore believed to account for the
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relaxant actions of these two agents (Katsuki et al., 1977; Waldman & Murad, 
1987; Murad, 1994), but this has not been tested directly in an intact blood 
vessel. Other nitrovasodilators such as glyceryl trinitrate are also converted to 
NO but in this case conversion is achieved by glutathione-S-transferase 
(Armstrong eta!., 1980), and catalase is not involved.
In this study we made a use of an inhibitor of catalase, 3-amino-1,2,4-triazole 
(AT, Heim et a!., 1956; Margoliash & Novogrodsky, 1958), in rat aorta to test 
the hypothesis that metabolism by catalase is necessary to express the 
relaxant activity of hydrogen peroxide, sodium azide and hydroxylamine.
5.1 Hydrogen peroxide-induced relaxations in endothelium- 
containing and endothelium-denuded rings
It was necessary to establish the nature of hydrogen peroxide-induced 
relaxation prior to addressing the more complex topic of the role of catalase.
5.1.1 Hydrogen peroxide-induced relaxation in endothelium- 
containing rings
Following induction of PE (100 nM)-induced tone (1.6 ± 0.1 g, n=7) in 
endothelium-containing rings of rat aorta, hydrogen peroxide (100 nM-1 mM) 
produced powerful concentration-dependent relaxation. The maximum 
relaxation induced by hydrogen peroxide at 1 mM was 96.2 ± 1 .0  % (n=7. 
Figure 5.1 and 5.2). Addition of hydrogen peroxide elicited a biphasic 
response: a brief contraction which was more pronounced for concentrations ^ 
0.1 mM followed by a powerful relaxation (Figure 5.1).
1 1 9
5.1.2 Hydrogen peroxide-induced relaxation in endothelium- 
denuded rings
Hydrogen peroxide also relaxed endothelium-denuded rings. In endothelium- 
denuded rings, a lower concentration of PE (10 nM) was required to induce a 
similar degree of tone (1.5 ± 0.1 g, n=7) as in endothelium-containing rings 
(1.6 ± 0.1 g, n=7), but in these higher concentrations of hydrogen peroxide (30 
pM-1 mM) were required to produce relaxation. The maximal relaxation 
induced by hydrogen peroxide in endothelium-denuded rings at 1 mM was
96.0 ± 1.6 % (n=7. Figure 5.1 and 5.2). As seen in endothelium-containing 
rings, addition of hydrogen peroxide at concentrations >0.1 mM produced a 
biphasic response i.e. a brief contraction followed by a powerful relaxation 
(Figure 5.1)
5.2 Effects of N^-nitro-L-arginm e methyl ester (L-NAME) on 
hydrogen peroxide-induced relaxation
5.2.1 Effects of L-NAME on hydrogen peroxide-induced relaxation in 
endothelium-containing rings
The effects of the NO synthase inhibitor, L-NAME (Rees et a/., 1990a), were 
investigated in order to determine if NO, derived from L-arginine/NO pathway, 
mediated the endothelium-dependent component of hydrogen peroxide- 
induced relaxation. Endothelium-containing rings were pretreated with L- 
NAME (30 pM) for 20 min. Under these conditions, lower concentrations of PE 
(10-30 nM) were required to induce a similar degree of tone (1.5 ±0.1 g, n=7) 
to that of control rings (1.6 ± 0.1 g, n=7) contracted with PE (100 nM). This 
was necessary since L-NAME potentiated PE-induced tone by blocking the
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Figure 5.1 Individual experimental tracings showing the ability of hydrogen 
peroxide (H2 O 2 ) to produce a concentration-dependent relaxation of 
phenylephrine (PE)-contracted endothelium-containing (+EC) and 
endothelium-denuded (-EC ) rings of rat aorta. Drug concentrations are 
expressed in log molar units.
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synthesis of basal NO. in the presence of L-NAME hydrogen peroxide-induced 
relaxation at concentrations of 100 nM-30 pM was abolished, but no effect 
was seen on relaxation induced at higher concentrations (> 0.1 mM) (Figure
5.2 and 5.3). In addition, L-NAME had no effect on the contractile response 
observed at concentrations >0 .1  mM of hydrogen peroxide (Figure 5.3). 
These findings suggested that both the contractile and the relaxant actions of 
hydrogen peroxide at concentrations >0.1 mM were not mediated by NO.
Furthermore, the inhibitory action of L-NAME on relaxation induced by 
hydrogen peroxide at lower concentrations (100 nM-30 pM) was prevented in 
the presence of the substrate for NO synthesis, L-arginine (2 mM, Figure 5.3). 
These results supported the conclusion of earlier studies that endothelium- 
dependent component is mediated via enhanced production of NO (Furchgott, 
1991; Zembowicz et al., 1993). ,
5.2.2 Effects of L-NAME on hydrogen peroxide-induced reiaxation in 
endotheiium-denuded rings
In contrast to the effects in endothelium-containing rings, L-NAME (30 pM) 
had no effect on hydrogen peroxide (0.1-1 mM)-induced relaxation in 
endothelium-denuded rings (Figure 5.2). In endothelium-denuded rings the 
concentration of PE was lowered to 10 nM to induce a similar degree of tone 
(1.5 ± 0.1 g, n=7) to endothelium-containing rings (1.6 ± 0.1 g, n=7).
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Figure 5.2 Concentration-response curves showing relaxation to hydrogen 
peroxide (H2O2 ) on phenylephrine-contracted rings of rat aorta: endothelium- 
containing rings in the absence ( • )  and presence of N^-nitro-L-arginine 
methyl ester (L-NAME, 30 pM, a) and endothelium-denuded rings in the 
absence (■) and presence of L-NAME (30 pM, ▼). Note that L-NAME blocked 
the endothelium-dependent component of relaxation to hydrogen peroxide but 
had no effect on the endothelium-independent component. Each point is the 
mean ± s.e. mean of 7 observations. *P<0.05 and **P<0.005 indicate a 
significant difference from relaxations obtained in untreated endothelium- 
denuded rings, respectively.
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Figure 5.3 Individual experimental tracings showing the relaxation to
hydrogen peroxide {H2O2 ) on phenylephrine (PE)-contracted endothelium- 
containing rings of rat aorta and blockade of the endothelium-dependent 
component of the relaxation following treatment with N^-nitro-L-arginine- 
methyl ester (L-NAME, 30 pM). Furthermore, pretreatment with L-arginine (L- 
arg, 2 mM) protected against the inhibitory action of L-NAME. Drug 
concentrations are expressed in log molar units.
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In order to investigate if both components of hydrogen peroxide-induced 
relaxation were mediated via activation of soluble guanylate cyclase, the 
effects of MeB, an inhibitor of soluble guanylate cyclase (Gruetter et al., 1979; 
Holzmann, 1982; Martin et a!., 1985a), were studied. Both endothelium- 
containing and endothelium-denuded rings were treated with MeB (30 pM) for 
20 min. Under these conditions, in endothelium-containing rings, lower 
concentrations of PE (3-10 nM) were required to induce a similar degree of 
tone (1.3 ± 0.1 g, n=7) to that of controls rings (1.5 ± 0.1 g, n=7) contracted 
with PE (100 nM). This was necessary since MeB potentiated PE-induced 
tone by blocking the actions of basal NO.
5.3 Effects of methylene blue (MeB) on hydrogen peroxide-
induced relaxation
i
i
In endothelium-denuded rings the concentration of PE was lowered to 10 nM 
to induce a similar degree of tone (1.4 ± 0.1 g, n=7) to endothelium-containing 
rings (1.5 ± 0.1 g, n=7). MeB (30 pM) significantly reduced the relaxation 
induced by hydrogen peroxide (100 nM-1 mM) at all concentrations. The 
maximal relaxation induced by hydrogen peroxide at 1 mM in endothelium- 
containing and endothelium-denuded rings was inhibited by 42.2 ± 4.0 % and
46.3 ± 2.6 %, respectively, (n=7 for both, Figure 5.4). Thus, both the 
endothelium-dependent and endothelium-independent components of 
relaxation induced by hydrogen peroxide appear to depend upon the 
stimulation of soluble guanylate cyclase.
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Figure 5.4 Concentration-response curves showing relaxation to hydrogen 
peroxide (H2O2 , • )  on phenylephrine-contracted endothelium-containing (a) 
and endothelium-denuded (b) rings of rat aorta. Pretreatment with methylene 
blue (30 pM, A) inhibited this relaxation. Each point is the mean ± s.e. mean of 
7 observations. **P<0.005 indicates a significant difference from maximal 
relaxation in untreated rings.
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5,4 Effects of catalase on hydrogen peroxide-induced
relaxation
endothelium-denuded rings (n=6 , Figure 5.5).
5.5 Effects of superoxide dismutase on hydrogen peroxide- 
induced relaxation
Pretreatment with catalase (1000 u ml"'), a scavenger of hydrogen peroxide 1
(Halliwell & Gutteridge, 1989), for 20 min powerfully inhibited the relaxation
Îinduced by hydrogen peroxide (100 nM-1 mM) at all concentrations. The 
maximal relaxation induced by hydrogen peroxide at 1 mM in endothelium- 
containing and endothelium-denuded rings was inhibited by 56.7 ± 6.0 % and 
53.5 ± 2.5 %, respectively, (n=6 for both, Figure 5.5). Increasing the
concentration of catalase to 3000 u ml""^  almost completely abolished the
%relaxant action of hydrogen peroxide in both endothelium-containing and vi|.
:
h'„
In contrast to the actions of catalase, pretreatment with superoxide dismutase 
(SOD, 50 u ml"'*, 20 min), a scavenger of superoxide anion (Halliwell & 
Gutteridge, 1989), did not affect the relaxant activity of hydrogen peroxide 
(100 nM-1 mM) in either endothelium-containing or endothelium-denuded 
rings (n=6 . Figure 5.6).
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Figure 5.5 Concentration-response curves showing relaxation to hydrogen 
peroxide (H2O2 , • )  on phenylephrine-contracted endothelium-containing (a) 
and endothelium-denuded (b) rings of rat aorta. Pretreatment with catalase at 
1000 u mh'l (■) or 3000 u mh^ (a) inhibited this relaxation. Each point is the 
mean ± s.e. mean of 6 observations. **P<0.005 and ***P<0.001 indicate a 
significant difference from maximal relaxation in untreated rings, respectively.
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Figure 6.6 Concentration-response curves showing relaxation to hydrogen 
peroxide (H2O2 ) on phenylephrine-contracted endothelium-containing rings in 
the absence (•) and presence of superoxide dismutase (SOD, 50 u m |- \ a ) 
and endothelium-denuded rings in the absence (■) and presence of SOD (50 
u m|-1, T). Note that SOD had no effect on relaxation. Each point is the mean 
± s.e. mean of 6 observations.
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6.6 Relaxant actions of 3-amino-1,2,4-triazo[e
The effects of the inhibitor of catalase, 3-amino-1,2,4-triazole (AT, Heim et al., 
1956; Margoliash & Novogrodsky, 1958), were studied in endothelium- 
denuded rings. AT (1-100 mM) produced a concentration-dependent 
relaxation of PE (30 nM)-induced tone. The maximal relaxation induced by AT 
at 100 mM was 65.1 ±4.7 % (n=6 , Figure 5.7).
In order to investigate if the relaxation induced by AT was due to activation of 
soluble guanylate cyclase, the effects of MeB were studied. Pretreatment with 
MeB (30 pM, 20 min) had no effect on the relaxant activity of AT (1-100 mM, 
n=6 . Figure 5.7). The relaxant action of AT is therefore unlikely to be mediated 
via stimulation of soluble guanylate cyclase.
5.7 Effects of 3 amino-1,2,4-triazole (AT) on the ability of 
catalase to inhibit hydrogen peroxide-induced relaxation
In order to establish the conditions necessary for optimum inhibition of 
endogenous catalase, a series of experiments was conducted using AT to 
inhibit exogenous catalase (bovine liver). Pretreatment of endothelium- 
denuded rings of rat aorta with catalase (1000 u ml"'I) for 30 min led to a 50.4 
± 0.5 % (n=5) reduction in the maximal relaxation induced by hydrogen 
peroxide (Figure 5.8). When the catalase inhibitor, AT (50 mM, Heim et a!., 
1956; Margoliash & Novogrodsky, 1958), was present together with catalase 
during the 30 min incubation, the ability to inhibit hydrogen peroxide relaxation 
was partially blocked (by 48.8 ± 3.0 %, n=6 . Figure 5.8).
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Figure 5.7 Concentration-response curves showing relaxation to 3-amino- 
1,2,4-triazole (AT, • )  on phenylephrine-contracted endothelium-denuded rings 
of rat aorta and the lack of effect of methylene blue (30 pM, a) on this 
relaxation. Each point is the mean ± s.e. mean of 6 observations.
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Increasing the period of incubation to 90 min, however, led to complete 
blockade of the ability of catalase to inhibit hydrogen peroxide-induced 
relaxation (Figure 5.8). It can be concluded that AT does indeed inhibit the 
activity of catalase and that the onset of inhibition is very slow. Consequently, 
in all the experiments involving attempted inhibition of endogenous catalase
by AT, the tissues were incubated with the drug for 90 min.
Î
5.8 Effects of 3-amino-1,2,4-triazole (AT) on relaxation induced 
by hydrogen peroxide
Having established the ability of AT (50 mM, 90 min) to inhibit exogenous
Icatalase, we sought to determine the effects of inhibition of endogenous 
catalase on hydrogen peroxide-induced relaxation. In endothelium-denuded |
rings pretreatment with AT (50 mM, 90 min) depressed PE (10-30 nM)~ 
induced tone by 31.8 ± 2.2 % (n=15), but we ensured that the level of tone 
(1.2 ± 0.1 g, n=15) before relaxation was similar to that of untreated 
preparations (1.3 ±0.1 g, n=15) by increasing the concentration of PE (to 30- 
100 nM). Treatment with AT (50 mM, 90 min), however, had no effect on 
relaxation induced by hydrogen peroxide (10 pM-1 mM, n=12. Figure 5.9).
This finding may suggest that metabolism of hydrogen peroxide by catalase or 
formation of compound I has no role in hydrogen peroxide-induced relaxation. I
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Figure 5.8 Concentration-response curves showing relaxation to hydrogen 
peroxide (H2O2 , • )  on phenylephrine-contracted endothelium-denuded rings 
of rat aorta and blockade of this relaxation following pretreatment with catalase 
(1000 u ml""^) for 30 min (a) or 90 min (■). Incubation with 3-amino-1,2,4- 
triazole (50 mM) for 30 min (t ) partially inhibited the ability of catalase to block 
H2 0 2 ”induced relaxation, whereas incubation for 90 min (♦) produced 
complete inhibition. Each point is the mean ± s.e. mean of 5-6 observations. 
**P<0.005 and ***P<0.001 indicate a significant difference from maximal 
relaxation in untreated rings, respectively.
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Figure 5.9 Individual experimental traces (a) and concentration-response 
curves (b) showing relaxation to hydrogen peroxide (H2O2 , • )  on 
phenylephrine (PE)-contracted endothelium-denuded rings of rat aorta and the 
lack of effect of inhibition of endogenous catalase with 3-amino-1,2,4-triazole 
(AT, 50 mM, 90 min, t) on this relaxation. Each point is the mean ± s.e. mean 
of 8-12 observations.
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5.9 Vasodilator actions of sodium azide, hydroxylamine and 
glyceryl trinitrate
Sodium azide (1-300 nM, Figure 5.10, 5.11, 5.12 and 5.13), hydroxylamine (1- 
300 nM, Figure 5.10, 5.14 and 5.15) and glyceryl trinitrate (1-100 nM, Figure
5.10 and 5.16) each produced powerful concentration-dependent relaxation of 
endothelium-denuded rings of rat aorta precontracted with PE (10-30 nM, n=5- 
8 for each).
5.10 Effects of methylene blue (MeB) on relaxations induced 
by sodium azide, hydroxylamine and glyceryl trinitrate
In order to investigate if the relaxations induced by sodium azide, 
hydroxylamine and glyceryl trinitrate were mediated via activation of soluble 
guanylate cyclase, the effects of MeB, an inhibitor of soluble guanylate 
cyclase (Gruetter et a/., 1979; Holzmann, 1982; Martin et a/., 1985a), were 
studied. Treatment of PE-contracted (10-30 nM) endothelium-denuded rings 
with MeB (30 pM) for 20 min powerfully blocked relaxations induced by sodium 
azide (1-300 nM), hydroxylamine (1-300 nM) and glyceryl trinitrate (1-100 nM) 
at all concentrations. The maximal relaxation induced by each was reduced by
39.0 ± 4.7 %, 27.4 ± 1.1 % and 28.0 ± 1.1 %, respectively (n=6-8 for each, 
Figure 5.10). Thus, relaxations by all three nitrovasodilators appear to depend 
upon the stimulation of soluble guanylate cyclase.
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Figure 5.10 Concentration-response curves showing relaxation to (a) sodium 
azide (NaNg, #) (b) hydroxylamine (NHgOH, #) and (c) glyceryl trinitrate (GTN, 
• )  on phenylephrine-contracted endothelium-denuded rings of rat aorta and 
blockade of this relaxation by methylene blue (30 pM, A). Each point is the 
mean ± s.e. mean of 6-8 observations. ***P<0.0Q1 indicates a significant 
difference from maximal relaxation in untreated rings.
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5.11 Effects of 3-amino-1,2,4-triazole (AT) on relaxations 
induced by vasodilators
To test the hypothesis that metabolism by catalase is required for vascular 
relaxation induced by sodium azide and hydroxylamine (Katsuki et al., 1977;
Waldman & Murad, 1987; Murad, 1994), but not glyceryl trinitrate which is 
proposed to be metabolised by a distinct pathway (Armstrong et a!., 1980;
Feelisch, 1991; Schroder, 1992), the effects of AT were therefore studied on 
relaxations induced by these nitrovasodilators.
;
5.11.1 Effects of AT on sodium azide-induced relaxation
If endogenous catalase is important in mediating relaxation induced by sodium
azide then its inactivation with AT will be expected to inhibit the relaxant 
effects of this nitrovasodilator. Pretreatment of endothelium-denuded rings
with AT (50 mM) for 30, 60 and 90 min, to inhibit endogenous catalase,■
produced a time-dependent inhibition of relaxation induced by sodium azide 
(Figure 5.12), with 90 min incubation being the most effective (n=6 for each).
Furthermore, treatment of endothelium-denuded rings for 90 min with AT (1-50 
mM) shifted the concentration-response curve for sodium azide (NaNg, 1-300 
nM) to the right in a concentration-dependent manner: the EC50 values were 
shifted 11.4-, 77.0-, 528- and 1668-fold by AT at concentrations of 1, 5, 10 
and 50 mM, respectively (Figure 5.11, 5.12 and 5.13, n=5-8 for each). These 
results suggested a role for endogenous catalase in sodium azide-induced
relaxation. S
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Figure 5.11 individual experimental tracings showing relaxation to sodium 
azide (NaNg) on phenylephrine (PE)-contracted endothelium-denuded rings of 
rat aorta and the blockade of this relaxation following inhibition of endogenous 
catalase with 3-amino-1,2,4-triazole (AT, 50 mM, 90 min). Drug concentrations 
are expressed in log molar units.
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Figure 5.12 Concentration-response curves showing relaxation to sodium 
azide (NaNg, • )  on phenylephrine-contracted endothelium-denuded rings of 
rat aorta. Incubation with 3-amino-1,2,4-triazole (50 mM) produced a time- 
dependent inhibition of this relaxation: 30 min (■), 60 min ( a )  and 90 min ( t ) .  
Each point is the mean ± s.e. mean of 6 observations.
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Figure 5.13 Concentration-response curves showing relaxation to sodium 
azide (NaN^, #) on phenylephrine-contracted endothelium-denuded rings of 
rat aorta and concentration-dependent shifts to the right following inhibition of 
endogenous catalase with 3-amino-1,2,4-triazole (90 min) at 1 mM (♦), 5 mM 
(■), 10 mM (a), and 50 mM (t). Each point is the mean ± s.e. mean of 5-8 
observations.
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5.11.2 Effects of AT on hydroxylamine-induced relaxation
If endogenous catalase is important in mediating relaxation induced by 
hydroxylamine then its inactivation with AT will be expected to inhibit the 
relaxant actions of this nitrovasodilator. As with sodium azide, treatment of 
endothelium-denuded rings for 90 min with AT (5-50 mM) shifted the 
concentration-response curve for hydroxylamine (1-300 nM) to the right in a 
concentration-dependent manner: the EC50 values were shifted 6.4-, 59.9- 
and 190-fold by AT at concentrations of 5, 10 and 50 mM, respectively (Figure 
5.14 and 5.15, n=6 for each). These results suggested a role for endogenous 
catalase in hydroxylamine-induced relaxation. AT at all concentrations tested 
inhibited the actions of sodium azide more powerfully than hydroxylamine.
5.11.3 Effects of AT on glyceryl trinitrate-induced relaxation
In contrast to its ability to block relaxation induced by sodium azide and 
hydroxylamine, AT (50 mM, 90 min) had no effect on relaxation induced by 
another nitrovasodilator, glyceryl trinitrate (GTN, 1-100 nM) in endothelium- 
denuded rings (n=7, Figure 5.16). These results are consistent with the 
metabolism of GTN by a distinct pathway (Armstrong et al., 1980; Feelisch, 
1991; Schroder, 1992).
5.11.4 Effects of AT on acetylcholine-induced relaxation
Pretreatment with AT (50 mM, 90 min) had no effect on the endothelium- 
dependent relaxation induced by acetylcholine (10 nM-3 pM, n=6 , Figure 
5.17). This result confirmed the selectivity of AT.
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Figure 5.14 Individual experimental tracings showing relaxation to 
hydroxylamine (NH2OH) on phenylephrine (PE)-contracted endothelium- 
denuded rings of rat aorta and the blockade of this relaxation following 
inhibition of endogenous catalase with 3-amino-1,2,4-triazole (AT, 50 mM, 90 
min). Drug concentrations are expressed in log molar units.
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Figure 5.15 Concentration-response curves showing relaxation to 
hydroxylamine (NH2OH, • )  on phenylephrine-contracted endothelium- 
denuded rings of rat aorta and concentration-dependent shifts to the right 
following inhibition of endogenous catalase with 3-amino-1,2,4-triazole (90 
min) at 5 mM (■), 10 mM (A), and 50 mM (t). Each point is the mean ± s.e. 
mean of 6 observations.
1 43
c0
1
0)o r
120 
100 -  
80 - 
60 - 
40 
20 H 
0
 1--------------- 1----------------1-
-10 -9 -8 -7
log [GTN] M
■6
Figure 5.16 Concentration-response curves showing relaxation to glyceryl 
trinitrate (GTN, #) on phenylephrine-contracted endothelium-denuded rings of 
rat aorta and the lack of effect of Inhibition of endogenous catalase with 3- 
amino-1,2,4-triazoie (50 mM, 90 min, t) on this relaxation. Each point is the 
mean ± s.e. mean of 6 observations.
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Figure 5.17 Concentration-response curves showing relaxation to 
acetylcholine (ACh, e) on phenylephrine-contracted endothelium-containing 
rings of rat aorta and the lack of effect of inhibition of endogenous catalase 
with 3-amino-1,2,4-triazole (50 mM, 90 min, ▼) on this relaxation. Each point is 
the mean ± s.e. mean of 6-7 observations.
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Chapter 6
Assessment of the effects of catalase In 
nitric oxide formation from sodium azide 
and hydroxylamine
In the previous Chapter (Chapter 5) we indirectly established, by means of 
functional studies, the role of catalase in relaxations induced by two powerful 
nitrovasodilators, sodium azide and hydroxylamine. In this Chapter, the role of 
catalase was investigated further by adopting a more direct approach i.e. by 
measuring NO formation from sodium azide and hydroxylamine.
It has been proposed that conversion of sodium azide and hydroxylamine to 
NO requires the presence of low concentrations of hydrogen peroxide and 
thus occurs as a consequence of the peroxidase activity of catalase (Theorell 
& Ehrenberg, 1952; Kell in & Hartree, 1954; Nicholls, 1964; Klebanoff & 
Nathan, 1993).
NO has a short half-life of around 5 seconds under physiological conditions 
(Griffith et al., 1984). It decays to the more stable end products, nitrite and 
nitrate, but predominantly the former in vitro (see Methods). Consequently, 
measuring nitrite formation from sodium azide and hydroxylamine was chosen 
as a convenient way to assess the role of catalase in NO formation from these 
nitrovasodilators.
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6.1 Nitrite formation from sodium azide
6.1.1 Role of hydrogen peroxide
The role of hydrogen peroxide in the conversion of sodium azide to NO by 
catalase was studied in a cell-free system. In these studies the reaction 
mixtures contained phosphate buffer (pH 5.6, 0.08 M), catalase (bovine liver, 
1000 u ml“ ' )^, sodium azide (0.3 mM) and hydrogen peroxide (1 pM-10 mM) 
and were incubated for 1 h at 37 °C. Figure 6.1 shows that catalase alone or in 
combination with sodium azide, failed to produce any nitrite. In contrast, in the 
presence of hydrogen peroxide a concentration-dependent rise in nitrite 
formation was seen. Hydrogen peroxide at a concentration of 1 mM was seen 
to be optimal and increased nitrite formation to 24.5 ± 0.5 pM (n=6 . Figure 
6.1). These findings suggested that the conversion of sodium azide to NO by 
catalase required the presence of hydrogen peroxide.
6.1.2 Role of catalase
Having established the optimum concentration of hydrogen peroxide required 
for the formation of nitrite, the concentration dependence of catalase was 
investigated. In these studies the reaction mixtures contained phosphate 
buffer (pH 5.6, 0.08 M), sodium azide (0.3 mM), hydrogen peroxide (1 mM) 
and catalase (100-1000 u mb'*) and were incubated for 1h at 37 °C. Nitrite 
production Increased with increasing concentrations of catalase: at a 
concentration of 1000 u ml -1, the level of nitrite produced was 23.3 ± 0.6 pM 
(n=6 , Figure 6.2). The intrinsic colour of catalase precluded the use of 
concentrations of the enzyme higher than 1000 u mh^ in the 
spectrophotometric assay.
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Figure 6.1 The formation of nitrite [NO2 "] from sodium azide (NaN^) by 
catalase (CAT) in a cell-free system requires the presence of hydrogen 
peroxide (H2 O2 ). The reaction mixtures contained phosphate buffer (pH 5.6, 
0.08 M), CAT (1000 u m|-1), NaNs (0.3 mM) and H2O2 (1 pM-10 mM) in a 
final volume of 80 pi and were incubated for 1 h at 37 °C. Control incubations 
with each of NaN^, CAT and H2O2 alone and with NaN^ and CAT were also 
performed. Each column is the mean ± s.e. mean of 6 observations. 
**P<0.005 and ***P<0.001 respectively indicate a significant difference from 
reaction mixtures containing CAT and NaNg but not H2O2
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Figure 6.2 Catalase (CAT) produced a concentration-dependent formation of 
nitrite [NO2 I  from sodium azide (NaNs) in the presence of hydrogen peroxide 
(H2O2) in a cell-free system. The reaction mixtures contained phosphate 
buffer (pH 5.6, 0.08 M), H2O2 (1 mM), NaNa (0.3 mM) and CAT (100-1000 u 
mb'*) in a final volume of 80 pi and were incubated for 1h at 37 °C. Control 
incubations with each of NaNa, CAT and H2O2 alone and with NaNa and CAT 
were also performed. Each column is the mean ± s.e. mean of 6 observations. 
**P<0.005 and ***P<0.001 respectively indicate a significant difference from 
reaction mixtures containing CAT and NaNa but not H2O2 .
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6.1.3 Concentratîon-dependence of sodium azide in the formation of 
nitrite
Having established the optimum conditions and concentrations of catalase 
and hydrogen peroxide required for the formation of nitrite in the above 
experiments, the concentration dependence of sodium azide (10 pM-3 mM) 
was investigated. As in the experiments above, sodium azide Incubated for 1h 
alone or together with catalase, failed to produce any significant formation of 
nitrite. However, in the presence of both catalase (1000 u mb'!) and hydrogen 
peroxide (1 mM), sodium azide (10 pM-3 mM) was converted in a 
concentration-dependent manner to nitrite: the maximum concentration of 
nitrite produced was 23.4 ± 0.6 pM from a concentration of 0.3 mM sodium 
azide (n=6 . Figure 6.3). At higher concentrations of sodium azide a slight 
decrease in nitrite formation was observed.
6.1.4 Time course of nitrite formation
Having established that the presence of hydrogen peroxide was necessary for 
the formation of nitrite from sodium azide by catalase, the time course of this 
effect was studied over 1h. Figure 6.4 shows that formation of nitrite was first 
seen at 3 min (3.1 ± 0.2 pM) and production continued to rise to 23.2 ± 0.7 pM 
at 60 min (n=5). The production of nitrite throughout this period was almost 
linear.
All the above findings indicate that catalase metabolises sodium azide to NO 
and this requires the presence of hydrogen peroxide.
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Figure 6.3 The catalase (CAT)-dependent formation of nitrite [NO2"] from a 
range of concentrations of sodium azide (NaN^) in the presence of hydrogen 
peroxide (H2O2) in a cell-free system. The reaction mixtures contained 
phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u mh"^), H2O2 (1 mM) and 
NaNg (10 pM-3 mM) in a final volume of 80 pi and were incubated for 1h at 37 
°C. Control incubations with each of NaNg, CAT and H2O2 alone and with 
NaNg and CAT were also performed. Each column is the mean ± s.e. mean of 
6 observations. **P<0.005 and ***P<0.001 respectively indicate a significant 
difference from reaction mixtures containing CAT and NaNg but not H2O2
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Figure 6.4 Time-course of the catalase (CAT)-dependent formation of nitrite 
[NO2 I  from sodium azide (NaNs) in the presence of hydrogen peroxide 
(H2O2) in a cell-free system. The reaction mixtures contained phosphate 
buffer (pH 5.6, 0,08 M), CAT (1000 u mM), H2O2 (1 mM) and NaNg (0.3 mM) 
in a final volume of 80 pi and were incubated for 0-60 min at 37 °C. Each point 
is the mean ± s.e. mean of 5 observations. ***P<0.001 indicates a significant 
increase from nitrite formation at 0 time.
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6.2 Nitrite formation from hydroxylamine
Hydroxylamine is another powerful nitrovasodilator which is thought to be 
converted to NO by catalase. To assess the formation of nitrite from 
hydroxylamine, the reaction mixtures containing phosphate buffer (pH 5.6, 
0.08 M), hydrogen peroxide (1 mM), catalase (1000 u mh'^) and a range of 
concentrations of hydroxylamine (10 pM-30 mM) were incubated for 1h at 37 
°C.
In a similar fashion to sodium azide, hydroxylamine (10 pM-30 mM) was 
converted in a concentration-dependent manner to nitrite by catalase in the 
presence but not in the absence of hydrogen peroxide. The maximum 
concentration of nitrite obtained was 8.7 ± 0.7 pM from a concentration of 10 
mM hydroxylamine (n=6-20, Figure 6.5). At a higher concentration of 
hydroxylamine (30 mM), a considerable reduction in nitrite formation was 
observed (Figure 6.5).
An attempt was made to determine if nitrite formation from hydroxylamine 
could be increased by varying the concentration of hydrogen peroxide. In 
these experiments increasing the concentration of hydrogen peroxide from 1 
mM to 100 mM increased the formation of nitrite from hydroxylamine at 3 mM 
and 10 mM from 5.6 ±0.1 pM to 9.3 ± 0.3 pM and from 7.6 ± 0.2 pM to 10.0 ± 
0.1 pM, respectively (n=6-12. Figure 6 .6 ).
These findings indicate that hydroxylamine, like sodium azide, is converted to 
NO by catalase in the presence but not in the absence of hydrogen peroxide. 
They also show that hydroxylamine is a less effective substrate than sodium 
azide.
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Figure 6.5 The catalase (CAT)-dependent formation of nitrite [N0 2 '] from a 
range of concentrations of hydroxylamine (NH2OH) in the presence of 
hydrogen peroxide (H2O2) in a cell-free system. The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u ml“1), H2O2 (1 
mM) and NH2OH (10 pM-30 mM) in a final volume of 80 pi and were 
incubated for 1 h at 37 °C. Control incubations with each of NH2 OH, CAT and 
H2O2 alone and with NH2OH and CAT were also performed. Each column is 
the mean ± s.e. mean of 6-20 observations. *P<0.05, **P<0.005 and 
***p<0 001 respectively indicate a significant difference from reaction mixtures 
containing CAT and NH2OH but not H2O2 .
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Figure 6.6 The catalase (CAT)-dependent formation of nitrite [NO2 "] from 
hydroxylamine (NH2OH) in the presence of a range of concentrations of 
hydrogen peroxide (H2O2) in a cell-free system. The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u ml~1), NH2OH (3 
mM or 10 mM) and H2O2 (1-100 mM) in a final volume of 80 pi and were 
incubated for 1 h at 37 °C. Control incubations with each of NH2OH, CAT and 
H2O2 alone and with NH2OH and CAT were also performed. Each column is 
the mean ± s.e. mean of 6-12 observations. ***P<0.001 indicates a significant 
difference from reaction mixtures containing CAT and NH2OH but not H2O2 . 
^P <0 .005 indicates a significant difference from reaction mixtures containing 
NH2OH and CAT and H2O2 (1 mM).
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6.3 Nitrite formation from glyceryl trinitrate
In contrast to sodium azide and hydroxylamine, the formation of NO from the 
nitrovasodilator, glyceryl trinitrate, is believed not to involve catalase. Instead, 
conversion is reported to occur by the action of glutathione-S-transferase 
(Armstrong et a/., 1980) or cytochrome P450 (Schroder, 1992), or by a direct 
reduction by tissue thiols (Feelisch, 1991). An attempt was therefore made to 
determine if catalase was indeed unable to convert glyceryl trinitrate to nitrite 
in our system. Indeed, no nitrite was generated when glyceryl trinitrate (1 mM) 
was incubated for 1 h at 37 °C with catalase (1000 u mh'^) in the presence of 
hydrogen peroxide (1 mM, Figure 6.7). In contrast, glyceryl trinitrate (1 mM) 
but not sodium azide (1 mM) or hydroxylamine (1 mM) was reduced to nitrite 
by the thiol, L-cysteine (3 mM) following a 1h incubation at 37 °C (n=6 . Figure 
6 .8). The maximum concentration of nitrite obtained from glyceryl trinitrate (1 
mM) was 93.7 ± 1.5 pM (Figure 6 .8). These data are therefore consistent with 
a distinct pathway for generation of NO from glyceryl trinitrate.
6.4 Use of the glucose-glucose oxidase system in nitrite 
formation from sodium azide
The sustained generation of hydrogen peroxide by the glucose/glucose 
oxidase system has been reported to be more efficient than a single high 
concentration of hydrogen peroxide in supporting the catalase-dependent 
formation of NO from sodium azide (Klebanoff & Nathan, 1993). 
Consequently, in order to investigate this experiments were conducted In 
which the formation of nitrite from sodium azide by catalase was observed in 
the presence and absence of the glucose/glucose oxidase system.
1 5 6
25
c 20
ceE 15 -
10 -
CM
O
0
GTN NH2OH NaNg
Figure 6.7 The catalase (CAT)-dependent formation of nitrite from sodium 
azide (NaN^) and hydroxylamine (NH2OH) but not glyceryl trinitrate (GTN) in 
the presence of hydrogen peroxide (H2 O2) in a cell-free system. The reaction 
mixtures contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u ml"1), 
H2O2 (1 mM) and NaNg (1 mM), NH2OH (1 mM) or GTN (1 mM) and were 
incubated for 1h at 37 °C. Each column is the mean ± s.e. mean of 6 
observations. ***P<0.001 indicates a significant difference from reaction 
mixtures containing CAT and H2O2 and GTN.
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Figure 6.8 The formation of nitrite [NO2"] from glyceryl trinitrate (GTN) but not 
sodium azide (NaNg) or hydroxylamine (NH2OH) by L-cysteine (L-cys) in a 
cell-free system. The reaction mixtures contained HEPES buffer (pH 7.4, 5 
mM), NaNg (1 mM), NH2OH (1 mM) or GTN (1 mM) together with L-cys (3 
mM) and were incubated for 1 h at 37 °0. Control incubations with each of L- 
cys, GTN, NaNg and NH2OH alone were also performed. Each column is the 
mean ± s.e. mean of 6 observations. ***P<0.001 indicates a significant 
difference from reaction mixtures containing GTN but not L-cys.
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The ability of a range of concentrations of the enzyme, glucose oxidase (1~ 
1000 mu ml"1), together with a fixed concentration of glucose (5 mM) to 
promote nitrite formation from sodium azide was investigated. The reaction 
mixtures contained phosphate buffer (pH 5.6. 0.08 M), catalase (1000 u ml“1), 
sodium azide (0.3 mM), glucose (5 mM) and glucose oxidase (1-1000 mu ml" 
1) and were incubated for 1h at 37 “C. Figure 6.9 shows that nitrite production 
increased with increasing concentrations of glucose oxidase: the maximum 
concentration of nitrite obtained was 45.1 ± 0.4 pM from a concentration of 
300 mu ml"1 glucose oxidase (n=6 ).
These findings confirmed the slightly greater efficiency of glucose/glucose 
oxidase system over hydrogen peroxide in facilitating catalase-dependent 
formation of nitrite from sodium azide (Klebanoff & Nathan, 1993).
Having established the optimum concentration of glucose oxidase, the time 
course of nitrite formation was studied over 1h. Figure 6.10 shows that 
formation of nitrite was first seen at 3 min (5.2 ± 0.2 pM) and production Îcontinued to rise almost linearly to 42.7 ± 1.3 pM at 60 min (n=6 ).
3:
Having established the optimum conditions in the above experiments, we then 
studied how nitrite formation varied with the concentration of sodium azide (10 
pM-3 mM). In presence of both catalase (1000 u ml"1) and the glucose (5 
mM)/glucose oxidase (300 mu ml"1) system, sodium azide (10 pM-3 mM) was 
converted in a concentration-dependent manner to nitrite during the 1h 
incubation. The maximum concentration of nitrite obtained was 44.5 ± 0.8 pM 
from a concentration of 0.3 mM sodium azide (n=6 , Figure 6.11), which was 
about 2-fold greater than that obtained with hydrogen peroxide (1 mM, see 
Figures 6.1, 6.2 and 6.3). At concentrations of sodium azide > 1 mM, a 
considerable reduction in nitrite formation was observed (Figure 6.11).
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Figure 6.9 The catalase (CAT)-dependent formation of nitrite [NO2 I  from 
sodium azide (NaN^) in the presence of a range of concentrations of glucose 
(GLU)/glucose oxidase (GO) in a cell-free system. The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u ml"1), NaNg (0.3 
mM) and GLU (5 mM)/ GO (1-1000 mu ml"1) in a final volume of 80 pi and 
were incubated for 1h at 37 °C. Control incubation with each of NaNg, CAT 
and GLU alone and with NaN^ and CAT, and with GLU and GO were also 
performed. Each column is the mean ± s.e. mean of 6 observations. *P<0.05, 
**P<0.005 and ***P<0.001 respectively indicate a significant difference from 
reaction mixtures containing CAT and NaN^ but not H2 O2 .
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Figure 6.10 Time-course of the catalase (CAT)-dependent formation of nitrite 
[NO2 "] from sodium azide (NaNg) in the presence of glucose (GLU)/glucose 
oxidase (GO) in a cell-free system. The reaction mixtures contained 
phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u m|-1), NaNg (0.3 mM) and 
GLU (5 mM)/GO (300 mu mh”^ ) in a final volume of 80 pi and were incubated 
for 0-60 min at 37 °C. Each point is the mean ± s.e. mean of 6 observations. 
**P<0.005 and ***P<0.001 indicate a significant increase from nitrite formation 
at 0 time, respectively.
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Figure 6.11 The catalase (CAT)-dependent formation of nitrite [NOg-] from a 
range of concentrations of sodium azide (NaNg) in the presence of glucose 
(GLU)/glucose oxidase (GO) in a cell-free system. The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u m|-1), GLU (5 
mM)/GO (300 mu mb'!) and NaNg (10 pM-3 mM) in a final volume of 80 pi and 
were incubated for 1h at 37 °C. Control incubations with each of NaN^, CAT 
and GLU alone and with NaNg and CAT, and with GLU and GO were also 
performed. Each column is the mean ± s.e. mean of 6 observations. *P<0.05, 
**P<0.005 and ***P<0.001 respectively indicate a significant difference from 
reaction mixtures containing CAT and NaNg but not H2O2
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6.5 Use of the glucose/glucose oxidase system in nitrite 
formation from hydroxylamine
Since hydroxylamine was a poor substrate for nitrite formation by catalase in 
the presence of a fixed concentration of hydrogen peroxide, an attempt was 
made to determine if formation could be increased by replacing hydrogen 
peroxide by the glucose/glucose oxidase system. The optimum concentration 
of glucose (5 mM)/glucose oxidase (300 mu m\~ )^ found in the previous 
experiments were incubated with catalase (1000 u mb'*) and a range of 
concentrations of hydroxylamine (10 pM-30 mM) for 1h at 37 °C. In these 
experiments the maximum concentration of nitrite obtained was 8.49 ± 0.2 pM 
from a concentration of 10 mM hydroxylamine (n=6-11, Figure 6.12), which 
was not significantly different from that obtained with hydrogen peroxide (see 
Figures 6.5 and 6 .6 ).
Thus, the glucose/glucose oxidase system, despite significantly increasing the 
catalase-dependent formation of nitrite from sodium azide failed to enhance 
production from hydroxylamine.
6.6 Inhibition of catalase-dependent formation of nitrite from  
sodium azide by 3-amino-1,2,4-triazole
In Chapter 5, it was clear that 3-amino-l ,2,4-triazole (AT) inhibited the relaxant 
actions of sodium azide and hydroxylamine in rat aorta indicating an important 
role for endogenous catalase. Furthermore, the results from this Chapter have 
shown that NO, assessed as nitrite, can indeed be generated from sodium 
azide and hydroxylamine by catalase in the presence of hydrogen peroxide. 
Consequently, it was important to investigate if the formation of nitrite from 
sodium azide by catalase could be blocked by AT. In these experiments the
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Figure 6.12 The catalase (CAT)-dependent formation of nitrite [N0 2 i  from a 
range of concentrations of hydroxylamine (NH2OH) in the presence of glucose 
(GLU)/glucose oxidase (GO) in a cell-free system. The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u m|-1), GLU (5 mM)/ 
GO (300 mu m|-1) and NH2OH (10 pM-30 mM) in a final volume of 80 pi and 
were incubated for 1 h at 37 °C. Control incubations with each of NH2OH and 
CAT alone and together, and with GLU and GO were also performed. Each 
column is the mean ± s.e. mean of 6-11 observations. **P<0.005 and 
***p<0 001 respectively indicate a significant difference from reaction mixtures 
containing CAT and NH2OH but not H2O2 .
1 6 4
reaction mixtures contained phosphate buffer (pH 6.5, 0.08 M), catalase (300 
or 1000 u ml“ '1), hydrogen peroxide (1 mM), sodium azide (0.3 mM) and AT 
(0.1-100 mM) and were incubated for 1 or 3h at 37 °C.
When AT (1-100 mM) was present during the 1h incubation, the catalase- 
dependent formation of nitrite from sodium azide in the presence of hydrogen 
peroxide was inhibited only slightly: a maximum inhibition of 36.4 ± 1.2 % was 
obtained with AT at 100 mM (n=6 . Figure 6.13). If, however, the duration of the 
incubation was extended to 3h together with a reduction of the catalase 
concentration to 300 u m l- \  the ability of AT to block formation of nitrite was 
enhanced. A maximum inhibition of 77.7 ± 6.3 % was obtained with AT at 100 
mM (n=6-20. Figure 6.14).
Since hydroxylamine was a poorer substrate than sodium azide, no 
experiments were conducted to determine if AT blocked the catalase- 
dependent formation of nitrite using this agent.
Our biochemical experiments indicate that AT indeed blocks the catalase- 
dependent conversion of sodium azide to nitrite in the presence of hydrogen
I
peroxide and the blockade is slow, consistent with its known slow onset of 
action (Heim ef al., 1956; Margoliash & Novogrodsky, 1958).
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Figure 6.13 Graph showing the inhibition by 3-amino-1,2,4-triazole (AT) of the 
catalase (CAT)-dependent formation of nitrite [NO2"] from sodium azide 
(NaNg) in the presence of hydrogen peroxide (H2O2). The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (1000 u mh'^), H2O2 (1 
mM). NaNg (0.3 mM) and AT (1-100 mM) and were incubated for 1 h at 37 °C. 
Each point is the mean ± s.e. mean of 6 observations.
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Figure 6.14 Graph showing the inhibition by 3-amino-1,2,4-triazole (AT) of the 
catalase (CAT)-dependent formation of nitrite [N0 2 “] from sodium azide 
(NaNg) in the presence of hydrogen peroxide (H2O2). The reaction mixtures 
contained phosphate buffer (pH 5.6, 0.08 M), CAT (300 u m|-^), H2O2 (1 mM), 
NaNg (0.3 mM) and AT (0.1-100 mM) and were incubated for 3h at 37 °C. 
Each point is the mean ± s.e. mean of 6-20 observations.
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Chapter 7
Assessment of the hydrogen peroxide- 
induced impairment of vascular reactivity 
and the role of endogenous catalase
Hydrogen peroxide, a powerful oxidant, is a normal metabolite (Chance et al., 
1979) formed in all subcellular compartments (Boveris et ai., 1972). 
Mitochondria are the major source of hydrogen peroxide in cells (Boveris & 
Chance, 1973; Dionisi et a!., 1975) where it is formed due to dismutation of 
superoxide anion (Freeman & Crapo, 1981; 1982).
In this Chapter, we assessed the damage induced by hydrogen peroxide to 
vascular responsiveness and investigated the role of endogenous catalase in 
protection against this damage. In order to investigate the role of endogenous 
catalase, we made a use of the inhibitor of this enzyme, 3-amino-1,2,4-triazole 
(Heim eta!., 1956; Margoliash & Novogrodsky, 1958).
7.1 Effects of incubation with hydrogen peroxide on 
phenylephrine (PE)-induced contraction
Following induction of PE (10 nM)-induced contraction (1.3 ± 0.1 g, n=12) in 
endothelium-containing rings, addition of hydrogen peroxide (0.1 mM) 
produced a powerful long-lasting relaxation (79.5 ± 1.5 %, n=12), as 
previously reported in Chapter 5. When the incubation was continued for 15, 
30 or 60 min and the tissues were washed, subsequent PE (10 nM)-induced 
contraction was completely unaffected (1.3 ± 0.1 g following 60 min 
incubation, n=6-12, Figure 7.1a).
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In order to assess the effects of higher concentrations of hydrogen peroxide 
on PE-induced contraction, the concentration of hydrogen peroxide was 
increased to 1 mM. In these experiments following induction of PE (10 nM)- 
induced contraction (1.3 ± 0 .1  g, n=12) in endothelium-containing rings, 
addition of hydrogen peroxide (1 mM) produced a powerful long-lasting 
relaxation (96.2 ± 3.5 %, n=12), as previously reported in Chapter 5. When the 
incubation was continued for 15, 30 or 60 min and the tissues were washed, 
subsequent PE (10 nM)-induced contraction was inhibited in a time-dependent 
manner. Incubation of endothelium-containing rings with hydrogen peroxide (1 
mM) for 15 min followed by washout, had no effect on PE (10 nM)-induced 
contraction (n=12. Figure 7.1b and 7.3). In contrast, incubation for 30 min 
followed by washout significantly depressed PE (10 nM)-induced contraction 
(by 36.5 ± 3.1 %, n=12, Figure 7.1b, 7.6b and 7.8). We ensured, however, that 
in relaxation studies the level of contraction prior to adding acetylcholine was 
similar (1.2 ±0.1 g, n=12) to that of untreated preparations (1.3 ± 0.1 g, n=12) 
by increasing the concentration of PE to 100 nM. Furthermore, incubation with 
hydrogen peroxide for 60 min followed by washout depressed PE (10 nM)- 
induced contraction (n=6-12, Figure 7.1b and 7.3) to such an extent that the 
maximum contraction obtained in these tissues was only 0.6 ± 0.03 g with PE 
at 3 pM. These findings suggest that hydrogen peroxide (1 mM) induces 
damage to the vascular smooth muscle .
7.2 Effects of incubation with hydrogen peroxide on 
acetylcholine (ACh)-induced relaxation
7.2.1 Effects of incubation with hydrogen peroxide (0.1 mM) on 
ACh-induced relaxation
In order to determine if hydrogen peroxide impairs endothelial function,
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Figure 7.1 (a) Incubation of endothelium-containing rat aortic rings with 
hydrogen peroxide (H2O2 , 0.1 mM) for 15, 30 or 60 min followed by washout 
had no effect on subsequent phenylephrine (PE, 10 nM)-induced contraction, 
(b) Incubation of endothelium-containing rings with H2O2 (1 mM) for 15 min 
followed by washout had no effect on PE (10 nM)-induced contraction. 
Extending the incubation period to 30 or 60 min followed by washout, 
however, significantly depressed the contraction generated. Each column is 
the mean ± s.e. mean of 6-12 observations. *P<0.05 and ***P<0.001 indicate 
a significant difference from rings receiving PE only, respectively.
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the effects of incubation with hydrogen peroxide (0.1 mM) for various times 
were assessed on ACh (10 nM-3 pM)-induced relaxation. Following induction 
of PE (10-30 nM)-induced contraction (1.3 ± 0.1 g, n=6 ) in endothelium- 
containing rings, incubation with hydrogen peroxide (0.1 mM) for 15, 30 or 60 
min followed by washout and re-contraction with PE (10-30 nM), had no effect 
on subsequent ACh (10 nM-3 pM)~induced relaxation (n=6 , Figure 7.2a). 
Thus, hydrogen peroxide (0.1 mM) did not appear to impair endothelial 
function.
7.2.2 Effects of incubation with hydrogen peroxide (1 mM) on ACh- 
induced relaxation
In order to determine if higher concentrations of hydrogen peroxide had any 
effect on endothelial function, the effects of incubation with hydrogen peroxide 
(1 mM) for various times were assessed on ACh-induced relaxation.
7.2.2.1 Effects of short exposure to hydrogen peroxide (1 mM) on 
ACh-induced relaxation
Following induction of PE (10-30 nM)-induced contraction (1.2 ±0.1 g, n=12), 
incubation of endothelium-containing rings with hydrogen peroxide (1 mM) for 
15 min followed by washout and re-contraction with PE resulted in a profound 
potentiation of subsequent relaxation at each concentration of ACh (greatest 
enhancement was seen at 100 nM, n=12, Figure 7.2b, 7.3, 7.4 and 7.5a).
In order to investigate if the potentiation of ACh-induced relaxation seen 
following a short (15 min) exposure to hydrogen peroxide (1 mM) was 
sustained, a second concentration-response curve to ACh was constructed
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Figure 7.2 (a) Concentration-response curves showing relaxation to 
acetylcholine (ACh, • )  following incubation with hydrogen peroxide (H2O2 , 0.1 
mM) for 15 min (a ), 30 min (■) or 60 min (t) followed by washout on 
phenylephrine-contracted endothelium-containing rings of rat aorta, (b) 
Concentration-response curves showing relaxation to ACh (•) and potentiation 
of this following incubation with H2O2 (1 mM) for 15 min followed by washout 
(a). Furthermore, incubation with H2O2 (1 mM) for 30 min (■) or GO min (v) 
followed by washout resulted in a significant blockade of ACh-induced 
relaxation. Each point is the mean ± s.e. mean of 5-12 observations. *P<0.05, 
**P<0.005 and ***P<0.001 indicate a significant difference from relaxations 
obtained in untreated rings, respectively.
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Figure 7.3 Individual experimental traces showing the potentiation of 
acetylcholine (ACh)-induced relaxation after 15 min incubation with hydrogen 
peroxide (H2O2 , 1 mM) followed by washout and blockade of relaxation 
following incubation with H2O2 for 60 min followed by washout on 
phenylephrine (PE)-contracted endothelium-containing rings of rat aorta. Drug 
concentrations are expressed in log molar units.
173
after 2h in the same tissue. This second concentration-response curve to ACh 
demonstrated a substantial blockade of relaxation: the greatest blockade v\/as 
seen at 100 nM where the relaxation was reduced from 91.4 ± 3.9 % to 27.4 ± 
4.5 % (n=8-9, Figure 7.4).
7.2.2.2 Effects of longer exposure to hydrogen peroxide (1 mM) on 
ACh-induced relaxation
In contrast to short (15 min) exposure, incubation of endothelium-containing 
rings, precontracted with PE (10-30 nM), with hydrogen peroxide (1 mM) for 
30 and 60 min followed by washout and re-contraction with PE resulted in a 
profound blockade of ACh-induced relaxation: the maximal relaxation induced 
by ACh (3 pM) was reduced by 17.3 ± 0.6 % and 55.9 ± 2.7 %, respectively 
(n=6-12, Figure 7.2b).
The above findings demonstrate that hydrogen peroxide causes a 
concentration- and time-dependent impairment of ACh-induced relaxation.
7.2.3 Effects of exogenous catalase on impairment of ACh-induced 
relaxation by hydrogen peroxide
Catalase removes hydrogen peroxide by converting it to water and oxygen 
(Cheeseman & Slater, 1993). Consequently, the ability of catalase (1000 u ml" 
'^ ) to protect against the impairment induced by hydrogen peroxide (1 mM) of 
ACh-induced relaxation was studied. In these experiments endothelium- 
containing rings were pretreated with catalase (1000 u ml""1) for 15 min prior to 
the incubation with hydrogen peroxide (1 mM). Pretreatment with catalase 
completely prevented the ability of hydrogen peroxide (15 min, followed by 
washout) to potentiate ACh-induced relaxation (n=5, Figure 7.5a).
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Figure 7.4 Concentration-response curves showing relaxation to acetylcholine 
(ACh, #) on phenylephrine-contracted endothelium-containing rings of rat 
aorta, potentiation of this relaxation following incubation with hydrogen 
peroxide (H2O2 , 1 mM) for 15 min followed by washout (a ) and subsequent 
blockade (■), evident from a second concentration-response curve constructed 
after 2h in the same tissue. Each point is the mean ± s.e. mean of 8-9 
observations. *P<0.05, **P<0.005 and ***P<0.001 indicate a significant 
difference from relaxations obtained in untreated rings, respectively.
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Figure 7.5 Concentration-response curves showing relaxation to acetylcholine 
(ACh, •), potentiation of this relaxation after 15 min incubation with hydrogen 
peroxide (H2O2 , 1 mM) followed by washout (a, a) and blockade of relaxation 
after 60 min incubation with H2O2 (1 mM) followed by washout (b, t) on 
phenylephrine-contracted endothelium-containing rings of rat aorta. 
Pretreatment with catalase (1000 u ml"1, ■) completely protected against both 
the augmentation and inhibition produced by H2O2 . Each point is the mean ± 
s.e. mean of 5-6 observations. *P<0.05, **P<0.0G5 and ***P<0.001 indicate a 
significant difference from relaxations obtained in untreated rings, respectively.
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It also completely prevented the blockade of ACh-induced relaxation following 
60 min incubation with hydrogen peroxide (n=6 , Figure 7.5b).
7.3 Effects of 3-amino-1-2,4,-triazole (AT) on hydrogen 
peroxide-induced impairment of PE-induced contraction
If endogenous catalase is important in protecting vascular function from 
hydrogen peroxide, then its inactivation with AT would be expected to 
potentiate the inhibitory effects of this oxidant. Consequently, experiments 
were carried out to investigate the effects of AT on the ability of hydrogen 
peroxide (0.1 or 1 mM) to depress PE-induced contraction. In these 
experiments, incubation of endothelium-containing rings with AT (50 mM, 90 
min, followed by washout) alone, to inhibit endogenous catalase, had no effect 
on subsequent PE (10 nM)-induced contraction (1.3 ±0.1 g, n=10, Figure 7.6a 
and 7.6b). Similarly, incubation of tissues with hydrogen peroxide (0.1 mM, 30 
min, followed by washout) alone had no effect on PE (10 nM)-induced 
contraction (n=6-10, Figure 7.1a, 7.6a). Furthermore, incubation of tissues 
with AT (50 mM) for 90 min together with hydrogen peroxide (0.1 mM) for the 
last 30 min followed by washout had no effect on PE (10 nM)-induced 
contraction (n=6-10, Figure 7.6a).
The effects of AT together with hydrogen peroxide at 1 mM on PE-induced 
contraction were also studied. In these experiments, incubation of 
endothelium-containing rings with hydrogen peroxide (1 mM, 30 min, followed 
by washout) alone significantly depressed subsequent PE (10 nM)-induced 
contraction (by 36.2 ± 3.7 %, n=10. Figure 7.1b, 7.6b and 7.8). In contrast to 
its lack of effect when combined with hydrogen peroxide at 0.1 mM, treatment 
with AT (50 mM, 90 min) markedly potentiated the ability of hydrogen
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peroxide at 1 mM (present during the final 30 min of 90 min incubation, 
followed by washout) to depress PE (10 nM)-induced contraction: depression 
was increased to 98.0 ± 2.5 % (P<0.001, n=6-10, Figure 7.6b). In relaxation 
studies involving the combination of AT and hydrogen peroxide (1 mM, 30 
min), an attempt was made to raise the level of contraction to that of untreated 
preparations (1.3 ±0.1 g, n=10) by increasing the concentration of PE, but the 
maximum contraction obtained in these tissues was only 0.6 ± 0.02 g with PE 
at 3 pM (n=10, Figure 7.8).
These findings suggest that endogenous catalase is important in protecting 
vascular smooth muscle against impairment by high (1 mM) concentrations of 
hydrogen peroxide.
7.4 Effects of inhibiting endogenous catalase with 3-amino- 
1,2,4-triazole (AT) on hydrogen peroxide-induced impairment 
of vascular relaxation of rat aorta
7.4.1 Effects of inhibition of endogenous catalase by AT on 
hydrogen peroxide-induced impairment of endothelium-dependent 
relaxation
Having established the effects of hydrogen peroxide alone and together with 
the inhibition of endogenous catalase with AT on PE-induced contraction, the 
effects of this combined treatment were studied on the endothelium- 
dependent relaxation induced by ACh.
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Figure 7.6 (a) Incubation with the inhibitor of catalase, 3-amino-1,2,4-triazole 
(AT, 50 mM, 90 min, followed by washout) alone, incubation with hydrogen 
peroxide (H2O2 , 0.1 mM, 30 min, followed by washout) alone, or the 
combined treatment with AT (50 mM, 90 min) and H2O2 (0.1 mM, present 
during the last 30 min of the 90 min incubation, followed by washout) had no 
effect on phenylephrine (PE, 10 nM)-induced contraction in endothelium- 
containing rings of rat aorta, (b) Incubation with H2O2 (1 mM, 30 min, followed 
by washout), however, significantly depressed PE-induced contraction. 
Furthermore, contraction was depressed further if H2O2 (1 mM) was present 
during the last 30 min of the 90 min incubation with AT. Each column is the 
mean ± s.e. mean of 6-10 observations. *P<0.05, ***P<0.001 indicate a 
significant difference from rings receiving PE only, respectively, or between 
groups joined by brackets.
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7.4.1.1 Effects of AT with hydrogen peroxide at 0.1 rnM on ACh-
induced relaxation
Treatment with AT (50 mM) for 90 min followed by washout, to inhibit 
endogenous catalase, alone (n=12, Figure 7.7 and 7.8), or incubation with low
concentrations of hydrogen peroxide (0.1 mM) alone for 30 min followed by 
washout had no effect on subsequent ACh-induced relaxation (n=12. Figure 
7.2a and 7.7). Furthermore, treatment of endothelium-containing rings with AT 
(50 mM) for 90 min together with hydrogen peroxide (0.1 mM) for the last 30 
min followed by washout had no effect on ACh (10 nM-3 pM)-induced 
relaxation (n=6 . Figure 7.7).
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7.4.1.2 Effects of AT with hydrogen peroxide at 1 mM on ACh- 
induced relaxation
Incubation of endothelium-containing rings with hydrogen peroxide (1 mM) 
alone for 30 min followed by washout produced a significant inhibition (21.0 ± 
0.7 %) of maximal ACh-induced relaxation at 3 pM (Figure 7.2b, 7.8 and 7.9).
In contrast to its lack of effect when combined with hydrogen peroxide at 0.1 
mM, treatment with AT (50 mM, 90 min) markedly potentiated the ability of 
hydrogen peroxide at 1 mM (present during the final 30 min of 90 min 
incubation, followed by washout) to inhibit ACh (10 nM-3 pM)-induced 
relaxation. The blockade of maximal relaxation induced by ACh at 3 pM was 
increased to 68.0 ± 6.2 % (P<0.001 for each, n=6-10, Figure 7.8 and 7.9).
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Figure 7.7 Concentration response curves showing relaxation to acetylcholine 
(ACh, • )  on phenylephrine-contracted endothelium-containing rings of rat 
aorta and the lack of effect of inhibition of endogenous catalase with 3-amino- 
1,2,4-triazole (AT, 50 mM, 90 min, followed by washout, v) or incubation with 
hydrogen peroxide (HgOg, 0.1 mM, 30 min, followed by washout, ■) on this 
relaxation. Furthermore, incubation with AT (50 mM, 90 min) together with 
H2O2 (0.1 mM) during the final 30 min followed by washout (a) also had no 
effect on this relaxation. Each point is the mean ± s.e. mean of 6-12 
observations.
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Figure 7.8 Individual experimental traces showing the lack of effect of the 
inhibitor of catalase, 3-amino-1,2,4-triazole (AT, 50 mM, 90 min, followed by 
washout), on acetylcholine (ACh)-induced relaxation of phenylephrine (PE)- 
contracted endothelium-containing rings of rat aorta. Also shown is blockade 
of ACh-induced relaxation following incubation with hydrogen peroxide (H2O2 , 
1 mM, 30 min, followed by washout), and the potentiation of this blockade 
following inhibition of endogenous catalase with AT (50 mM, 90 min). H2O2 
alone or, more profoundly, together with AT also depressed PE-induced 
contraction. Drug concentrations are expressed in log molar units.
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Figure 7.9 Concentration-response curves showing relaxation to acetylcholine 
(ACh, • )  on phenylephrine-contracted endothelium-containing rings of rat 
aorta and blockade of relaxation following incubation with hydrogen peroxide 
(H2O2 , 1 mM, 30 min, followed by washout, ■). Furthermore, following 
inhibition of endogenous catalase with 3-amino-1,2,-4-triazole (AT, 50 mM, 90 
min) incubation with H2O2 (1 mM, present for last 30 min of the 90 min 
incubation, followed by washout) now produced a much greater blockade (A) 
of relaxation induced by ACh. Each point is the mean ± s.e. mean of 6-10 
observations. **P<0.005 and ***P<0.001 indicate a significant difference from 
maximal relaxation in untreated rings, respectively. *P < 0 .0 0 1  indicates a 
significantly greater blockade following combined treatment with AT and H2O2 
than with H2O2 alone.
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These findings suggest an important role for endogenous catalase in 
protecting ACh-induced relaxation against impairment by high (1 mM) 
concentrations of hydrogen peroxide.
7.4.2 Effects of inhibition of endogenous catalase by AT on 
hydrogen peroxide-induced impairment of endothelium- 
independent relaxation
Since inhibition of endogenous catalase with AT potentiated the impairment of 
endothelium-dependent, ACh-induced relaxation of rat aorta following 
treatment with hydrogen peroxide (1 mM), the effects on relaxation induced by 
the endothelium-independent relaxants, glyceryl trinitrate and isoprenaline, 
were examined.
7.4.2.1 Effects of AT with hydrogen peroxide at 0.1 mlVI on 
relaxations Induced by glyceryl trinitrate and isoprenaline
Incubation of endothelium-denuded rings with AT (50 mM, 90 min, followed by 
washout), had no effect on relaxations induced by glyceryl trinitrate (GTN, 1- 
100 nM, n=6-10, Figure 7.10a) or isoprenaline (ISO, 10 nM-3 pM, n=6-10. 
Figure 7.11a).
Incubation with a low concentration of hydrogen peroxide (0.1 mM, 30 min, 
followed by washout) alone or in combination with AT (50 mM, 90 min, 
followed by washout) failed to affect relaxations induced by GTN or ISO (n=10. 
Figure 7.10a and 7.1 la).
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7A.2.2 Effects of AT with hydrogen peroxide at 1 mM on relaxations 
induced by glyceryl trinitrate and isoprenaline
Incubation of endothelium-denuded rings with a higher concentration of 
hydrogen peroxide (1 mM) for 30 min followed by washout did, however, 
inhibit maximal relaxation induced by GTN and ISO by 28.6 ±1.9  % and 29.9 
± 1.3 %, respectively, (n=G, Figure 7.10b and 7.11b). Furthermore, as was 
seen with ACh, inhibition of endogenous catalase with AT (50 mM, 90 min) 
significantly enhanced the ability of hydrogen peroxide (1 mM, present during 
the final 30 min of 90 min incubation, followed by washout) to block relaxation 
induced by GTN or ISO: the blockade of maximal relaxation induced by GTN 
and ISO was increased to 73.1 ±7 .1  % and 64.0 ± 5.5 %, respectively 
(P<0.001 for each, n=6 . Figure 7.10b and 7.11b).
The data presented in this Chapter suggest that hydrogen peroxide produces 
non-selective damage to the vascular smooth muscle resulting in loss of 
contractile and relaxant actions, and that endogenous catalase plays an 
important role in protection against this damage.
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Figure 7.10 (a) Concentration-response curves showing relaxation to glyceryl 
trinitrate (GTN, • )  on phenylephrine (PE)-contracted endothelium-denuded 
rings of rat aorta and the lack of effect of inhibition of endogenous catalase 
with 3-amino-1,2,4-triazole (AT, 50 mM, 90 min, followed by washout, ▼) or 
incubation with hydrogen peroxide (H2O2 , 0.1 mM, 30 min, followed by 
washout, ■) on this relaxation. Furthermore, incubation with AT (50 mM, 90 
min) together with H2O2 (0.1 mM) during the final 30 min followed by washout 
(a) also had no effect on this relaxation, (b) Concentration-response curves 
showing relaxation to GTN (•) on PE-contracted endothelium-denuded rings 
and blockade of relaxation following incubation with H2O2 (1 mM, 30 min, 
followed by washout, ■). Furthermore, following inhibition of endogenous 
catalase with AT (50 mM, 90 min) incubation with H2O2 (1 mM, present for 
last 30 min of the 90 min incubation, followed by washout) now produced a 
much greater blockade (a) of relaxation. Each point is the mean ± s.e. mean 
of 6-10 observations. ***P<0.001 indicates a significant difference from 
maximal relaxation in untreated rings. *P < 0 .0 0 1  indicates a significantly 
greater blockade following combined treatment with AT and H2O2 than with 
H2O2 alone.
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Figure 7.11 (a) Concentration-response curves showing relaxation to 
isoprenaline (ISO, • )  on phenylephrine (PE)-contracted endothelium-denuded 
rings of rat aorta and the lack of effect of Inhibition of endogenous catalase 
with 3-amino-1,2,4-triazole (AT, 50 mM, 90 min, followed by washout, t) or 
incubation with hydrogen peroxide (H2O2 . 01 mM, 30 min, followed by 
washout, ■) on this relaxation. Furthermore, incubation with AT (50 mM, 90 
min) together with H2O2 (0.1 mM) during the final 30 min followed by washout 
(a) also had no effect on this relaxation, (b) Concentration-response curves 
showing relaxation to ISO (•) on PE-contracted endothelium-denuded rings 
and blockade of relaxation following incubation with H2O2 (1 mM, 30 min, 
followed by washout, ■). Furthermore, following inhibition of endogenous 
catalase with AT (50 mM, 90 min) incubation with H2O2 (1 mM, present for 
last 30 min of the 90 min incubation, followed by washout) now produced a 
much greater blockade (a) of relaxation. Each point is the mean ± s.e. mean 
of 6-10 observations. ***P<0.001 indicates a significant difference from 
maximal relaxation in untreated rings. *P < 0 .0 0 1  indicates a significantly 
greater blockade following combined treatment with AT and H2O2 than with 
H2O2 alone.
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DISCUSSION
Chapter 8
8.1 Effects of superoxide anion on basal and agonist- 
stimulated activity of NO
The importance of the endothelium in the regulation of vascular tone has 
become increasingly apparent over the last decade. The demonstration of the 
phenomenon of “endothelium-dependent relaxation”, in 1980, by Furchgott 
and Zawadzki and its mediation by a labile factor termed endothelium-derived 
relaxing factor (EDRF), has revolutionised our understanding of how local 
vascular tone is regulated. This has led to a re-examination of the 
mechanisms by which various vasoactive mediators produce their effects. 
Many vasoactive substances have now been classified as acting entirely 
through the endothelium to produce vasorelaxation, whereas other agents 
exert their effects on the smooth muscle. EDRF-mediated vasorelaxation is 
associated with enhanced levels of cGMP in the smooth muscle cells, resulting 
from the stimulation of soluble guanylate cyclase (Holzmann, 1982; Rapoport 
& Murad, 1983). Similarly, nitrovasodilators produce vasorelaxation by the 
formation of NO and enhancement in cGMP levels (Murad, 1994), suggesting 
a common mechanism of action. Indeed, in 1987, Palmer et al. demonstrated 
that NO accounts for the biological actions of EDRF and therefore EDRF may 
be considered as an endogenous nitrovasodilator. EDRF is derived from either 
of the guanidino nitrogens of L-arginine by the constitutively expressed 
enzyme, NO synthase (Rees eta!., 1989; 1990a; Müisch & Busse, 1990).
In addition to NO, endothelial cells are a potential source of superoxide anion 
(Rosen & Freeman, 1984). Recently, the interaction between NO and 
superoxide anion has received a great deal of attention. This interaction leads
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to various consequences: destruction of the vasodilator effects of EDRF and 
authentic NO in cascade bioassay systems (Gryglewski et al., 1986b; Rubanyi 
& Vanhoutte, 1986a; Furchgott et al., 1990); induction of endothelium- 
dependent vasoconstriction in arterial rings from loss of the dilator actions of 
basally produced NO (Katusic & Vanhoutte, 1989; Ohistein & Nichols, 1989); 
and production of a cytotoxic oxidant, peroxynitrite (Beckman et al., 1990). 
This widespread potential for loss of NO-induced vasodilatation and 
production of peroxynitrite following the reaction of NO with superoxide anion 
has led to the suggestion that this process contributes to a number of 
pathological situations such as hypertension, ischemia-reperfusion damage, 
hypercholesterolemia/atherosclerosis, diabetes and cytotoxic brain injury (Wei 
et al., 1985; Downey, 1990; Minor et al., 1990; Mügge et al., 1991a; 
Langenstroer & Pieper, 1992; Lipton et al., 1993).
In vascular endothelium, the production of NO is subject to complex control; it 
is stimulated by a large number of mediators such as acetylcholine (ACh; 
Furchgott & Zawadzki, 1980a) and by the physical shearing force of the 
flowing blood (Pohl et al., 1986). In the present study, agonist-stimulated 
activity of NO was determined by assessing ACh-induced relaxation. In 
addition, there is a basal production of NO which exerts a tonic vasodilator 
action on endothelium-containing arterial rings (Eglème et al., 1984; Martin et 
al., 1986; Martin, 1988). Basal activity of NO was assessed indirectly by 
measuring the endothelium-dependent depression of phenylephrine (PE)~ 
induced vasoconstriction (Martin et al., 1986). This endothelium-dependent 
depression of vasoconstriction would be expected to be blocked or enhanced 
by agents which inhibit or enhance the activity of NO, respectively.
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Recent reports have suggested differences in the effects of drugs on basal 
and agonist-stimulated activity of NO. For example, the sulphydryl alkylating 
agent, N-ethylmaleimide, selectively inhibits the activity of NO stimulated by 
agonists from cultured endothelial cells, but has no effect on basal activity of 
NO (Siegle et al., 1989). Furthermore, in the perfused vascular bed of the 
rabbit ear, N^-nitro-L-arginine methyl ester (L-NAME) inhibits both basal and 
agonist-stimulated activity of NO, but only in the former case is blockade 
reversed by L-arginine (Randall & Griffith, 1991). Moreover, in the Isolated 
coronary artery of the greyhound, the inhibitor of acetyl-coA lysolecithin 
acyltransferase, thimerosal, has a complex action, transiently producing 
endothelium-dependent relaxation and then blocking agonist-stimulated but 
not basal production of NO (Crack & Cocks, 1992). In addition to these data, 
work from our own laboratory has shown in the rat aorta, that N^-monomethyl- 
L-arginine (L-NMMA) selectively inhibits basal but not agonist-stimulated 
activity of NO (Frew et al., 1993). Such studies may suggest a difference in the 
chemical nature of basal and agonist-stimulated EDRF.
In this part of the study, we sought to determine if basal and ACh-stimulated 
activity of NO in rat aorta were equally sensitive to destruction by superoxide 
anion. These experiments were considered important in relation to the 
reported ability of superoxide dismutase to potentiate the effects of basal NO 
but to have no effect on the relaxant actions of ACh in arterial rings 
(Abrahamsson etal., 1992), suggesting differential actions of superoxide anion 
on basal and agonist-stimulated activity. In our experiments the effects of 
superoxide anion were assessed either by generating the free radical using 
hypoxanthine/xanthine oxidase or pyrogallol (Halliwell & Gutteridge, 1989), or 
by increasing the background level of the free radical by inhibiting the 
endogenous Cu-Zn form of superoxide dismutase with diethyIdithiocarbamate 
(DETCA, Fleikkila etal., 1976; Cocco etal., 1981 ; Flalliwell & Gutteridge.
1989).
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8.1.1 Effects of superoxide dismutase on basal and ACh- 
stimulated activity of NO
Superoxide dismutase (SOD) scavenges superoxide anion CO2") by
converting it to hydrogen peroxide (H2 O2 ) and oxygen (Halliwell & Gutteridge, 
1989; Cheeseman & Slater, 1993).
SOD
*02“ + *02“ + 2H^ H2O2 + O2
It is well established that exogenously added SOD potentiates both basal and 
agonist-stimulated activity of NO in cascade bioassay systems (Gryglewski et 
al., 1986b; Rubanyi & Vanhoutte, 1986a). In isolated arterial rings SOD also 
appears to potentiate basal activity (Ohistein & Nichols, 1989; Langenstroer & 
Pieper, 1992) but, surprisingly has no effect on agonist-stimulated activity of 
NO (Abrahamsson et al., 1992). Clearly, the apparent differential effects of 
SOD on basal and agonist-stimulated activity of NO need to be explained. I
We found that SOD (Cu-Zn-containing isoform, from bovine erythrocytes, 1- 
300 u mh^) produced powerful concentration-dependent relaxation of 
phenylephrine (PE)-contracted endothelium-containing rings of rat aorta but 
had no effect on endothelium-denuded rings. The relaxation induced by SOD 
appeared to be mediated by NO since pretreatment of endothelium-containing 
rings with N^-nitro-L-arginine (L-NOARG, 30 pM), an inhibitor of NO synthesis 
(Moore et al., 1990), completely blocked this effect. The relaxant effects of 
SOD are therefore likely to have arisen from removal of superoxide anions 
generated either within the tissue or the oxygenated Krebs' solution, which 
were destroying basally produced NO. Indeed, endothelial cells in culture have 
been shown to generate and release superoxide anion (Rosen & Freeman,
;
m
1984). The Krebs' solution oxygenated with gas mixtures containing 95 % 
oxygen provides a ready source for superoxide anion generation. Having 
established that exogenous SOD induced endothelium-dependent relaxation, 
almost certainly through potentiation of basal activity of NO, the effects of this 
enzyme on ACh-stimulated activity of NO were determined. In keeping with 
Abrahamsson and co-workers (1992), we found that a concentration of SOD 
(50 u m|-1) which induced almost maximal potentiation of basal activity of NO 
had absolutely no effect on ACh-induced relaxation. The background levels of 
superoxide anion therefore appeared to be exerting a selective destructive 
action on basal but not agonist-stimulated activity of NO. An explanation for 
this was not obvious, but in order to gain further insight into the mechanisms 
that may be responsible for this difference, the effects of generators of 
superoxide anion were examined.
8.1.2 Effects of hypoxanthine/xanthine oxidase on basal and 
ACh-stimulated activity of NO
The hypoxanthine/xanthine oxidase (HX/XO) system is commonly used for the 
generation of superoxide anions. HX/XO is a simple enzymic system where 
XO catalyses the conversion of HX to xanthine and superoxide anion. 
Xanthine is further converted to uric acid by XO with concomitant release of 
another superoxide anion. The biological significance of this superoxide anion 
generating system becomes increasingly apparent under pathological 
conditions such as ischemia-reperfusion injury where levels of hypoxanthine 
increase as does conversion of xanthine dehydrogenase to xanthine oxidase 
(Kloner et al., 1989). The validity of this system to generate superoxide anion 
has been well established using the known ability of the radical to reduce 
oxidised cytochrome C (Fridovich, 1970; Berman & Martin, 1993). This 
reduction is associated with an increase in absorbance at 550 nm. Using this
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technique, it was shown that HX and XO when present in combination led to 
reduction of oxidised cytochrome C, indicating the successful generation of 
superoxide anion.
Following induction of tone with PE, HX (0.1 mM)/XO (16 mu ml""l) produced 
two effects on rings of rat aorta. The first of these effects was an immediate 
and profound rise in PE-induced tone in endothelium-containing rings. This 
effect, however, was absent in endothelium-denuded rings. It was also absent 
in endothelium-containing rings pretreated with the NO synthase inhibitors, L- 
NMMA (30 pM, Rees et al., 1989; 1990a) or L-NOARG (30 pM, Moore et al.,
1990). The absolute dependence of the HX/XO-elicited rise of tone in PE- 
contracted rings upon the presence of endothelium suggests that it is due to 
destruction of basal NO by superoxide anion. This conclusion was indeed 
confirmed in experiments in which SOD (35 u mh^) produced an immediate 
reversal of the potentiation of PE-induced tone produced by HX/XO. 
Furthermore, the increase in PE-induced tone was not seen if the tissues were 
pretreated with SOD (250 u mh'l). These results are therefore consistent with 
the previously reported endothelium-dependent vasoconstrictor action of 
superoxide anion (Katusic & Vanhoutte, 1989; Ohistein & Nichols, 1989) 
mediated through destruction of basal NO.
These experiments were complicated by the fact that superoxide anion 
generating systems also give rise to other reactive species. Indeed, HX/XO 
was seen to produce a secondary effect, consisting of a delayed (about 5 min) 
fall in tone which was seen in both endothelium-containing and endothelium- 
denuded rings. It was thought likely that this relaxation resulted from the 
spontaneous dismutation of superoxide anion to form hydrogen peroxide. This, 
in fact, was confirmed with the use of catalase (CAT) which removes hydrogen 
peroxide by converting it to water and oxygen (Halliwell & Gutteridge, 1989;
Cheeseman & Slater, 1993) as follows:
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CAT
2 H 2 O 2  ->  2 H 2 O  + O 2
Specifically, we found that the delayed relaxant action of HX/XO in both 
endothelium-containing and endothelium-denuded rings was abolished by the 
addition of catalase, confirming the involvement of hydrogen peroxide. 
Moreover, in presence of catalase (3000 u ml“"'), HX/XO was seen to produce 
only one effect; an immediate and sustained rise in PE-induced tone in 
endothelium-containing but not endothelium-denuded rings. Hydrogen 
peroxide is known to promote relaxation by two means, i.e. via an increased 
production of NO (Gryglewski et al., 1986b) and by a direct effect on vascular 
smooth muscle (Burke & Wolin, 1987; Furchgott, 1991; Zembowicz et al., 
1993).
Since both superoxide anion and hydrogen peroxide are present and, provided 
there is a sufficient source of ferric iron, it is possible that hydroxyl radicals 
could also be formed by the Fenton reaction (Cross et al., 1987; Halliwell & 
Gutteridge, 1989) as follows;
Fe^^ + *02“ Fe^^ + O2 
Fe2+ + H2O2 -> Fe3+ + "OH + OH"
Also, it is feasible that endothelial NO reacts with superoxide anion to 
generate peroxynitrite anion which itself is a powerful oxidant and which can 
also lead to formation of hydroxyl radical by an iron-independent pathway 
(Beckman et al., 1990) as shown below.
NO* + *02“ ONOO"
ONOO- + H+ ONOOH
ONOOH *OH + *N02
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These reactive oxygen species generated from superoxide anion can damage 
the endothelium and thereby impair endothelium-dependent relaxations 
(Kvietys et al., 1989; Beckman et al., 1990; Todoki et al., 1992; Dowell et al., 
1993). Since we wished to examine specifically the interaction between NO 
and superoxide anion, catalase (3000 u ml""!) was included in all experiments 
in order to remove hydrogen peroxide.
A major novel finding of this study was that despite almost completely blocking 
basal activity of NO, as indicated by the profound enhancement of PE-induced 
tone in endothelium-containing rings, HX (0.1 mM)/XO (16 mu mh^) had no 
effect on the relaxation produced by ACh at any concentration. Thus, these 
results suggest a greater sensitivity of basal than ACh-stimulated activity of 
NO to destruction by superoxide anion.
8.1.3 Effects of pyrogallol on basal and ACh-stimulated  
activity of NO
Pyrogallol is known to generate superoxide anion by autooxidation. It is 
believed to autooxidise to its semiquinone which then reacts reversibly with 
oxygen to form quinone and superoxide anion (Halliwell & Gutteridge, 1989). 
We utilised pyrogallol as another source of superoxide anion, to determine if it 
affected basal and ACh-stimulated activity of NO in a similar way to HX/XO.
Like HX/XO, pyrogallol (0.1 mM) produced an immediate and profound rise in 
PE-induced tone in endothelium-containing rings of rat aorta. However, unlike 
with HX/XO exogenous SOD (250 u mh^) only partially reversed the 
augmentation of tone by pyrogallol, suggesting that only part of this rise 
(approx. 26 %) is mediated through generation of superoxide anion. Also 
unlike HX/XO, which enhanced PE-induced tone in endothelium-containing
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rings only, pyrogallol also augmented tone in endothelium-denuded rings. 
However, the rise obtained was less than that obtained in endothelium- 
containing rings. The origin of endothelium-independent augmentation of tone 
by pyrogallol is unclear, but it is unrelated to the ability of the drug to generate 
superoxide anion since it was unaffected by SOD (250 u ml-1). The 
endothelium-dependent component is, however, likely to be due to the 
destruction of basal NO by superoxide anion.
Like HX/XO, pyrogallol also produced a delayed (about 5 min) fall in tone in 
both endothelium-containing and endothelium-denuded rings which was 
blocked by catalase and is therefore likely to have resulted from the build up of 
hydrogen peroxide. In view of this, all subsequent experiments were 
conducted in the presence of catalase (3000 u ml"^) to prevent the 
accumulation of hydrogen peroxide.
The effects of pyrogallol were then assessed on ACh-induced relaxation. In 
common with HX (0.1 mM)/XO (16 mu mh^), pyrogallol (0.1 mM), despite 
substantially blocking basal activity of NO, had no effect on ACh-induced 
relaxation at any concentration in endothelium-containing rings.
Thus, the results obtained with HX/XO and pyrogallol, together with those 
demonstrating SOD-induced relaxation, clearly highlighted a greater sensitivity 
of basal than agonist-stimulated activity of NO to destruction by superoxide 
anion. What was less clear at this stage, however, was whether the data 
suggested a chemical difference between basal and agonist-stimulated NO. 
Indeed, it has been hypothesised that EDRF is a mixture of NO and a stable 
NO-releasing molecule such as an S-nitrosothiol (Myers et al., 1990). 
Specifically, it has been proposed that basal EDRF is free NO whereas the 
enhanced formation of EDRF elicited by endothelium-dependent relaxants
such as ACh may be attributed to Ca2+-dependent exocytosis of recently
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formed S-nitrosothiol (Myers et al., 1990; Ignarro, 1991; Cooks & Angus,
1991). Furthermore, Kukreja et al. (1993) compared the effects of NO and S- 
nitrosocysteine on cerebral arteriolar caliber in relation to the associated 
increment in nitrite concentration in the effluent and concluded that S- 
nitrosocysteine resembled EDRF more closely than did authentic NO.
Although our results, so far, indicated a difference in the susceptibility of basal 
and ACh-stimulated NO to destruction by superoxide anion, it was not yet 
clear if the difference was absolute or one of degree. Consequently, the level 
of superoxide anion generation was increased by employing higher 
concentrations of HX/XO and pyrogallol and the effects on ACh-induced 
relaxation were examined.
8.1.4 Effects of higher concentration of HX/XO and pyrogallol 
on ACh-induced relaxation
Increasing the concentration of HX to 1 mM (keeping XO at 16 mu mb'!) and 
pyrogallol to 0.3 mM, however, now led in each case to a profound blockade of 
ACh-induced relaxation in PE-contracted endothelium-containing rings. In 
addition, the duration of relaxation induced by ACh was affected dramatically; 
in control tissues relaxation to high concentrations of ACh (> 0.1 pM) was 
sustained but in the presence of each of the superoxide generators, relaxation 
was transient. As in previous studies (Wei et al., 1985; Rubanyi & Vanhoutte, 
1986b; Abrahamsson et al., 1992), the inhibition of ACh-induced relaxation 
was likely to have occurred as a consequence of destruction of agonist- 
stimulated NO by superoxide anion. This was confirmed in our experiments in 
which pretreatment with exogenous SOD (250 u ml"'^) completely protected 
against the inhibitory effects of HX/XO or pyrogallol. Thus, it may be 
concluded from these results that the differential sensitivity of basal and
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agonist-stimulated NO Is one of a degree rather than being absolute and that 
higher concentrations of superoxide anion are required to destroy agonist- 
stimulated NO than basal NO. It was still not clear why basal activity of NO 
should be more sensitive to destruction by superoxide anion than agonist- 
stimulated.
8.1.6 Effects of diethyidithiocarbamate on basal and ACh- 
stimulated activity of NO
It was possible that the greater sensitivity of basal than ACh-stimulated NO to 
destruction might reflect differential protection by endogenous SOD. This 
hypothesis was tested by inhibiting the enzyme.
Mammalian cells contain two major forms of SOD; a Cu-Zn-containing form 
which is located both extracellularly and intracellularly and a Mn-containing 
form which resides mainly in the mitochondria (Hassan, 1988). Cu-Zn SOD, 
but not Mn-SOD, is irreversibly inactivated by diethyidithiocarbamate (DETCA, 
Heikkila etal., 1976; Cocco et al., 1981; Halliwell & Gutteridge, 1989). DETCA 
irreversibly binds Cu at the active site and removes the metal from the 
enzyme. The copper ion appears to function in the enzymic reaction, whereas 
the zinc stabilises the enzyme (Taniguchi, 1992). DETCA inhibits Cu-Zn SOD 
both intracellularly and extracellularly (Kelner et al., 1989), leading to 
increased levels of superoxide anion, as detected by lucigenin-eiicited 
chemiluminescence (Cherry et al., 1990; Omar et al., 1991). Previous studies 
have shown that treatment of cultured endothelial cells in a cascade bioassay 
with DETCA leads to loss of NO activity and this was likely to have resulted 
from destruction rather than reduced synthesis of NO since the release of total 
nitrogen oxides, as measured by chemiluminescence, was unaffected (Mügge 
etal., 1991b).
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In this study, we found that treatment with DETCA (0.1 mM) for 1h followed by 
extensive washing, to remove any non-specific effects of the drug, enhanced 
the sensitivity of endothelium-containing rings to PE. Furthermore, L-NMMA 
(30 pM) which would ordinarily augment PE-induced tone in endothelium- 
containing rings through blocking synthesis of basal NO, failed to do so in 
DETCA-treated tissues. The effects of pretreatment with DETCA were also 
studied on endothelium-denuded rings. In contrast to the augmentation of tone 
in endothelium-containing rings, DETCA had no effect on the sensitivity of 
endothelium-denuded rings to PE. Thus, the augmentation of PE-induced tone 
in DETCA-treated, endothelium-containing tissues was likely to have occurred 
from the complete loss of basal activity of NO.
The restoration of basal activity of NO following addition of exogenous SOD 
(Cu-Zn-containing isoform from bovine erythrocytes, 250 u mb'!) to DETCA- 
treated tissues, albeit reduced in comparison to control tissues, indicates that 
the loss had occurred as a consequence of destruction by the greater steady- 
state levels of superoxide anion. Thus, the effects of DETCA suggest that 
endogenous Cu-Zn SOD plays a vital role in protecting basal activity of NO 
from destruction by superoxide anion. Furthermore, in these experiments 
where treatment with DETCA had led to a complete loss of basal activity of 
NO, ACh-induced relaxation was blocked only slightly, further strengthening 
the view that basal and agonist-stimulated activity are differentially sensitive to 
destruction by superoxide anion.
Others have reported that increasing the concentration of DETCA above 0.1 
mM can lead to almost complete loss of ACh-induced relaxation (Mügge et al., 
1991b; Omar et al., 1991) and we indeed confirmed this. We found that 
DETCA (0.1-3 mM, 1h, followed by washout) produced a concentration- 
dependent inhibition of ACh-induced relaxation. We also investigated the
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ability of exogenous SOD (250 u ml"^) to reverse the inhibitory effect of 
DETCA on ACh-induced relaxation and found that it could not. This might 
suggest that this particular action of DETCA occurs by an action independent 
of inhibition of SOD. Alternatively, it has been concluded that this action 
results from the ability of DETCA to inhibit intracellular Cu-Zn SOD (Mügge et 
al., 1991b; Omar et al., 1991), the activity of which cannot be restored by the 
membrane impermeant nature of exogenous SOD. Consistent with this 
proposed intracellular site of action is the ability of DETCA to inhibit relaxations 
induced by nitrovasodilators such as glyceryl trinitrate and nitroprusside, which 
promote relaxation through the generation of NO inside smooth muscle cells 
(Omar et al., 1991). Only by restoring intracellular SOD activity and examining 
whether relaxation is restored will definitive proof of the proposed intracellular 
actions of DETCA be obtained. This could be achieved by using membrane 
permeant forms of SOD such as polyethylene glycol-conjugated SOD (Liu et 
al., 1989), liposome encapsulated SOD (Freeman et al., 1985) or low 
molecular weight SOD-iike mimetics such as tiron (Pagano et al., 1993). To 
date, however, this has not been attempted.
In this study we reasoned that if Cu-Zn SOD was important in protecting 
agonist-stimulated activity of NO then its inactivation with DETCA would be 
expected to potentiate the inhibitory effects of the superoxide generators, 
HX/XO and pyrogallol. Consequently, experiments were carried out to 
investigate the effects of DETCA on the ability of HX/XO and pyrogallol to 
inhibit ACh-induced relaxation. In our experiments we found that following 
pretreatment with a low concentration of DETCA (0.1 mM, 1h, followed by 
washout), subsequent treatment with concentrations of HX (0.1 mM)/XO (16 
mu ml"”!) or pyrogallol (0.1 mM) that had no effect on ACh-induced relaxation 
by themselves in control tissues each now produced profound blockade of 
relaxation. It was likely that these inhibitions had occurred as a consequence
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of elevated levels of superoxide anion since they were blocked following 
pretreatment with exogenous SOD (250 u ml"”^ ). Clearly, therefore, 
endogenous Cu-Zn SOD protects agonist-stimulated NO from destruction by 
superoxide anion and this can be abolished following treatment with DETCA. 
Moreover, since exogenous SOD, which cannot enter cells, fully restores ACh- 
induced relaxation in DETCA-treated tissues, it is likely that the enhanced 
blocking ability of HX/XO and pyrogallol results from inhibition of extracellular 
SOD. With HX/XO this is not surprising since XO too is unable to enter cells 
due to its large size and is therefore only likely to generate superoxide anion 
extracellularly. Pyrogallol on the other hand can enter cells and is likely to 
generate superoxide anion both extracellularly and intracellularly via 
autooxidation (Halliwell & Gutteridge, 1989).
It is not easy to account for the greater apparent sensitivity of basal over 
agonist-stimulated activity of NO to destruction by superoxide anion. Our 
proposed explanation, however, is that under normal circumstances, 
endogenous Cu-Zn SOD activity lowers levels of superoxide anion, which may 
originate from endothelial cells or from the oxygenated Krebs' solution, to such 
an extent that only the low levels of NO produced under basal conditions can 
be destroyed but high levels produced following stimulation by ACh cannot. 
However, if the levels of superoxide anion are increased further, either by 
generation of the free radical or by reducing its breakdown by inhibiting Cu-Zn 
SOD with DETCA, the higher levels of NO produced following agonist 
stimulation can now be destroyed. This explanation may also account for the 
inability of exogenous SOD to potentiate agonist-stimulated activity of NO in 
arterial rings (Abrahamsson et al., 1992; Mian & Martin, 1995a), since there is 
already sufficient endogenous SOD present. In contrast, SOD is probably able 
to potentiate the activity of basal and agonist-stimulated NO in a cascade 
bioassay system (Gryglewski et al., 1986b; Rubanyi & Vanhoutte, 1986a)
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because there is no SOD in the intervening space to protect it from the 
destructive action of superoxide anion.
In conclusion, our findings suggest that both basal and agonist-stimulated 
activity of NO can be destroyed by superoxide anion. The apparently greater 
sensitivity of the former may not necessarily indicate a chemical difference 
from agonist-stimulated NO but may simply reflect differences in 
concentration. Furthermore, the importance of the extracellular form of Cu-Zn 
SOD in protecting endothelial NO was firmly established, whereas only 
circumstantial evidence for the importance of the intracellular form of the 
enzyme was obtained.
8.2 Role of catalase In relaxations induced by 
hydrogen peroxide and nitrovasodilators
As already discussed above, it was clearly established that the delayed 
relaxant effect of superoxide anion generators in rat aorta is mediated by 
hydrogen peroxide since exogenously added catalase blocks this effect.
It is also well established that hydrogen peroxide induces vascular relaxation 
by both endothelium-dependent and endothelium-independent mechanisms. 
The endothelium-dependent component is thought to be mediated via 
enhanced synthesis of NO, whilst the endothelium-independent component is 
due to a direct stimulatory effect on smooth muscle soluble guanylate cyclase 
(Burke & Wolin, 1987; Furchgott, 1991; Zembowicz et al., 1993). The 
mechanism by which hydrogen peroxide stimulates soluble guanylate cyclase 
is not fully elucidated but it has been proposed to occur through a process 
dependent upon the metabolism of hydrogen peroxide by catalase (Burke & 
Wolin, 1987; Wolin & Burke, 1987). Specifically, these authors have proposed
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that the active species is compound I, i.e. the catalase-hydrogen peroxide 
complex formed as an intermediate in the conversion of hydrogen peroxide to 
H2O and O2 .
Catalase not only promotes the decomposition of hydrogen peroxide (Chance 
et al., 1952), but also exhibits peroxidase activity, i.e. it catalyses the 
oxidation of various substrates in the presence of low concentrations of 
hydrogen peroxide (Keilin & Hartree, 1945; Theorell & Ehrenberg, 1952; 
Nicholls, 1964). Two well characterised substrates for peroxidation are sodium 
azide and hydroxylamine which undergo oxidation to nitrous oxide, nitrogen 
and NO (Theorell & Ehrenberg, 1952; Keilin & Hartree, 1954; Nicholls, 1964). 
The NO thus produced is believed to underly the ability of sodium azide and 
hydroxylamine to activate soluble guanylate cyclase and promote vascular 
relaxation (Katsuki etal., 1977; Waldman & Murad, 1987; Murad, 1994).
In this part of the study we utilised an inhibitor of catalase, 3-amino~1,2,4- 
triazole (AT, Heim et al., 1956; Margoliash & Novogrodsky, 1958) which acts 
by binding to compound I thereby Inhibiting catalytic activity, in rat aorta to test 
the hypothesis that metabolism by catalase is necessary to express the 
relaxant activity of hydrogen peroxide, sodium azide and hydroxylamine. For 
comparison, the effects of AT were also examined on relaxation produced by 
another nitrovasodilator, glyceryl trinitrate which is converted to NO not by 
catalase but by glutathione-S-transferase (Armstrong et al., 1980) or 
cytochrome P450 (Schroder, 1992), or by a direct reduction by tissue thiols 
(Feelisch, 1991).
8.2.1 Hydrogen peroxide-induced relaxations in endothelium- 
containing and endothelium-denuded rings and the role of 
catalase
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We examined the nature of hydrogen peroxide-induced relaxation prior to 
addressing the more complex topic of the role of catalase. We found that low 
concentrations (100 nM-30 pM) of hydrogen peroxide selectively produced 
concentration-dependent relaxation in endothelium-containing rings. Hydrogen 
peroxide also relaxed endothelium-denuded rings, but in these higher 
concentrations (0.1-1 mM) were required to produce relaxation. These results 
indicate that in rat aorta, the relaxation induced by hydrogen peroxide has 
endothelium-dependent and endothelium-independent components, and are 
thus consistent with previous studies (Furchgott, 1991; Zembowicz et al., 
1993).
The effects of scavengers of hydrogen peroxide and superoxide anion, i.e. 
catalase and SOD, respectively, were investigated on the relaxations induced 
by hydrogen peroxide. As expected, hydrogen peroxide-induced relaxations in 
both endothelium-containing and endothelium-denuded rings were significantly 
reduced if the tissues had been pretreated with catalase (1000 or 3000 u ml" 
'^ ). In contrast, SOD (50 u mb'!) did not change the relaxant activity of 
hydrogen peroxide in either endothelium-containing or endothelium-denuded 
rings, confirming that hydrogen peroxide, but not other reactive oxygen 
species such as superoxide anion, is involved in these relaxations.
The effects of the NO synthase inhibitor, L-NAME (Rees et al., 1990a), were 
investigated in order to determine if NO, derived from L-arginine/NO pathway, 
mediated the endothelium-dependent component of hydrogen peroxide- 
induced relaxation. The results of these experiments were clear; pretreatment 
of endothelium-containing rings with L-NAME (30 pM) abolished endothelium- 
dependent component of hydrogen peroxide-induced relaxation. Furthermore, 
the inhibitory action of L-NAME on relaxation induced by hydrogen peroxide at 
low concentrations (100 nM-30 pM) was prevented in the presence of the
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substrate for NO synthesis, L-arginine (2 inM). These results supported the 
conclusion of earlier studies that the endothelium-dependent component is 
mediated via enhanced production of NO (Furchgott, 1991; Zembowicz et al., 
1993). In contrast, L-NAME had no effect on relaxations induced by hydrogen 
peroxide (0.1-1 mM) in endothelium-denuded rings, indicating that this occurs 
via a mechanism that is independent of NO. Addition of hydrogen peroxide to 
both endothelium-containing and endothelium-denuded rings was seen to elicit 
a biphasic response: a brief contraction which was more pronounced for 
concentrations >0 . 1  mM followed by a powerful sustained relaxation. A 
previous study (Zembowicz et al., 1993) observed this effect only in 
endothelium-containing rings of rabbit aorta, and reported that L-NAME 
abolished it. In our experiments, however, we found L-NAME to have 
absolutely no effect. The mechanism by which hydrogen peroxide induces 
these contractions is not clear, but it has been proposed that it may involve 
activation of a serine esterase and/or phospholipase C (Sheehan et al., 1993).
In order to investigate the mechanism by which hydrogen peroxide produces 
vascular relaxation, the effects of an inhibitor of soluble guanylate cyclase, 
methylene blue (MeB, Gruetter et al., 1979; Holzmann, 1982; Martin et al., 
1985a), were examined. In contrast to L-NAME, MeB (30 pM) blocked 
relaxations induced by hydrogen peroxide in both endothelium-containing and 
endothelium-denuded rings. Thus, both the endothelium-dependent and 
endothelium-independent components appear to depend upon the stimulation 
of soluble guanylate cyclase. This conclusion is supported by a previous study 
(Zembowicz et al., 1993) showing the ability of hydrogen peroxide to enhance 
the levels of cGMP in both endothelium-containing and endothelium-denuded 
rings of rabbit aorta. In any event, the endothelium-dependent component 
mediated via NO, would be expected to occur via elevation of cGMP. 
Furthermore, biochemical studies have shown that low concentrations of
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hydrogen peroxide activate soluble guanylate cyclase in tissue homogenates, 
although higher concentrations lead to inhibition of the enzyme (White et al., 
1976), presumably as a result of its oxidant actions, thus mimicking the well 
characterised inhibitory actions of the oxidants, MeB and potassium 
ferricyanide (Gruetter ef a/., 1979; Holzmann, 1982). The mechanism by which 
hydrogen peroxide stimulates soluble guanylate cyclase remains obscure, but 
the ability of catalase to potentiate this action has led to the suggestion that an 
Intermediate in its metabolism, perhaps compound I (i.e. the catalase- 
hydrogen peroxide complex), is the active species (Burke & Wolin, 1987; 
Wolin & Burke, 1987). Consistent with this hypothesis is the inhibition of 
hydrogen peroxide-induced relaxation of bovine pulmonary artery by ethanol 
(Burke-Wolin & Wolin, 1990), which decreases formation of the compound I 
species of catalase. It was therefore possible that the mechanism of 
endothelium-independent relaxation induced by hydrogen peroxide in rat aorta 
also involved the catalase-dependent activation of soluble guanylate cyclase. 
Consequently, we attempted to test the role of catalase by employing AT, an 
established inhibitor of this enzyme which acts irreversibly by binding to 
compound I (Heim etal., 1956; Margoliash & Novogrodsky, 1958).
The experiments with AT were complicated by the fact that it produced 
powerful concentration-dependent relaxation of PE-contracted endothelium- 
denuded rings. In order to investigate if the relaxation induced by AT (1-100 
mM) was due to activation of soluble guanylate cyclase, the effects of MeB 
were studied. MeB (30 pM), however, had no effect on the relaxant activity of 
AT, suggesting that it is unlikely to be mediated via stimulation of soluble 
guanylate cyclase.
In order to establish the conditions necessary for optimum inhibition of 
endogenous catalase, a series of experiments was conducted using AT to
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inhibit exogenous catalase (bovine liver). Pretreatment of endothelium- 
denuded rings with catalase (1000 u ml""!) for 30 min led to a profound 
reduction in the maximal relaxation induced by hydrogen peroxide. When the 
catalase inhibitor, AT (50 mM, Heim ef al., 1956; Margoliash & Novogrodsky, 
1958), was present together with catalase during the 30 min incubation, the 
ability to inhibit hydrogen peroxide-induced relaxation was partially blocked (by 
48.8 ± 3.0 %). Increasing the incubation period to 90 min, however, led to 
complete blockade of the ability of catalase to inhibit hydrogen peroxide- 
induced relaxation. From these results it was concluded that AT does indeed 
inhibit the activity of catalase and that the onset of inhibition is slow. This slow 
onset of action is supported by previous studies and is thought to result from 
the ability of AT to bind to the intermediate compound I, which will exist only at 
low concentration, rather than to catalase (Heim et al., 1956; Margoliash & 
Novogrodsky, 1958).
Having established the ability of AT to inhibit exogenous catalase, we felt 
confident to address the proposed role of catalase in hydrogen peroxide- 
induced relaxation in endothelium-denuded rings. In fact, in our experiments, 
treatment with AT (50 mM, 90 min) to inhibit endogenous catalase failed to 
have any effect on hydrogen peroxide-induced relaxation of rat aortic rings. 
Contrary to previous reports (Burke & Wolin, 1987; Wolin & Burke, 1987; 
Burke-Wolin & Wolin, 1990), our findings thus suggested that metabolism of 
hydrogen peroxide or formation of compound I is not required for expression of 
the relaxant activity of hydrogen peroxide. An alternative explanation is 
therefore required to account for the requirement for catalase in the activation 
of soluble guanylate cyclase by hydrogen peroxide (Burke & Wolin, 1987; 
Wolin & Burke, 1987; Burke-Wolin & Wolin, 1990). Although speculative at this 
stage, in view of the dual actions of hydrogen peroxide, i.e. stimulant at low 
concentrations and inhibitory at high concentrations (White et al., 1976), it is
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possible that catalase, by destroying hydrogen peroxide, will lower its 
concentration to such an extent that only the stimulant and not the inhibitory 
actions are seen. Such a conclusion rests heavily on our assumption that AT 
did indeed inhibit Intracellular catalase in rat aorta and evidence to support this 
was sought by examining the effects of the agent on relaxation induced by a 
range of nitrovasodilators.
8.2.2 Vasodilator actions of sodium azide, hydroxylamine and 
glyceryl trinitrate
The three nitrovasodilators employed, sodium azide, hydroxylamine and 
glyceryl trinitrate all produced powerful, concentration-dependent relaxation in 
endothelium-denuded rings of rat aorta. It is well established that the relaxant 
actions of these nitrovasodilators proceed through activation of soluble 
guanylate cyclase and elevation of smooth muscle cGMP content (Arnold et 
al., 1977; Katsuki et al., 1977; Waldman & Murad, 1987; Murad, 1994). 
Consistent with this view was our ability to inhibit relaxation by all three 
nitrovasodilators using MeB, an inhibitor of soluble guanylate cyclase (Gruetter 
etal., 1979; Holzmann, 1982; Martin etal., 1985a).
In order for the nitrovasodilators to stimulate soluble guanylate cyclase they 
must first must be chemically modified to yield the active principle, NO (Katsuki 
etal., 1977; Waldman & Murad, 1987; Murad, 1994). For glyceryl trinitrate, this 
has been proposed to occur via metabolism by glutathione-S-transferase 
(Armstrong et al., 1980) or cytochrome P450 (Schroder, 1992), or by a direct 
reduction by tissue thiols (Feelisch, 1991). In contrast, the seminal work of 
Murad and his colleagues (Mittal et al., 1975) showed that the activation of 
soluble guanylate cyclase in tissue homogenates by sodium azide and 
hydroxylamine required the presence of high molecular weight factors, later
identified as catalase and other peroxidase enzymes (Miki et al., 1976).
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Although biochemical evidence supporting the role of catalase in the activation 
of soluble guanylate cyclase by sodium azide and hydroxylamine is strong 
(Miki et al., 1976; Katsuki et al., 1977; Craven et al., 1979), direct proof of the 
involvement of this enzyme in vascular relaxation is lacking. We reasoned that 
if endogenous catalase is important in mediating relaxation induced by sodium 
azide and hydroxylamine then its inactivation with AT will be expected to 
Inhibit the relaxant effect of these agents.
8.2.3 Effects of AT on relaxations induced by sodium azide, 
hydroxylamine and glyceryl trinitrate
We found that pretreatment of endothelium-denuded rings with AT (1-50 mM) 
for 30, 60 and 90 min produced a concentration- and time-dependent inhibition 
of the relaxation induced by sodium azide. Incubation for 90 min was found to 
be the most effective in inhibiting sodium azide-induced relaxation and this is 
consistent with our previous results demonstrating the slow inhibition of 
exogenous catalase by AT. These data thus suggest a role for endogenous 
catalase in this relaxation. Similarly, pretreatment of endothelium-denuded 
rings with AT (5-50 mM) for 90 min shifted the concentration-response curve 
for hydroxylamine to the right in a concentration-dependent manner. The 
action of AT on relaxation induced by sodium azide and hydroxylamine was 
highly selective since relaxation induced by glyceryl trinitrate was completely 
unaffected, consistent with its metabolism by a separate pathway (Armstrong 
etal., 1980; Feelisch, 1991; Schroder, 1992).
Although AT at all concentrations tested inhibited the relaxant actions of both 
sodium azide and hydroxylamine, it inhibited the actions of the former more 
powerfully than the latter. The maximum shifts in EC50 values for sodium 
azide and hydroxylamine obtained with AT at 50 mM were 1668-fold and 190-
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fold, respectively. Despite this difference, sodium azide and hydroxylamine 
were almost equipotent as relaxants of rat aorta. These results perhaps 
suggest a possible additional catalase-independent activation pathway for the 
latter agent. Nevertheless, the ability of AT to inhibit relaxation induced by 
sodium azide and hydroxylamine provides firm evidence that the agent does 
indeed inhibit endogenous catalase in rat aorta. This finding thus strengthens 
our conclusion (section 8 .2 .1) that endogenous catalase is not involved in the 
relaxant actions of hydrogen peroxide.
In a related theme, It has been proposed that hydroxylamine may be 
generated as an intermediate in the endothelial production of NO from L- 
arginine (DeMaster et al., 1989; Schmidt et al., 1990). This raised the 
possibility that the last step in the formation of NO by endothelium might 
involve the metabolism of hydroxylamine by endogenous catalase. We tested 
this hypothesis by studying the effects of inhibiting endogenous catalase with 
AT on endothelium-dependent relaxation induced by ACh in rat aortic rings. 
We found, however, that AT (50 mM, 90 min) had absolutely no effect on ACh- 
induced relaxation, thus arguing against the above proposal. These 
experiments do, however, provide further support for the selectivity of AT in 
blocking relaxation induced by sodium azide and hydroxylamine.
In the above experiments we have established the role of catalase in 
relaxations induced by two powerful nitrovasodilators, sodium azide and 
hydroxylamine. It has been proposed that conversion of sodium azide and 
hydroxylamine to NO requires the presence of low concentrations of hydrogen 
peroxide and thus occurs as a consequence of the peroxidase activity of 
catalase (Theorell & Ehrenberg, 1952; Keilin & Hartree, 1954; Nicholls, 1964; 
Klebanoff & Nathan, 1993). Consequently, we investigated the role of catalase 
further by adopting a more direct approach, i.e. by measuring the production of
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sNO from sodium azide, hydroxylamine and glyceryl trinitrate. In these 
experiments, NO production was assessed by measuring the formation of 
nitrite, its major stable in vitro product (Stuehr & Marietta, 1987a,b). A series of 
experiments was carried out to establish suitable reagent concentrations,
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reaction conditions and an appropriate time-course for the generation of nitrite. %
8.2.4 Measurement of nitrite formation from sodium azide, 
hydroxylamine and glyceryl trinitrate
The Greiss reaction has been widely used to establish an assay for measuring 
accumulation of nitrite in biological systems. The assay is based on If
diazotization, where NO, generated from acidified nitrite, combines with 
sulphanilic acid and the resulting diazo product couples with N-(l-naphthyl)- 
ethylenediamine to produce an intense pink colour (Green et a!., 1982). In this 
study, neither hydrogen peroxide (1 mM) nor catalase (1000 u mb'!) was found 
to lead to formation of nitrite from sodium azide during a 60 min incubation. In 
contrast, when all three were present in combination, a rapid development of 
pink colour (measured quantitatively at 550 nm) was observed indicating that 
nitrite was being produced from sodium azide. The production, in fact, 
appeared to be almost linear during the 60 min incubation suggesting a simple 
one-step enzymic reaction, unaffected by substrate depletion. Our finding that 
catalase catalysed the formation of nitrite from sodium azide only in the 
presence of hydrogen peroxide suggested that the reaction occurred by the 
peroxidase activity of the enzyme, and is consistent with previous studies
(Theorell & Ehrenberg, 1952; Keilin & Hartree, 1954; Nicholls, 1964; Klebanoff ;
:!& Nathan, 1993). i
comparison with sodium azide and hydroxylamine.
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A recent study (Markert et al., 1994) failed to detect nitrite formation from 
hydroxylamine by catalase in the presence of hydrogen peroxide, but under 
the conditions of our experiments (higher concentrations of hydroxylamine, 
catalase and hydrogen peroxide), we found that it could indeed act as a 
substrate. The maximum levels of nitrite generated, however, were lower (8.7 
± 0.7 pM) than those obtained from sodium azide (23.4 ± 0.6 pM). An attempt 
was made to determine if the levels of nitrite generated from hydroxylamine 
could be increased by increasing the concentration of hydrogen peroxide. In 
these experiments, increasing the concentration of hydrogen peroxide from 1 
mM to 100 mM increased slightly the levels of nitrite generated (10.0 ± 0.1 
pM), but these were still less than those obtained using sodium azide, 
suggesting that hydroxylamine is a less effective substrate than sodium azide. 
These findings are consistent with our earlier results demonstrating the greater
inhibition by AT of relaxation induced by sodium azide than by hydroxylamine,
perhaps again suggesting an additional catalase-independent route of 
metabolism of the latter to NO in vascular smooth muscle. I
In contrast to findings with sodium azide and hydroxylamine, no nitrite was 
generated when glyceryl trinitrate (1 mM) was incubated with catalase in the 
presence of hydrogen peroxide, thus highlighting the selectivity of the enzyme. 
Moreover, glyceryl trinitrate (1 mM) but not sodium azide (1 mM) or 
hydroxylamine (1 mM) was reduced to nitrite by the thiol, L-cysteine (3 mM) 
during a 60 min incubation. These findings are therefore consistent with 
distinct pathways for the generation of NO from glyceryl trinitrate in
-I;
8.2.5 Use of the glucose/glucose oxidase system in the 
generation of nitrite from sodium azide and hydroxylamine by 
catalase
The low, sustained generation of hydrogen peroxide by the glucose/glucose 
oxidase system has been reported to be more efficient than a single high 
concentration of hydrogen peroxide in supporting the catalase-dependent 
formation of NO from sodium azide (Klebanoff & Nathan, 1993). 
Consequently, in some experiments the glucose (5 mM)/glucose oxidase (300 
mu ml""') system was utilised and the effects on nitrite formation from sodium 
azide and hydroxylamine by catalase compared with those obtained using a 
high standard concentration (1 mM) of hydrogen peroxide. We found that 
sodium azide (10 pM-3 mM) was converted to nitrite in a concentration- 
dependent manner by catalase in the presence of the glucose/glucose oxidase 
system. Moreover, the maximum concentration obtained with sodium azide at 
0.3 mM was some 2-fold greater (44.5 ± 0.8 pM) if the glucose/glucose 
oxidase system was used instead of hydrogen peroxide. These findings thus 
confirm the greater efficiency of this system over hydrogen peroxide in 
facilitating the catalase-dependent formation of nitrite from sodium azide 
(Klebanoff & Nathan, 1993).
Since hydroxylamine was a poor substrate for nitrite formation by catalase in 
the presence of a fixed concentration of hydrogen peroxide, an attempt was 
made to determine if formation could be increased by replacing hydrogen 
peroxide by the glucose/glucose oxidase system. We found, however, that the 
glucose/glucose oxidase system, despite significantly increasing the catalase- 
dependent formation of nitrite from sodium azide, failed to enhance nitrite 
production from hydroxylamine.
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8.2.6 Effects of AT on catalase-dependent formation of nitrite 
from sodium azide
Our study using AT, an inhibitor of catalase, thus provides direct proof that 
metabolism of sodium azide and hydroxylamine to NO by catalase underlies 
the relaxant actions of these nitrovasodilators. In contrast, our study lends no
So far, we have established that AT inhibits the relaxant action of sodium 
azide and hydroxylamine in rat aorta indicating an important role for
i’iendogenous catalase. Furthermore, we have shown that NO, assessed as
nitrite, can indeed be generated from sodium azide and hydroxylamine by 
catalase in the presence of hydrogen peroxide. Consequently, it was important 
to investigate if the formation of nitrite from sodium azide by catalase could be
blocked by AT. Indeed, we found that AT (0.1-100 mM) produced a
'ÿ.concentration-dependent blockade of the catalase-dependent conversion of 
sodium azide (0.3 mM) to nitrite in the presence of hydrogen peroxide. The I
blockade was only slight during a 1h incubation and the maximum inhibition 
obtained was 36.4 ± 1 . 2  % at 100 mM AT. If, however, the duration of the 
incubation was extended to 3h together with a reduction of the catalase 
concentration (from 1000 to 300 u mh^), the ability of AT to block formation of 
nitrite was enhanced: a maximum inhibition of 77.7 ± 6.3 % was obtained at 
100 mM AT. These results indicate that AT indeed blocks the catalase- 
dependent conversion of sodium azide to nitrite in the presence of hydrogen 
peroxide and that the blockade is slow, consistent with its known slow onset of 
action (Heim etal., 1956; Margoliash & Novogrodsky, 1958).
■ I
:Since hydroxylamine was a poorer substrate than sodium azide, no 
experiments were conducted to determine if AT blocked the catalase- 
dependent formation of nitrite from this agent.
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support to the proposed concept that metabolism of hydrogen peroxide by 
catalase is necessary for expression of its relaxant activity (Burke & Wolin, 
1987; Wolin & Burke, 1987).
8.3 Hydrogen peroxide-induced impairment of vascular 
reactivity of rat aorta
The vascular endothelium is constantly exposed to reactive oxygen species 
including hydrogen peroxide generated from blood cells such as neutrophils, 
platelets and monocytes (Verkerk & Jondkind, 1992). The reaction of 
hydrogen peroxide with membrane lipids of endothelial cells may have 
damaging effects on the vessel wall. Hydrogen peroxide can also exert 
damaging effects on vascular smooth muscle cells (Verkerk & Jondkind,
1992). Endothelial cells and vascular smooth muscle cells, however, are not 
passive in this process of peroxidation. They express endogenous antioxidant 
defence systems such as glutathione peroxidase and catalase to detoxify 
hydrogen peroxide (Halliwell & Gutteridge, 1989; Cheeseman & Slater, 1993).
In this part of the study we investigated the damage induced by hydrogen 
peroxide to vascular responsiveness and explored the role of endogenous 
catalase in protection against this damage. In order to investigate this role of 
endogenous catalase, we again made use of the inhibitor of catalase, AT 
(Heim etal., 1956; Margoliash & Novogrodsky, 1958).
8.3.1 Effects of incubation with hydrogen peroxide on PE- 
induced contraction and endothelium-dependent relaxations
As discussed above (section 8.2.1) we found that incubation with hydrogen 
peroxide (1 mM) resulted in profound relaxation of endothelium-containing and
endothelium-denuded rings of rat aorta. When present for 15, 30 or 60 min
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followed by washout, the ability of the tissues to contract in response to PE 
was severely depressed in a time-dependent manner. This action, in contrast 
to the relaxant action of hydrogen peroxide was not reversed by treatment with 
catalase and was essentially irreversible. It was also not produced by a lower 
concentration of hydrogen peroxide (0.1 mM) which also induces powerful 
relaxation. It has been demonstrated previously that superoxide anion by 
oxidising catecholamines abolishes their contractile effects (Wolin & Belloni, 
1985). It was considered possible therefore that hydrogen peroxide degraded 
PE in our experiments thereby inhibiting its contractile actions. This seems 
unlikely, however, since a recent report (lesaki et a/., 1994) demonstrated that 
PE, unlike noradrenaline and adrenaline, is not degraded by hydrogen 
peroxide. These authors suggested that hydrogen peroxide may reduce 
vasoactive amine-induced contractions of vascular smooth muscle by 
adversely affecting the signal transduction pathways which increase the 
intracellular Ca^+ concentrations of vascular smooth muscle cells (lesaki et 
al., 1994). Furthermore, hydrogen peroxide has been shown to impair 
glycolytic substrate metabolism in cardiac myocytes (Josephson et al., 1991), 
leading to ATP depletion which in turn decreases the ability of cells to respond 
to agonists, as energy is required for cellular activity. Such findings therefore 
suggest that the ability of hydrogen peroxide to depress subsequent 
contraction to PE results from a damaging action of the oxidant.
The effects of incubation with various concentrations of hydrogen peroxide for 
different times were also investigated on the endothelium-dependent 
relaxation of rat aorta induced by ACh. We found that following induction of 
PE-induced tone, incubation of endothelium-containing rings with hydrogen 
peroxide (0.1 mM) for 15, 30 or 60 min followed by washout and re-contraction 
with PE, failed to produce any apparent damage to ACh-induced relaxation. In 
contrast, incubation with a higher concentration (1 mM) of hydrogen peroxide
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Ifor 15, 30 or 60 min followed by washout, did produce powerful effects on 
ACh-induced relaxation. Specifically, we found that incubation with hydrogen 
peroxide (1 mM) for 15 min, followed by washout, led to an unexpected 
potentiation of relaxation at each concentration of ACh. This potentiation, 
however, was not sustained as was evident from a second concentration- 
response curve to ACh constructed after 2h in the same tissue. This second 
concentration-response curve to ACh, in fact, demonstrated a substantial 
blockade of relaxation. Thus, the initial potentiation appeared to be a prelude 
to more permeant blockade by hydrogen peroxide. In contrast to the short 
exposure, incubation of endothelium-containing rings with hydrogen peroxide 
(1 mM) for 30 or 60 min, followed by washout, led to ACh-induced relaxation 
being greatly inhibited. As expected, pretreatment with catalase (3000 u mh'^) 
completely prevented the ability of hydrogen peroxide to initially increase and 
then impair ACh-induced relaxation. In contrast, once blockade was 
established it could not be reversed either by washing or by subsequent 
treatment with catalase. These findings thus demonstrate an overall 
concentration- and time-dependent, and essentially irreversible impairment of 
endothelium-dependent relaxation by hydrogen peroxide.
In view of the ability of hydrogen peroxide to depress contraction to PE (see 
above), it was not clear if the depression of ACh-induced endothelium- 
dependent relaxation resulted from damage to the endothelium or vascular 
smooth muscle, but evidence from the literature does show clear impairment 
of endothelial function by hydrogen peroxide. For example, work from our own 
laboratory has shown that hydrogen peroxide impairs the barrier function of 
porcine aortic endothelial monolayers (Berman & Martin, 1993). It has been 
proposed that hydrogen peroxide acts by rapidly diffusing into cells where it 
comes into contact with Fe2+ resulting in the formation of hydroxyl radicals 
which may finally be responsible for endothelial cell damage (Kvietys et al.,
2 1 8
1989). This, however, was not found to be the case for porcine endothelial 
monolayers (Berman & Martin, 1993), since catalase which removes hydrogen 
peroxide but not scavengers of hydroxyl radical such as mannitol and *
dimethylthiourea, was able to protect against the hydrogen peroxide-induced 
impairment of endothelial function.
An alternative explanation proposed for the damaging actions of hydrogen 
peroxide involves actions on intracellular Ca2+ homeostasis. It has been 
reported that exposure of cardiac myocytes (Josephson et al., 1991), renal 
tubular cells (Ueda & Shah, 1992), vascular endothelial cells (Hirosumi et al.,
1988; Franceschi et al., 1990; Geeraerts et al., 1991), and vascular smooth 
muscle cells (Krippeit-Drews et al., 1995) to hydrogen peroxide leads to 
sustained increases in intracellular Ca2+ levels resulting in tissue injury. The 
mechanisms by which these increases in intracellular Ca^+ might cause tissue 
injury include lipid peroxidation (Flirosumi et al., 1988; Geeraerts et al., 1991), 
activation of Ca2+-dependent proteases (Geeraerts et al., 1991), and 
alterations in the cytoskeleton (Hinshaw et al., 1989). Hydrogen peroxide may 
thus have impaired endothelium-dependent relaxation and depressed PE- 
induced contraction via widespread Ca2+-dependent damage to the 
endothelium and the vascular smooth muscle.
The potential role of endogenous catalase in protecting vascular reactivity 
against hydrogen peroxide-induced damage was investigated with the use of 
AT (Heim et al., 1956; Margoliash & Novogrodsky, 1958). In these 
experiments, treatment of endothelium-containing rings with AT (50 mM, 90 
min, followed by washout) alone had no effect on subsequent PE-induced 
contraction showing that the drug did not produce any non-selective action. In 
contrast, this treatment with AT (50 mM, 90 min) potentiated the ability of 
hydrogen peroxide at 1 mM but not at 0.1 mM (present during the final 30 min
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of 90 min incubation, followed by washout) to depress PE-induced contraction. 
This finding indeed suggested a potential role for endogenous catalase in 
protecting vascular smooth muscle cells from damage induced by high (1 mM) 
but not low (0.1 mM) concentrations of hydrogen peroxide .
The effects of inhibiting endogenous catalase with AT together with hydrogen 
peroxide were also examined on ACh-induced relaxation. In these 
experiments, treatment of endothelium-containing rings with AT (50 mM, 90 
min, followed by washout) alone had no effect on ACh-induced relaxation. 
Furthermore, treatment with AT (50 mM, 90 min) together with hydrogen 
peroxide (0.1 mM, present for the final 30 min of 90 min incubation, followed 
by washout) also had no effect on ACh-induced relaxation. These findings 
suggest that endogenous catalase has no role in protection against low 
concentrations of hydrogen peroxide. In contrast, treatment with AT (50 mM, 
90 min) markedly potentiated the ability of hydrogen peroxide at 1 mM 
(present during the final 30 min of 90 min incubation, followed by washout) to 
block ACh-induced relaxation. These results together with those showing 
enhanced impairment of PE-induced contraction by hydrogen peroxide in AT- 
treated tissues clearly suggest an important role for endogenous catalase in 
protecting vascular cells from the effects of high concentrations of hydrogen 
peroxide. Consistent with these findings are previous studies (Cohen & 
Hochstein, 1963; Nicholls, 1972; Jones et al., 1981; Dobrina & Patriarca, 
1986; Verkerk & Jondkind, 1992) demonstrating in many cell types that 
catalase acts as a high capacity, but low affinity scavenger of hydrogen 
peroxide and is more important at high concentrations of the oxidant. They 
also show, in contrast, that glutathione peroxidase acts as a high affinity, low 
capacity scavenger, preferentially metabolising low concentrations of 
hydrogen peroxide.
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8.3.2 Effects of incubation with hydrogen peroxide on endothelium-
independent relaxations
Since it was not clear whether the enhanced ability of hydrogen peroxide to 
impair endothelium-dependent, ACh-induced relaxation of rat aorta following 
treatment with AT was due to endothelial or smooth muscle damage, the 
effects on relaxation induced by the endothelium-independent relaxants, 
glyceryl trinitrate and isoprenaline, were examined. Consistent with the 
findings with ACh, incubation of endothelium-denuded rings with hydrogen 
peroxide (0.1 mM, 30 min, followed by washout) alone, incubation with AT (50 
mM, 90 min, followed by washout) alone, or incubation with AT (50 mM, 90 
min) together with hydrogen peroxide (0.1 mM, present during the final 30 min 
of 90 min incubation, followed by washout) had no effect on relaxations 
induced by glyceryl trinitrate or isoprenaline. In contrast, increasing the 
concentration of hydrogen peroxide to 1 mM (30 min, followed by washout) 
produced a substantial blockade of relaxation induced by glyceryl trinitrate or 
isoprenaline. Furthermore, this blockade by hydrogen peroxide was 
significantly enhanced in tissues in which endogenous catalase had been 
inhibited with AT. The ability of hydrogen peroxide either alone, or in 
combination with AT, to inhibit the endothelium-independent relaxations 
induced by glyceryl trinitrate and isoprenaline clearly suggest a damaging 
action on the vascular smooth muscle.
In conclusion, our findings suggest that the oxidant, hydrogen peroxide, 
produces a non-selective damaging action on the vascular smooth muscle 
resulting in loss of the contractile and relaxant actions. Potentiation of these 
damaging actions by AT is consistent with a role for endogenous catalase in 
protecting vascular smooth muscle function from oxidant damage by hydrogen 
peroxide. The possibility that a component of the impairment of ACh-induced
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relaxation by hydrogen peroxide involved an additional damaging action on the 
endothelium was suspected but not proven.
8.4 General conclusions
Endothelial cells possess the antioxidant machinery necessary to protect 
themselves against toxic reactive oxygen species. In normal situations a 
delicate equilibrium exists between free radical production and these 
antioxidant systems. However, in different pathological processes, such as 
ischemia-reperfusion, atherosclerosis, diabetes, or during inflammatory 
responses, the generation of free radicals is increased and the balance is 
modified, contributing to the endothelial damage associated with these 
processes (Halliwell, 1982; Downey, 1990; Minor ef a/., 1990; Langenstroer & 
Pieper, 1992). Our work with DETCA has established that the extracellular, 
and perhaps also the intracellular isoform of Cu-Zn SOD is important in 
protecting endothelium-derived NO from destruction by superoxide anion. 
These isoforms of SOD are likely to play an important role in many 
pathological conditions where involvement of free radicals has been 
implicated. The ability to restore functional SOD activity would thus be 
expected to offer enormous therapeutic potential in a large number of vascular 
diseases. SOD itself is unsuitable for therapeutic purposes because of its 
large size and inability to enter cells. Consequently, more research needs to 
be focused on the development of low molecular weight, membrane-permeant 
SOD-like agents as therapeutic tools in the treatment of vascular disease. In 
addition, our work with AT has confirmed the important role of endogenous 
catalase in protecting vascular function against the damage induced by the 
oxidant, hydrogen peroxide. The role of endogenous catalase in the 
expression of the relaxant activity of certain nitrovasodilators was also 
established.
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